
<html lang="en"     class="pb-page"  data-request-id="5c735d41-87c8-4bb5-bccd-ddbcb15110dd"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b00462;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2017.60.issue-19;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1" /></meta><meta name="dc.Creator" content="Daniel P.  Mould" /></meta><meta name="dc.Creator" content="Cristina  Alli" /></meta><meta name="dc.Creator" content="Ulf  Bremberg" /></meta><meta name="dc.Creator" content="Sharon  Cartic" /></meta><meta name="dc.Creator" content="Allan M.  Jordan" /></meta><meta name="dc.Creator" content="Matthis  Geitmann" /></meta><meta name="dc.Creator" content="Alba  Maiques-Diaz" /></meta><meta name="dc.Creator" content="Alison E.  McGonagle" /></meta><meta name="dc.Creator" content="Tim C. P.  Somervaille" /></meta><meta name="dc.Creator" content="Gary J.  Spencer" /></meta><meta name="dc.Creator" content="Fabrice  Turlais" /></meta><meta name="dc.Creator" content="Donald  Ogilvie" /></meta><meta name="dc.Description" content="Inhibition of lysine specific demethylase 1 (LSD1) has been shown to induce the differentiation of leukemia stem cells in acute myeloid leukemia (AML). Irreversible inhibitors developed from the no..." /></meta><meta name="Description" content="Inhibition of lysine specific demethylase 1 (LSD1) has been shown to induce the differentiation of leukemia stem cells in acute myeloid leukemia (AML). Irreversible inhibitors developed from the no..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 21, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00462" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00462" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00462" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00462" /></link>
        
    
    

<title>Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00462" /></meta><meta property="og:title" content="Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0021.jpeg" /></meta><meta property="og:description" content="Inhibition of lysine specific demethylase 1 (LSD1) has been shown to induce the differentiation of leukemia stem cells in acute myeloid leukemia (AML). Irreversible inhibitors developed from the nonspecific inhibitor tranylcypromine have entered clinical trials; however, the development of effective reversible inhibitors has proved more challenging. Herein, we describe our efforts to identify reversible inhibitors of LSD1 from a high throughput screen and subsequent in silico modeling approaches. From a single hit (12) validated by biochemical and biophysical assays, we describe our efforts to develop acyclic scaffold-hops from GSK-690 (1). A further scaffold modification to a (4-cyanophenyl)glycinamide (e.g., 29a) led to the development of compound 32, with a Kd value of 32 nM and an EC50 value of 0.67 μM in a surrogate cellular biomarker assay. Moreover, this derivative does not display the same level of hERG liability as observed with 1 and represents a promising lead for further development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00462"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00462">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00462&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00462&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00462&amp;href=/doi/10.1021/acs.jmedchem.7b00462" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 7984-7999</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00467" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00476" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+P.++Mould">Daniel P. Mould</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-6501-4938" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++Alli">Cristina Alli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ulf++Bremberg">Ulf Bremberg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sharon++Cartic">Sharon Cartic</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allan+M.++Jordan">Allan M. Jordan</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-3449-3993" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthis++Geitmann">Matthis Geitmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alba++Maiques-Diaz">Alba Maiques-Diaz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alison+E.++McGonagle">Alison E. McGonagle</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tim+C.+P.++Somervaille">Tim C. P. Somervaille</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary+J.++Spencer">Gary J. Spencer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrice++Turlais">Fabrice Turlais</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald++Ogilvie">Donald Ogilvie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Wilmslow Road, Manchester, M20 4BX, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, University of Manchester, Wilmslow Road, Manchester, M20 4BX, U.K.</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Beactica AB, Uppsala Business Park, Virdings allé 2, 75450, Uppsala, Sweden</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">⊥</span> <span class="aff-text">CRT Discovery Laboratories, Babraham Campus, Babraham, Cambridgeshire CB22 3AT, U.K.</span></div><div class="corresp-info"><strong>*</strong>Phone: +44 (0)161-446-8079. E-mail: <a href="/cdn-cgi/l/email-protection#b9d8d5d5d8d797d3d6cbddd8d7f9dacbccd297d4d8d7dad1dccacddccb97d8da97ccd2"><span class="__cf_email__" data-cfemail="6908050508074703061b0d0807290a1b1c02470408070a010c1a1d0c1b47080a471c02">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00462&amp;href=/doi/10.1021%2Facs.jmedchem.7b00462" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 7984–7999</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 11, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 March 2017</li><li><span class="item_label"><b>Published</b> online</span>21 September 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 October 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00462" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00462</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7984%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDaniel%2BP.%2BMould%252C%2BCristina%2BAlli%252C%2BUlf%2BBremberg%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D19%26contentID%3Dacs.jmedchem.7b00462%26title%3DDevelopment%2Bof%2B%25284-Cyanophenyl%2529glycine%2BDerivatives%2Bas%2BReversible%2BInhibitors%2Bof%2BLysine%2BSpecific%2BDemethylase%2B1%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7999%26publicationDate%3DOctober%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00462"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2696</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">25</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00462" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;P. Mould&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Alli&quot;},{&quot;first_name&quot;:&quot;Ulf&quot;,&quot;last_name&quot;:&quot;Bremberg&quot;},{&quot;first_name&quot;:&quot;Sharon&quot;,&quot;last_name&quot;:&quot;Cartic&quot;},{&quot;first_name&quot;:&quot;Allan&quot;,&quot;last_name&quot;:&quot;M. Jordan&quot;},{&quot;first_name&quot;:&quot;Matthis&quot;,&quot;last_name&quot;:&quot;Geitmann&quot;},{&quot;first_name&quot;:&quot;Alba&quot;,&quot;last_name&quot;:&quot;Maiques-Diaz&quot;},{&quot;first_name&quot;:&quot;Alison&quot;,&quot;last_name&quot;:&quot;E. McGonagle&quot;},{&quot;first_name&quot;:&quot;Tim&quot;,&quot;last_name&quot;:&quot;C. P. Somervaille&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;J. Spencer&quot;},{&quot;first_name&quot;:&quot;Fabrice&quot;,&quot;last_name&quot;:&quot;Turlais&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;Ogilvie&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;7984-7999&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00462&quot;},&quot;abstract&quot;:&quot;Inhibition of lysine specific demethylase 1 (LSD1) has been shown to induce the differentiation of leukemia stem cells in acute myeloid leukemia (AML). Irreversible inhibitors developed from the nonspecific inhibitor tranylcypromine have entered clinical trials; however, the development of effective reversible inhibitors has proved more challenging. Herein, we describe our efforts to identify reversible inhibitors of LSD1 from a high throughput screen and subsequent in silico modeling approaches. From a single hit (12) validated by biochemical and biophysical assays, we describe our efforts to develop acyclic scaffold-hops from GSK-690 (1). A further scaffold modification to a (4-cyanophenyl)glycinamide (e.g., 29a) led to the development of compound 32, with a Kd value of 32 nM and an EC50 value of 0.67 μM in a surrogate cellular biomarker assay. Moreover, this derivative does not display the same level of hERG liability as observed with 1 and represents a promising lead for further development.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00462&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00462" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00462&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00462" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00462&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00462" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00462&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00462&amp;href=/doi/10.1021/acs.jmedchem.7b00462" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00462" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00462" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00462%26sid%3Dliteratum%253Aachs%26pmid%3D28892629%26genre%3Darticle%26aulast%3DMould%26date%3D2017%26atitle%3DDevelopment%2Bof%2B%25284-Cyanophenyl%2529glycine%2BDerivatives%2Bas%2BReversible%2BInhibitors%2Bof%2BLysine%2BSpecific%2BDemethylase%2B1%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D19%26spage%3D7984%26epage%3D7999%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292119" title="Surface plasmon resonance">Surface plasmon resonance</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/jmcmar.2017.60.issue-19/20171012/jmcmar.2017.60.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inhibition of lysine specific demethylase 1 (LSD1) has been shown to induce the differentiation of leukemia stem cells in acute myeloid leukemia (AML). Irreversible inhibitors developed from the nonspecific inhibitor tranylcypromine have entered clinical trials; however, the development of effective reversible inhibitors has proved more challenging. Herein, we describe our efforts to identify reversible inhibitors of LSD1 from a high throughput screen and subsequent in silico modeling approaches. From a single hit (<b>12</b>) validated by biochemical and biophysical assays, we describe our efforts to develop acyclic scaffold-hops from GSK-690 (<b>1</b>). A further scaffold modification to a (4-cyanophenyl)glycinamide (e.g., <b>29a</b>) led to the development of compound <b>32</b>, with a <i>K</i><sub>d</sub> value of 32 nM and an EC<sub>50</sub> value of 0.67 μM in a surrogate cellular biomarker assay. Moreover, this derivative does not display the same level of hERG liability as observed with <b>1</b> and represents a promising lead for further development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66228" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66228" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Lysine specific demethylase 1 (LSD1) was the first histone demethylase to be discovered<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and has been found to play an important role in normal and malignant cells as a transcriptional repressor.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> LSD1 belongs to the FAD-dependent amine oxidase family of demethylases and catalyzes the demethylation of lysine residues of histones,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> specifically H3K4me1/2 and H3K9me1/2.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Aside from this role, it has become clear that LSD1 plays important scaffolding roles as part of the CoREST complex,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> especially in controlling the interaction with transcription factors such as growth factor independence (GFI) 1 and 1b.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> LSD1 and GFI1 in combination appear to balance the regulation of hematopoietic cell proliferation and differentiation in hematopoietic stem and progenitor cells.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> GFI1 interacts with LSD1 through binding of its C-terminal SNAG domain in the active site of LSD1, suggesting that LSD1 inhibitors may induce their phenotype through abrogation of this protein–protein interaction, and the downstream changes in gene expression this effects, rather than by inhibition of histone demethylation.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In addition, it has been established that LSD1 plays a key role in acute myeloid leukemia (AML) driven by mixed lineage leukemia (MLL) fusions,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> whereby overexpression of LSD1 maintains malignant stem and progenitor cells in a self-renewing state. This has helped to establish a novel treatment hypothesis in a hematological malignancy where the standard of care has changed little in the past three decades.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">There is also evidence that LSD1 inhibition could have a beneficial effect in a number of other disease areas. It has been shown that small cell lung cancer cell lines have high levels of LSD1 overexpression in almost all cases and some show sensitivity to LSD1 inhibition in vitro and in tumor xenografts.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The authors suggest a correlation between response and DNA hypomethylation. The consequence of inhibition is similar to AML, in that cells show a differentiation phenotype toward their original neuroendocrine state. LSD1 inhibition has also shown promise for the treatment of herpes simplex infection<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> and memory deficit,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and patents have been filed describing the potential use of LSD1 inhibitors in diseases associated with alterations in protein conformation, such as Alzheimer’s, Parkinson’s, and Huntingdon’s diseases.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> Irreversible inhibitors of LSD1 developed from the clinical monoamine oxidase (MAO) inhibitor tranylcypromine entered clinical trials in 2014. These inhibitors will provide valuable insights into the validation of targeting malignant stem and progenitor cells in AML patients. Preliminary clinical trials data of <i>rel</i>-<i>N</i><sup>1</sup>-[(1<i>R</i>,2<i>S</i>)-2-phenylcyclopropyl]-1,4-cyclohexanediamine (ORY-1001, Oryzon Genomics) has demonstrated promotion of blast cell differentiation in roughly two-thirds of patients in an extension cohort with specific subtypes of relapsed or refractory AML, although adverse effects limited the maximum tolerated dose.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Additional clinical trials are underway with tranylcypromine derivatives from GlaxoSmithKline (Clinicaltrials.gov identifier NCT02177812),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and Incyte Corporation (Clinicaltrials.gov identifier NCT02712905),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> although no results have yet been disclosed. The clinical efficacy of LSD1 inhibitors may ultimately be enhanced by way of combination therapies. For example, all-<i>trans</i>-retinoic acid (ATRA) therapy is already successfully used as a differentiation therapy in acute promyelocytic leukemia (APL), and research has suggested addition of an LSD1 inhibitor could enable this therapy to be more widely applicable to AML.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Emerging data suggests the wider applicability of this strategy to other epigenetic targets such as bromodomains<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and histone deacetylases.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">The development of reversible LSD1 inhibitors is not trivial due to the large size and polarity of the LSD1 substrate binding pocket. As such, progress has not matched that of the covalent inactivators of LSD1.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Reversible inhibitors such as GSK-690 (<b>1</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) have achieved good potency in biochemical and cellular assays,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> however, this compound strongly inhibits the human ether-a-go-go-related gene (hERG) cardiac ion channel, which prevented the progression of this series to the clinic.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Many other published reversible inhibitor series appear to have significant off-target and nonspecific effects.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In the past year, it has become apparent that there is commercial interest in developing reversible inhibitors, as evidenced by a number of patent applications from Quanticel Pharmaceuticals (<b>2</b>–<b>6</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) and Celgene.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31 ref32">(27-32)</a> Recently, the discovery and optimization of a series of thieno[3,2<i>-b</i>]pyrrole-5-carboxamides and the crystal structures of quinazoline-based reversible inhibitors has also been described.<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33-35)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compound <b>1</b> and examples from several series disclosed by Quanticel Pharmaceuticals (<b>2</b>–<b>6</b>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Herein, we describe our efforts toward the development of reversible inhibitors of LSD1 identified by high-throughput screening and using in silico design to develop submicromolar inhibitors of LSD1 that show activity in cellular assays.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44187" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44187" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Aniline <b>9</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) was prepared from nitrobenzene <b>7</b> via aromatic nucleophilic substitution with 3,5-dimethylpyrazole to afford <b>8</b>, which was reduced with zinc metal and ammonium formate. Aniline <b>9</b> was reacted with the requisite sulfonyl chloride in pyridine to afford compounds <b>10a</b>–<b>b</b>. As described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, compound <b>12</b> was formed by the reaction of aniline <b>11</b> with 4-acetatamidobenzenesulfonyl chloride. Compound <b>11</b> was also reacted with 4-methylphenylsulfonyl chloride in acetonitrile in the presence of pyridine to afford sulfonamide <b>13</b>. Compound <b>13</b> was alkylated with <i>tert</i>-butyl bromoacetate to afford the ester <b>14</b>. Deprotection with trifluoroacetic acid afforded acid <b>15</b> as a key intermediate.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> This was reacted with a variety of diamines under standard amide coupling conditions, with a Boc-deprotection step using 4 M HCl/dioxane if required, to give amides <b>16a</b>–<b>m</b>. Sulfonamides <b>18</b>–<b>20</b> were formed under standard conditions then alkylated with a Boc-protected chloroacetylpiperidine derivative (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00462/suppl_file/jm7b00462_si_001.pdf" class="ext-link">Supporting Information</a> for synthesis) to afford derivatives <b>21</b>–<b>23</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). To synthesize the methylene replacement analogues (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>), commercially available (4-cyanophenyl)glycine was reacted with a variety of Boc-protected substituted piperidines under standard amide coupling conditions to afford intermediates <b>25</b>–<b>28</b>. Alkylation with a variety of substituted benzyl bromides in DMF in the presence of potassium carbonate, and subsequent Boc-deprotection, afforded compounds <b>29a</b>–<b>e</b>, <b>30a</b>–<b>f</b>, <b>31</b>, and <b>32</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>10a</b>–<b>b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 3,5-dimethylpyrazole, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 16 h, 99%; (ii) Zn, ammonium formate, MeOH, 40 °C, 16 h, 78%; (iii) appropriate sulfonyl chloride, pyridine, 100 °C, 1 h, 41–70%.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>12</b> and <b>16a</b>–<b>m</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 4-acetamidobenzenesulfonyl chloride, DMAP, MeCN, μW, 100 °C, 1 h, 37%; (ii) 4-methylphenylsulfonyl, pyridine, MeCN, RT, 12 h, 89%; (iii) <i>tert</i>-butyl bromoacetate, K<sub>2</sub>CO<sub>3</sub>, DMF, 1 h, 96%; (iv) TFA, DCM, 1 h, 98%; (v) amine, DIPEA, COMU, DMF, then 4 M HCl/dioxane if Boc deprotection required, RT, 12–68%.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>21a</b>–<b>b</b>, <b>22</b>, and <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 1-acetylindoline-5-sulfonyl chloride, pyridine, MeCN, RT, 12 h, 84%; (ii) (<b>21a</b>) <i>tert</i>-butyl <i>N</i>-[(3<i>R</i>)-1-(2-chloroacetyl)-3-piperidyl]carbamate, K<sub>2</sub>CO<sub>3</sub>, cat. KI, DMF, 80 °C, 3 h, then TFA, 1 h, rt, 42%; (<b>21b</b>) <i>tert</i>-butyl <i>N</i>-[1-(2-chloroacetyl)-4-piperidyl]carbamate, K<sub>2</sub>CO<sub>3</sub>, 80 °C, 6 h, then 4 M HCl/dioxane, 70%; (iii) 2-methyl-2<i>H</i>-indazol-5-amine, pyridine, MeCN, rt, 12 h, 54%; (iv) <i>tert</i>-butyl <i>N</i>-[(3<i>R</i>)-1-(2-chloroacetyl)-3-piperidyl]carbamate, K<sub>2</sub>CO<sub>3</sub>, cat. KI, DMF, 80 °C, 3 h; then TFA, 1 h, rt, 25%; (v) 1-acetylindoline-5-sulfonyl chloride, pyridine, MeCN, RT, 12 h, 54%; (vi) <i>tert</i>-butyl <i>N</i>-[1-(2-chloroacetyl)-4-piperidyl]carbamate, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 6 h, then 4 M HCl/dioxane, 1 h RT, 52%.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>29a</b>–<b>e</b>, <b>30a</b>–<b>f</b>, <b>31</b>, and <b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Boc-protected diamine, DIPEA, COMU, DMF, rt, 1 h, 67–99%; (ii) substituted benzyl-bromide, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 1 h, then 4 M HCl/dioxane, rt, 1 h, 6–58%</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77832" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77832" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A library of ∼150000 compounds was screened against the LSD1 enzyme in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay at 30 μM with an initial hit rate of 0.3% (as defined by >70% inhibition). The resulting 472 compounds were tested for interference of the TR-FRET assay and for purity by LC-MS, then taken into 7- and 12-point IC<sub>50</sub> testing, yielding 72 hits with IC<sub>50</sub> values in the range of 4–102 μM.</div><div class="NLM_p">After resynthesis of the original hit matter for validation, we chose to develop a series of sulfonamides that appeared to offer an attractive start-point with multiple vectors for diversification (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). This series was optimized from compound <b>10a</b> to give <b>10b</b> with submicromolar activity in the biochemical assay. Both sides of the sulfonamide could be extensively modified while retaining potency; however, the aniline portion originating from the HTS could not be improved upon. Unfortunately, when tested in our previously described cellular assay,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a><b>10b</b> and related compounds were found to cause no induction of CD86 at 50 μM in human THP-1 AML cells (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). This disconnect was reinforced when the compounds were tested by surface plasmon resonance (SPR), where the binding response increased linearly with compound concentration (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C, inset), suggesting that no specific binding between compound and LSD1 protein was occurring. In addition, a competition assay with tranylcypromine demonstrated no abrogation of the interactions of these compounds with LSD1 (data not shown). Several other chemotypes emerging from the HTS were shown to display a similar lack of activity by SPR, suggesting the biochemical assay may be particularly susceptible to false positives and demonstrating the value of an orthogonal biophysical assay in the screening cascade.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Development and characterization of compound <b>10b</b>. (A) Biochemical assay; (B) surrogate cellular biomarker assay; (C) surface plasmon resonance sensorgram of the interaction between LSD1 and <b>10b</b> in 2-fold dilution series (highest concentration indicated in the graph).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">SPR analysis did identify a single compound (<b>12</b>) that displayed reversible binding activity (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), a sulfonamide that we hypothesized might be acting as a ring-opened isostere of the pyridine scaffold of compound <b>1</b>. While <b>1</b> was disclosed by GSK at the AACR Annual Meeting 2013 (Washington, DC, USA), very little work to develop this ligand had been published before 2015.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Certainly, the scope for potential core-hops had been seldom explored at the point at which we began to pursue this approach. To attempt to validate sulfonamides as a potential new scaffold, we used Cresset Spark and Torch software (Welwyn Garden City, U.K.) to align and identify potential new cores by searching fragment libraries for replacements with similar spatial and electronic features.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure of compound <b>12</b> with biochemical and SPR sensorgram indicating the highest tested concentration. <i>K</i><sub>d</sub> = 9.5 μM. <i>K</i><sub>d</sub> value was determined by SPR at 15 °C as the average of two experimental series (typically 10 concentrations).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">From this output, we designed initial targets, a series of sulfonamidoacetamides (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) that looked to offer ease of synthesis while offering low two-dimensional (2D) similarity in comparison to more recognizable pyridine replacements such as pyridazines or pyrazines. We incorporated the <i>para</i>-cyano and <i>para</i>-tolyl aryl groups from <b>1</b> for the initial development, focused on optimizing the basic center, by coupling a series of amines to a key sulfonamidoacetic acid intermediate to give compounds <b>16a</b>–<b>m</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). In contrast to the sulfonamides <b>10a</b>,<b>b</b>, these compounds showed specific and reversible binding to LSD1 by SPR, validating them as start points for further assay. Both primary and secondary amides decorated with basic amines were tolerated and displayed significantly improved levels of potency over <b>16a</b>. Initial optimization gave the 4-aminopiperidine derivative <b>16g</b>. Methylation α- to the basic center (<b>16k</b>) was also tolerated, alongside methylation on the nitrogen itself (<b>16l</b>, <b>16m</b>), however the activity appeared have reached a plateau, with no compounds achieving a <i>K</i><sub>d</sub> value below 2 μM.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cresset Torch alignment and structures of compound <b>1</b> (left) and <b>16g</b> (right). Similarity score 0.712. Blue field points (spheres) highlight energy minima for a positively charged probe, red for a negative probe. Yellow spheres represent an attractive van der Waals minimum for a neutral probe, and brown spheres represent hydrophobic regions. Oxygen atoms are shown in red, nitrogen in blue. The similarity score is based on the likeness of the field points in terms of their magnitude and position. A score of greater than 0.7 is considered a “good” score.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Optimization of Basic Center on the Acetamidosulfonamide Scaffold<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0013.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0014.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> and <i>K</i><sub>d</sub> values for selected compounds against the LSD1 enzyme in biochemical and biophysical assays. Standard deviation is given in parentheses. IC<sub>50</sub> determined from 10-point concentration/effect experiments. Geometric mean of at least two independent experimental determinations given. <i>K</i><sub>d</sub> values were determined by SPR at 15 °C as the average of two experimental series (typically 10 concentrations).</p></div></div><div></div></div><div class="NLM_p">Shortly after synthesizing these initial compounds, a patent from Quanticel disclosed several series of reversible LSD1 inhibitors featuring 6- and 5-membered monocyclic and 6,5-bicyclic core-hops (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Compounds from each series were claimed to display IC<sub>50</sub> values against LSD1 of less than 100 nM in biochemical and cellular assays. While the patent reduced the diversity of chemical space available to explore, it also provided useful learning, both in terms of the essential features of the compounds and which positions are more tolerant to change. For instance, the <i>para</i>-cyanophenyl and the presence of a basic nitrogen center are conserved throughout the examples in the patent, whereas the tolyl moiety was more amenable to optimization, and was successfully replaced with a number of mono- and bicyclic systems (e.g., <b>3</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).</div><div class="NLM_p">With this in mind, we investigated how the modification of the two aryl groups affected the activity (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Derivatives with an acetylindoline group were shown to give slightly better potency than the parent tolyl (<b>21a</b>,<b>b</b>). On the other hand, compound <b>22</b>, where the sulfonamide was reversed and the tolyl replaced with the favored 2-methylindazole from the Quanticel patent, showed a disappointing drop-off in activity. Adopting the substituted aniline group from the prior HTS series (<b>23</b>) showed no activity by biochemical assay or SPR, while the parent <b>20</b> (biochemical IC<sub>50</sub> = 1.6 μM; <i>K</i><sub>d</sub> > 100 μM) displayed the same nonspecific binding effects by SPR. Despite our optimization attempts, we were disappointed to find that potency could not be significantly improved further, and thus we looked to modify the core itself to establish whether potency could be improved..</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Aryl Modifications on the Acetamidosulfonamide Scaffold<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0015.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0016.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> and <i>K</i><sub>d</sub> values for selected compounds against the LSD1 enzyme in biochemical and biophysical assays. Standard deviation is given in parentheses. IC<sub>50</sub> determined from 10-point concentration/effect experiments. Geometric mean of at least two independent experimental determinations given. <i>K</i><sub>d</sub> values were determined by SPR at 15 °C as the average of two experimental series (typically 10 concentrations).</p></div></div><div></div></div><div class="NLM_p">Toward this aim, we replaced the SO<sub>2</sub> moiety with a methylene linker to give a (4-cyanophenyl)glycinamide core (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). This alteration has the benefit of a significant reduction in molecular weight and total polar surface area, which could afford increased membrane permeability and bioavailability. However, this modification also introduces an aniline functionality that could potentially be a metabolic liability.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Initially, we chose to adopt the 4-aminopiperidine from compound <b>16g</b> as the basic center and focused on modifications of the tolyl- group. Compound <b>29a</b> demonstrated a 5-fold improvement in potency compared to the matched-pair sulfonamide <b>16h</b> by both biochemical assay and SPR. In addition, a range of phenyl groups were tolerated and, in one case, improved potency further (<b>29c</b>). These beneficial modifications could be extended to bicyclic systems (<b>15e</b>). We then returned to investigate the basic center and found that homologating the 4-aminopiperidine unit to a piperidin-4-ylmethanamine gave a useful ∼4-fold increase in potency (e.g., <b>29a</b> vs <b>30a</b>) (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Modifying the p<i>K</i><sub>a</sub> of the basic center by introducing of a fluorine atom at the β-carbon to the amine was deleterious to activity, however, decreasing the flexibility of the amine by incorporation into a spirocycle (<b>32</b>) afforded a compound with <100 nM activity in the biochemical assay.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Aryl Optimization on the (4-Cyanophenyl)glycine Scaffold<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0017.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0018.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> and <i>K</i><sub>d</sub> values for selected compounds against the LSD1 enzyme in biochemical and biophysical assays. Standard deviation is given in parentheses. IC<sub>50</sub> determined from 10 point concentration/effect experiments. Geometric mean of at least two independent experimental determinations given. <i>K</i><sub>d</sub> values were determined by SPR at 15 °C as the average of two experimental series (typically 10 concentrations).</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Basic Center Optimization and Aryl Variation on the (4-Cyanophenyl)glycine Scaffold<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0019.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0020.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> and <i>K</i><sub>d</sub> values for selected compounds against the LSD1 enzyme in biochemical and biophysical assays. Standard deviation is given in parentheses. IC<sub>50</sub> determined from 10-point concentration/effect experiments. Geometric mean of at least two independent experimental determinations given. <i>K</i><sub>d</sub> values were determined by SPR at 15 °C as the average of two experimental series (typically 10 concentrations).</p></div></div><div></div></div><div class="NLM_p">In an attempt to rationalize the observed SAR, we performed docking studies by using the previously reported structure of LSD1 bound to tetrahydrofolate (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KUM">4KUM</a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Protein preparation and docking were performed in Glide (Schrödinger, New York, USA)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The crystal structure of <b>1</b> bound to LSD1 has been disclosed,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and from these data, the binding mode of compound <b>30f</b> was predicted, as displayed in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>. In this predicted pose, the nitrile forms a key hydrogen bonding interaction with K661. The basic center forms a network of ionic interactions with Asp555 and Asp556. This ionic interaction has been exploited previously by Vianello and co-workers.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> The 3-fluoro-4-methoxyphenyl group sits in a channel formed by Trp695, Ile356, Leu677, and Leu693. The ether oxygen is predicted to make a hydrogen bonding interaction with Gln358, however, if the phenyl group were to flip then it could also potentially form a similar interaction with Asn535. It is worthy of note that a wide variety of scaffold-hops can be tolerated, and this may be explained by a lack of contact between the protein and the scaffold itself, with the key interactions being located at distal ends of the ligands.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Top: Predicted binding mode of compound <b>30f</b> in the LSD1 active site (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KUM">4KUM</a>). Visualized using Maestro. Bottom: Protein–ligand interaction diagram with key hydrogen bond interactions highlighted (pink arrows).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To assess the effects of these derivatives on cells, compounds <b>1</b>, <b>30f</b>, and <b>32</b> were tested at seven concentrations in the THP-1 AML cell line to measure their effect on expression levels of CD86, a surrogate cellular biomarker of LSD1 inhibition (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Although compound <b>1</b> displayed the highest levels of potency in this assay (EC<sub>50</sub> = 0.30 μM), we were satisfied to find only a 2-fold drop off in activity to our most active derivative, <b>32</b> (EC<sub>50</sub> = 0.67 μM). The less active analogue <b>30f</b> displayed more modest activity (EC<sub>50</sub> = 4.1 μM), suggesting good correlation between the biochemical and cellular assay.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. CD86 cell assay results for compounds <b>1</b>, <b>30f</b>, and <b>32</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further assess cellular effects, we performed colony forming assays using two AML cell lines. This assay format indicates both proliferation of a cell population and the percentage of cells within that population with colony initiating activity.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> THP1 and MV4–11 cells were treated with 10 μM of <b>1</b> or <b>32</b> for 7 days in semisolid methylcellulose-based culture. Both compounds substantially reduced both colony forming frequency and the size of the colonies that did develop (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>), indicating significant antiproliferative activity in addition to inducing up-regulation of the cellular differentiation marker CD86. To explore whether these compounds induced apoptosis, we performed annexin V-perCP EF710/7AAD staining on THP-1 cells treated for 4 days with 10 μM of each of the compounds. A modest but significant increase in apoptosis was observed (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). These results, combined with the CD86 data, suggest that compounds such as <b>32</b> act predominantly to promote differentiation of AML cells, with concomitant reduction in clonogenic potential.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Top: Colony formation assay for THP-1 and MV4-11 cells dosed with 10 μM of compounds <b>1</b> and <b>32</b> for 7 days. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, ****<i>P</i> < 0.0001, statistical significance calculated using a one-way ANOVA with Dunnett’s tests between vehicle treated and compound dosed cells. Bottom: representative images of colonies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Annexin V-perCP EF710/7AAD double staining experiments results with THP-1 cell dosed with vehicle, or 10 μM <b>1</b> or <b>32</b> for 4 days in liquid culture. Early apoptotic cells = annexin V<sup>pos</sup>7-AAD<sup>neg</sup>; apoptotic cells = annexin V<sup>pos</sup>7-AAD<sup>pos</sup>. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, ****<i>P</i> < 0.0001, statistical significance calculated using one-way ANOVA analysis with Dunnett’s tests.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vitro ADME Properties</h3><div class="NLM_p">As inhibition of the hERG ion channel proved to be an insurmountable issue in furthering the development of <b>1</b> toward the clinic,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> we were keen to assess our compounds against this target. Compounds <b>29c</b>, <b>30f</b>, and <b>32</b> were tested in a patch clamp assay alongside being profiled for their metabolic stability (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Gratifyingly, these compounds displayed improved selectivity against hERG in comparison to <b>1</b> (IC<sub>50</sub> = 3.2 μM), with compound <b>32</b> displaying a ∼30-fold window of selectivity between LSD1 inhibition in cells and hERG inhibition. In addition, we observed low levels of clearance in mouse microsomes with all three compounds. Disappointingly, these compounds displayed poor membrane permeability and high levels of efflux in comparison to compound <b>1</b>, which could make achieving oral bioavailability challenging, although this liability does not appear to preclude the ability of the compounds to inhibit LSD1 in a cellular context.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Parameters for <b>1</b>, <b>29c</b>, <b>30f</b>, and <b>32</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center"><b>29c</b></th><th class="colsep0 rowsep0" align="center"><b>30f</b></th><th class="colsep0 rowsep0" align="center"><b>32</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco2 A–B mean <i>P</i><sub>app</sub> (10<sup>–6</sup> cm/s); (efflux ratio)</td><td class="colsep0 rowsep0" align="center">5.6 (3.2)</td><td class="colsep0 rowsep0" align="center">0.44 (48)</td><td class="colsep0 rowsep0" align="center">0.26 (58)</td><td class="colsep0 rowsep0" align="center">0.09 (58)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Mo Mic CL<sub>int</sub> (μL/min/10<sup>6</sup> cells)</td><td class="colsep0 rowsep0" align="center">3.43</td><td class="colsep0 rowsep0" align="center">3.6</td><td class="colsep0 rowsep0" align="center">4.5</td><td class="colsep0 rowsep0" align="center"><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Mo Mic <i>T</i><sub>1/2</sub> (min)</td><td class="colsep0 rowsep0" align="center">404</td><td class="colsep0 rowsep0" align="center">385</td><td class="colsep0 rowsep0" align="center">305</td><td class="colsep0 rowsep0" align="center">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG EC<sub>50</sub> (μM); (standard error)</td><td class="colsep0 rowsep0" align="center">3.2</td><td class="colsep0 rowsep0" align="center">>25</td><td class="colsep0 rowsep0" align="center">12.4 (3.4)</td><td class="colsep0 rowsep0" align="center">20.1 (4.6)</td></tr></tbody></table></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, we have developed a series of (4-cyanophenyl)glycine derivatives that show potent activity against LSD1 by both biochemical assay and SPR. Starting from a weakly active HTS hit <b>12</b>, we identified acyclic lead-like analogues of compound <b>1</b>. We successfully developed these initial start points, leading to the development of compound <b>32</b>, which potently inhibits LSD1 in biochemical, biophysical, and cellular assays. These compounds display much greater levels of selectivity over the hERG cardiac ion channel than compound <b>1</b>, a liability which precluded further development of that series. Compound <b>32</b> is an attractive tool compound for use in in vitro systems and as a start-point for future development. More generally, this work suggests the scaffold of compound <b>1</b> is broadly modifiable, and while the <i>p</i>-cyanophenyl group appears to form a key interaction with K661, modification of the tolyl- functionality and the position and orientation of the basic center is much more tolerant to modification.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78024" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78024" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div class="NLM_p">Flash column chromatography was performed using prepacked silica gel cartridges (KP-Sil SNAP, Biotage, Hengoed UK or RediSep Rf, Isco). Thin layer chromatography was conducted with 5 cm × 10 cm plates coated with Merck Type 60 F<sub>254</sub> silica gel to a thickness of 0.25 mm. All reagents obtained from commercial sources were used without further purification. Anhydrous solvents were obtained from the Sigma-Aldrich Company Ltd. (Dorset, UK) or Fisher Scientific UK Ltd. (Loughborough, UK) and used without further drying. HPLC grade solvents were obtained from Fisher Chemicals Ltd.</div><div class="NLM_p">All compounds prepared were >95% purity as determined by examination of both the LC-MS and <sup>1</sup>H NMR spectra unless otherwise indicated. Where Cl or Br were present, expected isotopic distribution patterns were observed.</div><div class="NLM_p">Proton (<sup>1</sup>H) and carbon (<sup>13</sup>C) NMR spectra were recorded on a 300 MHz Bruker Avance spectrometer. Solutions were typically prepared in either deuterochloroform (CDCl<sub>3</sub>), deuterated dimethyl sulfoxide (DMSO-<i>d</i><sub>6</sub>), or deuterated methanol (methanol-<i>d</i><sub>4</sub>) with chemical shifts referenced to tetramethylsilane (TMS) or deuterated solvent as an internal standard. <sup>1</sup>H NMR data are reported indicating the chemical shift (δ), the integration (e.g., 1H), the multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad; dd, doublet of doublets etc.), and the coupling constant (<i>J</i>) in Hz. Deuterated solvents were obtained from Goss Scientific (Crewe, UK). In general, basic N–H protons were not observed.</div><div class="NLM_p">LC-MS analyses were performed on a Waters (Elstree, UK) Acquity UPLC system fitted with BEH C18 1.7 μM columns (2.1 m × 50 mm) and with UV diode array detection (210–400 nm) with a Waters SQD detector. Analyses were performed with either buffered acidic or basic solvents and using gradients detailed in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00462/suppl_file/jm7b00462_si_001.pdf" class="ext-link">Supporting Information</a>.</div><div class="NLM_p last">Some compounds were purified by preparative (prep) HPLC on a Waters FractionLynx MS autopurification system, with a Waters XBridge 5 μm C18, 100 mm × 19 mm i.d. column, running at a flow rate of 20 mL/min with UV diode array detection (210–400 nm) and mass-directed collection using both positive and negative mass ion detection. Purifications were performed using buffered acidic or basic solvent systems as appropriate. Compound retention times on the system were routinely assessed using a 30–50 μL test injection and a standard gradient, then purified using an appropriately chosen focused gradient as detailed in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00462/suppl_file/jm7b00462_si_001.pdf" class="ext-link">Supporting Information</a>, based upon observed retention time.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Preparation of Compounds <b>10a</b>,<b>b</b></h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 1-(2-Methoxy-4-nitro-phenyl)-3,5-dimethylpyrazole (<b>8</b>)</h4><div class="NLM_p last">A suspension of 3-methoxy-4-fluoronitrobenzene (25 g, 146 mmol), 3,5-dimethylpyrazole (15.5 g, 161 mmol), and potassium carbonate (60.5 g, 438 mmol) in DMF (200 mL) was stirred overnight at 80 °C. The reaction mixture was added to water (500 mL) and the resulting yellow precipitate collected by filtration and dried to the title compound (35.8 g, 99%) as a yellow powder. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 7.95 (dd, <i>J</i> = 8.5, 2.4 Hz, 1H), 7.90 (d, <i>J</i> = 2.4 Hz, 1H), 7.54 (d, <i>J</i> = 8.5 Hz, 1H), 6.03 (s, 1H), 3.94 (s, 3H), 2.31 (s, 3H), 2.14 (s, 3H). LC-MS: (high pH) <i>t</i><sub>R</sub> 1.09 min, <i>m</i>/<i>z</i> 248.1 [M + H]<sup>+</sup>, 100% purity.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 4-(3,5-Dimethylpyrazol-1-yl)-3-methoxyaniline (<b>9</b>)</h4><div class="NLM_p last">A stirred suspension of 1-(2-methoxy-4-nitro-phenyl)-3,5-dimethylpyrazole (36 g, 0.145 mol), zinc powder (28.6 g, 0.44 mol) and ammonium formate (91.2 g, 1.46 mol) in methanol (250 mL) was heated overnight to 40 °C. The reaction mixture was passed through a hydrophobic frit and concentrated to dryness. The resulting residue was suspended between brine (250 mL) and DCM (500 mL), the organic layer passed through a hydrophobic frit and concentrated to dryness to afford the crude product. Recrystallization from hexanes afforded the title compound (24.7 g, 78%) as off-white needles. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 7.13–7.03 (m, 1H), 6.36 (m, 2H), 5.94 (s, 1H), 3.74 (s, 3H), 2.30 (s, 3H), 2.08 (s, 3H). LC-MS: (high pH) <i>t</i><sub>R</sub> 0.88 min, <i>m</i>/<i>z</i> 218.2 [M + H]<sup>+</sup>, 98% purity.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>N</i>-[4-(3,5-Dimethylpyrazol-1-yl)-3-methoxyphenyl]benzenesulfonamide (<b>10a</b>)</h4><div class="NLM_p last">A solution of benzenesulfonyl chloride (18 μL, 0.14 mmol) and 4-(3,5-dimethylpyrazol-1-yl)-3-methoxy-aniline (30 mg, 0.14 mmol) in pyridine (0.45 mL) was stirred at 100 °C for 1 h. The reaction was concentrated to dryness then purified by preparative HPLC (low pH gradient 3) to afford the title compound (20 mg, 41%) as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.39 (s, 1H), 7.90–7.75 (m, 2H), 7.65–7.42 (m, 3H), 7.02 (d, <i>J</i> = 8.4 Hz, 1H), 6.83 (d, <i>J</i> = 2.2 Hz, 1H), 6.67 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 5.94–5.81 (m, 1H), 3.62 (s, 3H), 2.09 (s, 3H), 1.91 (s, 3H).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>-[4-(3,5-Dimethylpyrazol-1-yl)-3-methoxyphenyl]-1,3-dimethyl-2-oxo-quinoline-6-sulfonamide (<b>10b</b>)</h4><div class="NLM_p last">A solution of 4-(3,5-dimethylpyrazol-1-yl)-3-methoxyaniline (28 mg, 0.13 mmol) and 1,3-dimethyl-2-oxo-quinoline-6-sulfonyl chloride (34 mg, 0.12 mmol) in pyridine (300 μL) was stirred at room temperature overnight. The reaction mixture was diluted with 2:1:1 (v:v:v) DMSO:water:MeCN (700 μL), then purified by preparative HPLC (low pH) to afford the title compound (39 mg, 70%) as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.62 (s, 1H), 8.15 (d, <i>J</i> = 2.2 Hz, 1H), 7.97–7.86 (m, 2H), 7.67 (d, <i>J</i> = 9.0 Hz, 1H), 7.08 (d, <i>J</i> = 8.4 Hz, 1H), 6.93 (d, <i>J</i> = 2.2 Hz, 1H), 6.75 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 5.90 (s, 1H), 3.66 (s, 3H), 3.64 (s, 3H), 2.12 (s, 3H), 2.07 (s, 3H), 1.91 (s, 3H). <sup>13</sup>C NMR (75 MHz, methanol-<i>d</i><sub>4</sub>) δ 144.1, 140.5, 137.6, 135.1, 133.2, 130.5, 128.7, 124.8, 122.1, 114.7, 114.0, 110.8, 106.8, 57.4, 30.9, 22.4, 15.7, 15.2. HRMS (ESI) <i>m</i>/<i>z</i> [M – H]<sup>−</sup> calcd for C<sub>23</sub>H<sub>23</sub>N<sub>4</sub>O<sub>4</sub>S 451.1445, found 451.1443.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Preparation of Compound <b>12</b></h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>N</i>-[4-[(4-Cyanophenyl)sulfamoyl]phenyl]acetamide (<b>12</b>)</h4><div class="NLM_p last">A solution of DMAP (50 mg, 0.42 mmol), <i>p</i>-cyanoaniline (50 mg, 0.42 mmol), and 4-acetamidobenzenesulfonyl chloride (99 mg, 0.42 mmol) in acetonitrile (5 mL) was heated by microwave irradiation to 100 °C for 1 h. The reaction was concentrated to dryness then purified by preparative HPLC (low pH gradient 2) to afford the title compound (49 mg, 37%) as colorless crystals. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.95 (s, 1H), 10.34 (s, 1H), 7.83–7.62 (m, 6H), 7.28–7.15 (m, 2H), 2.06 (s, 3H).</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Preparation of Compounds <b>16a</b>–<b>16m</b></h3><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-(4-Cyanophenyl)-4-methylbenzenesulfonamide (<b>13</b>)</h4><div class="NLM_p last">To a stirred solution of 4-cyanoaniline (5 g, 42.3 mmol) in pyridine (3.6 mL) and acetonitrile (9 mL) was added portionwise <i>p</i>-toluenesulfonyl chloride (8.88 g, 46.6 mmol). The reaction mixture was stirred at room temperature overnight, then water (50 mL) was added and the resulting light-orange precipitate collected by filtration, washed with water (3 × 20 mL), and dried under vacuum at 50 °C to afford the title compound (8.92 g, 77%) as a light-orange powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.99 (s, 1H), 7.78–7.61 (m, 4H), 7.43–7.33 (m, 2H), 7.32–7.15 (m, 2H), 2.34 (s, 3H). LC-MS: (high pH) <i>t</i><sub>R</sub> 0.82 min, <i>m</i>/<i>z</i> 271.1 [M – H]<sup>−</sup>, 100% purity.</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>tert</i>-Butyl 2-[4-Cyano-<i>N</i>-(<i>p</i>-tolylsulfonyl)anilino]acetate (<b>14</b>)</h4><div class="NLM_p last">To a stirred suspension of <i>N</i>-(4-cyanophenyl)-4-methylbenzenesulfonamide (2 g, 7.34 mmol) and potassium carbonate (2.02 g, 14.7 mmol) in DMF (20 mL) was added <i>tert</i>-butyl bromoacetate (1.30 mL, 8.81 mmol) and the reaction mixture heated to 80 °C for 1 h. The reaction mixture was diluted with water (50 mL) then extracted with DCM (2 × 20 mL). The combined organic layers were passed through a hydrophobic frit and concentrated to dryness to afford the title compound (2.71g, 97%) as an orange oil. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 7.66–7.51 (m, 4H), 7.41–7.23 (m, 4H), 4.35 (s, 2H), 2.43 (s, 3H), 1.40 (s, 9H). LC-MS: (high pH) <i>t</i><sub>R</sub> 1.32 min, <i>m</i>/<i>z</i> 387.1 [M + H]<sup>+</sup>, 94% purity.</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-[4-Cyano-<i>N</i>-(<i>p</i>-tolylsulfonyl)anilino]acetic Acid (<b>15</b>)</h4><div class="NLM_p last">A stirred solution of <i>tert</i>-butyl 2-[4-cyano-<i>N</i>-(<i>p</i>-tolylsulfonyl)anilino]acetate (2.9 g, 7.5 mmol) in trifluoroacetic acid (2.79 mL, 37.5 mmol) and DCM (30 mL) was heated to 30 °C for 1 h. The reaction mixture was concentrated to dryness to afford an orange oil. Purification by column chromatography (0–60% EtOAc in isohexane, then 10% MeOH in DCM) afforded the title compound as a colorless oil that solidified upon standing to give colorless crystals. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.06 (s, 1H), 7.87–7.75 (m, 2H), 7.65–7.53 (m, 2H), 7.39 (m, 4H), 4.55 (s, 2H), 2.38 (s, 3H). LC-MS: (high pH) <i>t</i><sub>R</sub> 0.63 min, <i>m</i>/<i>z</i> 319.1 [M – H]<sup>−</sup>, 96% purity.</div></div><div id="sec5_4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> General Method A</h4><div class="NLM_p last">To a stirred solution of 2-[4-cyano-<i>N</i>-(<i>p</i>-tolylsulfonyl)anilino]acetic acid (30. mg, 0.09 mmol), the appropriate bis-amine (1.2 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (45 μL, 0.27 mmol) in DMF (300 μL) was added COMU (58 mg, 0.14 mmol) and the reaction mixture stirred at room temperature for 6 h. The reaction mixture was concentrated to dryness and purified by mass directed preparative HPLC (high pH), to afford the desired product.</div></div><div id="sec5_4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> General Method B</h4><div class="NLM_p last">To a stirred solution of 2-[4-cyano-<i>N</i>-(<i>p</i>-tolylsulfonyl)anilino]acetic acid (30 mg, 0.09 mmol), the appropriate Boc-protected bis-amine (1.2 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (45 μL, 0.27 mmol) in DMF (300 μL) was added COMU (58 mg, 0.14 mmol), and the reaction mixture stirred at room temperature for 6 h. The reaction mixture was concentrated to dryness, and 4 M HCl in dioxane (1 mL) was added. This was stirred for 1 h, then concentrated to dryness and purified by mass directed preparative HPLC (high pH), to afford the desired product.</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-[4-Cyano-<i>N</i>-(<i>p</i>-tolylsulfonyl)anilino]-<i>N</i>-(3-pyridyl)acetamide (<b>16a</b>)</h4><div class="NLM_p last">Prepared by general method A using 3-aminopyridine to afford the title compound (24 mg, 65%) as a light-brown powder. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.68 (dd, <i>J</i> = 2.6, 0.8 Hz, 1H), 8.27 (dd, <i>J</i> = 4.8, 1.5 Hz, 1H), 8.07 (ddd, <i>J</i> = 8.4, 2.6, 1.5 Hz, 1H), 7.72–7.65 (m, 2H), 7.63–7.57 (m, 2H), 7.54–7.43 (m, 2H), 7.44–7.28 (m, 3H), 4.61 (s, 2H), 2.42 (s, 3H).</div></div><div id="sec5_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-[4-Cyano-<i>N</i>-(<i>p</i>-tolylsulfonyl)anilino]-<i>N</i>-[(3<i>R</i>)-quinuclidin-3-yl]acetamide (<b>16b</b>)</h4><div class="NLM_p last">Prepared by general method A using (<i>R</i>)-3-aminoquinuclidine dihydrochloride to afford the title product as an orange oil (14 mg, 35%). <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.49 (s, 1H), 7.75–7.63 (m, 2H), 7.60–7.50 (m, 2H), 7.42 (m, 2H), 7.40–7.34 (m, 2H), 4.42 (s, 2H), 4.17 (m, 1H), 3.74–3.60 (m, 1H), 3.34–3.19 (m, 4H), 3.02 (dd, <i>J</i> = 13.8, 4.7 Hz, 1H), 2.44 (s, 3H), 2.12 (q, <i>J</i> = 3.1 Hz, 1H), 1.99 (s, 3H), 1.86 (s, 1H).</div></div><div id="sec5_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-[4-Cyano-<i>N</i>-(<i>p</i>-tolylsulfonyl)anilino]-<i>N</i>-[(3<i>S</i>)-quinuclidin-3-yl]acetamide (<b>16c</b>)</h4><div class="NLM_p last">Prepared by general method A using (<i>S</i>)-3-aminoquinuclidine dihydrochloride to afford the title product as a yellow powder (11 mg, 28%). <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.46 (s, 1H), 7.70 (dd, <i>J</i> = 1.9, 8.7 Hz, 2H), 7.60–7.50 (m, 2H), 7.47–7.40 (m, 2H), 7.37 (d, <i>J</i> = 7.9 Hz, 2H), 4.43 (s, 2H), 4.19 (m, 1H), 3.72–3.62 (m, 1H), 3.29–3.22 (m, 3H), 3.04 (dd, <i>J</i> = 13.8, 4.7 Hz, 1H), 2.44 (s, 3H), 2.13 (m, 1H), 2.06–1.97 (m, 4H), 1.87 (s, 1H).</div></div><div id="sec5_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-(4-Cyanophenyl)-<i>N</i>-[2-[(1<i>S</i>,4<i>S</i>)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-2-oxo-ethyl]-4-methyl-benzenesulfonamide (<b>16d</b>)</h4><div class="NLM_p last">Prepared by general method B using (1<i>S</i>,4<i>S</i>)-2-Boc-2,5-diazabicyclo[2.2.1]heptane to afford the title compound (28 mg, 75%) as a white powder. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.50 (s, 1H), 7.78–7.60 (m, 2H), 7.64–7.47 (m, 2H), 7.50–7.25 (m, 4H), 4.43 (s, 2H), 4.18 (ddd, <i>J</i> = 8.3, 5.3, 3.3 Hz, 1H), 3.74–3.59 (m, 1H), 3.34–3.15 (m, 4H), 3.02 (ddd, <i>J</i> = 13.5, 5.3, 2.2 Hz, 1H), 2.43 (s, 3H), 2.18–1.90 (m, 2H), 1.88–1.76 (m, 1H)</div></div><div id="sec5_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-[2-[(3<i>R</i>)-3-Amino-1-piperidyl]-2-oxo-ethyl]-<i>N</i>-(4-cyanophenyl)-4-methyl-benzenesulfonamide (<b>16e</b>)</h4><div class="NLM_p last">Prepared by general method B using (<i>R</i>)-3-Boc-aminopiperidine to afford the title compound (14 mg, 37%) as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.85–6.78 (m, 2H), 6.78–6.68 (m, 2H), 6.60–6.53 (m, 2H), 6.51 (d, <i>J</i> = 8.1 Hz, 2H), 3.89 (d, <i>J</i> = 16.5 Hz, 1H), 3.81 (d, <i>J</i> = 16.5 Hz, 1H), 3.38 (d, <i>J</i> = 12.5 Hz, 1H), 3.29–3.08 (m, 1H), 2.96 (d, <i>J</i> = 13.7 Hz, 1H), 2.61–2.06 (m, 3H), 1.58 (s, 3H), 1.08–1.00 (m, 1H), 0.92–0.78 (m, 2H).</div></div><div id="sec5_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-[2-[(3<i>S</i>)-3-Amino-1-piperidyl]-2-oxo-ethyl]-<i>N</i>-(4-cyanophenyl)-4-methyl-benzenesulfonamide (<b>16f</b>)</h4><div class="NLM_p last">Prepared by general method B using (<i>S</i>)-3-Boc-aminopiperidine to afford the title compound (18 mg, 48%) as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.81–7.74 (m, 2H), 7.72–7.60 (m, 2H), 7.43–7.27 (m, 4H), 4.85 (d, <i>J</i> = 17.3 Hz, 1H), 4.70 (d, <i>J</i> = 17.3 Hz, 1H), 4.16–4.04 (m, 1H), 3.71 (d, <i>J</i> = 12.5 Hz, 2H), 3.10–2.86 (m, 1H), 2.86 (s, 1H), 2.73–2.51 (m, 1H), 2.38 (s, 3H), 1.95–1.12 (m, 4H).</div></div><div id="sec5_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-[2-(4-Amino-1-piperidyl)-2-oxo-ethyl]-<i>N</i>-(4-cyanophenyl)-4-methyl-benzenesulfonamide (<b>16g</b>)</h4><div class="NLM_p last">Prepared by general method B using 4-[(<i>tert</i>-butoxycarbonyl)amino]piperidine to afford the title compound (21 mg, 56%) as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.87–7.69 (m, 2H), 7.74–7.59 (m, 2H), 7.43–7.30 (m, 4H), 4.85 (d, <i>J</i> = 17.3 Hz, 1H), 4.70 (d, <i>J</i> = 17.3 Hz, 1H), 4.18 (d, <i>J</i> = 13.7 Hz, 1H), 3.88 (d, <i>J</i> = 13.7 Hz, 1H), 3.09 (m, 2H), 2.73–2.53 (m, 1H), 2.38 (s, 3H), 1.85 (m, 2H), 1.50–1.30 (m, 1H), 1.31–1.07 (m, 1H).</div></div><div id="sec5_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-[4-Cyano-<i>N</i>-(<i>p</i>-tolylsulfonyl)anilino]-<i>N</i>-(4-piperidyl)acetamide (<b>16h</b>)</h4><div class="NLM_p last">Prepared by general method B using 4-amino-1-Boc-piperidine to afford the title compound (19 mg, 51%) as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.15 (d, <i>J</i> = 7.6 Hz, 1H), 7.90–7.71 (m, 2H), 7.62–7.50 (m, 2H), 7.48–7.30 (m, 4H), 4.33 (s, 2H), 3.70–3.53 (m, 2H), 3.11–2.97 (m, 2H), 2.75–2.61 (m, 2H), 2.39 (s, 3H), 1.72–1.59 (m, 2H), 1.45–1.27 (m, 2H).</div></div><div id="sec5_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-[2-[(3<i>S</i>)-3-Aminopyrrolidin-1-yl]-2-oxo-ethyl]-<i>N</i>-(4-cyanophenyl)-4-methyl-benzenesulfonamide (<b>16i</b>)</h4><div class="NLM_p last">Prepared by general method B using (<i>S</i>)-3-(Boc-amino)pyrrolidine to afford the title compound (18 mg, 50%) as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.84–7.72 (m, 2H), 7.66 (dq, <i>J</i> = 8.6, 2.2 Hz, 2H), 7.50–7.27 (m, 5H), 4.65 (s, 1H), 4.61 (s, 1H), 3.69–3.48 (m, 1H), 3.47–3.07 (m, 3H), 2.38 (s, 3H), 2.13–1.85 (m, 1H), 1.85–1.52 (m, 1H).</div></div><div id="sec5_4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-[2-[(3<i>R</i>)-3-Aminopyrrolidin-1-yl]-2-oxo-ethyl]-<i>N</i>-(4-cyanophenyl)-4-methyl-benzenesulfonamide (<b>16j</b>)</h4><div class="NLM_p last">Prepared by general method B using (<i>R</i>)-3-(Boc-amino)pyrrolidine to afford the title compound (23 mg, 64%) as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.84–7.72 (m, 2H), 7.72–7.58 (m, 2H), 7.42–7.34 (m, 4H), 4.75–4.55 (m, 2H), 3.69–3.56 (m, 1H), 3.62–3.21 (m, 3H), 3.16 (m, 1H), 2.38 (s, 3H), 2.13–1.85 (m, 1H), 1.85–1.51 (m, 1H).</div></div><div id="sec5_4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-[2-(4-Amino-4-methyl-1-piperidyl)-2-oxo-ethyl]-<i>N</i>-(4-cyanophenyl)-4-methyl-benzenesulfonamide (<b>16k</b>)</h4><div class="NLM_p last">Prepared by general method B using <i>tert</i>-butyl <i>N</i>-(4-methyl-4-piperidyl)carbamate to afford the title compound (26 mg, 67%) as a white powder. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.57 (d, 2H), 7.49 (d, <i>J</i> = 8.2 Hz, 2H), 7.32 (d, <i>J</i> = 8.5 Hz, 2H), 7.26 (d, <i>J</i> = 8.0 Hz, 2H), 4.68 (d, <i>J</i> = 16.7 Hz, 1H), 4.57 (d, <i>J</i> = 16.7 Hz, 1H), 3.91 (m, 2H), 3.43–3.28 (m, 1H), 3.17–2.97 (m, 1H), 2.33 (s, 3H), 1.81 (s, 2H), 1.75–1.53 (m, 2H), 1.38 (s, 3H).</div></div><div id="sec5_4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-(4-Cyanophenyl)-4-methyl-<i>N</i>-[2-[4-(methylamino)-1-piperidyl]-2-oxo-ethyl]benzenesulfonamide (<b>16l</b>)</h4><div class="NLM_p last">Prepared by general method B using <i>tert</i>-butyl <i>N</i>-methyl-<i>N</i>-(piperidin-4-yl)carbamate to afford the title compound (21 mg, 39%) as a white powder. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.73–7.64 (m, 2H), 7.65–7.53 (m, 2H), 7.45–7.39 (m, 2H), 7.39–7.32 (m, 2H), 4.77 (d, <i>J</i> = 16.5 Hz, 1H), 4.63 (d, <i>J</i> = 16.5 Hz, 1H), 4.51 (d, <i>J</i> = 14.0 Hz, 1H), 4.18 (d, <i>J</i> = 14.0 Hz, 1H), 3.31–3.13 (m, 2H), 2.72 (s, 3H), 2.43 (s, 3H), 2.17 (m, 2H), 1.66 (qd, <i>J</i> = 12.3, 4.3 Hz, 1H), 1.43 (qd, <i>J</i> = 12.3, 4.3 Hz, 1H).</div></div><div id="sec5_4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-(4-Cyanophenyl)-<i>N</i>-[2-[4-(dimethylamino)-1-piperidyl]-2-oxo-ethyl]-4-methyl-benzenesulfonamide (<b>16m</b>)</h4><div class="NLM_p last">Prepared by general method A using 4-dimethylaminopiperidine to afford the title compound (26 mg, 65%) as a white powder. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.71–7.63 (m, 2H), 7.63–7.55 (m, 2H), 7.45–7.39 (m, 2H), 7.39–7.32 (m, 2H), 4.76 (d, <i>J</i> = 16.5 Hz, 1H), 4.64 (d, <i>J</i> = 16.5 Hz, 1H), 4.56 (d, <i>J</i> = 14.0 Hz, 1H), 4.20 (d, <i>J</i> = 14.0 Hz, 1H), 3.19 (t, <i>J</i> = 12.6 Hz, 1H), 2.78 (s, 6H), 2.74–2.59 (m, 1H), 2.43 (s, 3H), 2.12 (m, 2H), 1.75 (qd, <i>J</i> = 12.2, 4.2 Hz, 1H), 1.51 (dd, <i>J</i> = 12.2, 4.2 Hz, 1H).</div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Preparation of Compounds <b>21</b>–<b>27</b></h3><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-Acetyl-<i>N</i>-(4-cyanophenyl)indoline-5-sulfonamide (<b>18</b>)</h4><div class="NLM_p last">Prepared in a manner analogous to compound <b>11</b> to afford the title compound as a light-orange powder (486 mg, 84%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.95 (s, 1H), 8.11 (d, <i>J</i> = 8.4 Hz, 1H), 7.76–7.61 (m, 4H), 7.29–7.17 (m, 2H), 4.11 (t, <i>J</i> = 8.6 Hz, 2H), 3.15 (t, <i>J</i> = 8.6 Hz, 2H), 2.15 (s, 3H). LC-MS: (high pH) <i>t</i><sub>R</sub> 0.76 min, <i>m</i>/<i>z</i> 340.1 [M – H]<sup>−</sup>, 96% purity.</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 4-Cyano-<i>N</i>-(2-methylindazol-5-yl)benzenesulfonamide (<b>19</b>)</h4><div class="NLM_p last">To a stirred solution of 2-methyl-2<i>H</i>-indazol-5-amine (1 g, 6.8 mmol) in pyridine (0.9 mL) and acetonitrile (4 mL) was added 4-cyanobenzenesulfonyl chloride (1.51 g, 7.5 mmol). The reaction mixture was stirred at room temperature overnight, then water (50 mL) was added and the resulting light-orange precipitate collected by filtration, washed with water (3 × 20 mL), and dried under vacuum at 50 °C to the title compound (1.15 g, 54%) as a light-orange powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.36 (s, 1H), 8.25 (s, 1H), 8.00 (d, <i>J</i> = 8.4 Hz, 2H), 7.88–7.82 (m, 2H), 7.82–7.74 (m, 1H), 7.49 (dd, <i>J</i> = 9.1, 0.9 Hz, 1H), 7.36 (d, <i>J</i> = 2.0 Hz, 1H), 6.98 (dd, <i>J</i> = 9.1, 2.0 Hz, 1H), 4.11 (s, 3H). LC-MS: (high pH) <i>t</i><sub>R</sub> 0.74 min, <i>m</i>/<i>z</i> 311.1 [M – H]<sup>−</sup>, 100% purity.</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 1-Acetyl-<i>N</i>-[2-[(3<i>R</i>)-3-amino-1-piperidyl]-2-oxo-ethyl]-<i>N</i>-(4-cyanophenyl)indoline-5-sulfonamide (<b>21a</b>)</h4><div class="NLM_p last">A stirred suspension of <b>18</b> (30 mg, 0.09 mmol), <i>tert</i>-butyl <i>N</i>-[(3<i>R</i>)-1-(2-chloroacetyl)-3-piperidyl]carbamate (<b>SI1</b>, 27 mg, 0.10 mmol), potassium carbonate (18 mg, 0.13 mmol), and potassium iodide (2 mg) in DMF (800 μL) was stirred at 80 °C for 3 h. The reaction mixture was adsorbed onto silica and concentrated to dryness. Purification by CombiFlash (0–30% EtOAc in isohexane) afforded the Boc protected product. This was stirred in TFA (0.5 mL) and DCM (3 mL) then concentrated to dryness to afford the title compound (32 mg, 76%) as a white powder, TFA salt. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.19 (d, <i>J</i> = 8.8 Hz, 1H), 7.76–7.61 (m, 2H), 7.55 (d, <i>J</i> = 8.4 Hz, 2H), 7.44 (d, <i>J</i> = 8.4 Hz, 2H), 4.79 (d, <i>J</i> = 16.5 Hz, 1H), 4.67 (d, <i>J</i> = 16.5 Hz, 1H), 4.21 (t, <i>J</i> = 8.6 Hz, 2H), 3.93–3.77 (m, 1H), 3.67 (s, 3H), 3.24 (t, <i>J</i> = 8.9 Hz, 2H), 2.27 (s, 3H), 2.20–2.09 (m, 1H), 1.99–1.86 (m, 1H), 1.83–1.64 (m, 2H), 1.45 (d, <i>J</i> = 10.9 Hz, 1H).</div></div><div id="sec5_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-Acetyl-<i>N</i>-[2-(4-amino-1-piperidyl)-2-oxo-ethyl]-<i>N</i>-(4-cyanophenyl)indoline-5-sulfonamide (<b>21b</b>)</h4><div class="NLM_p last">A stirred suspension of <b>18</b> (50 mg, 0.15 mmol), <i>tert</i>-butyl <i>N</i>-[1-(2-chloroacetyl)-4-piperidyl]carbamate (<b>SI2</b>, 49 mg, 0.18 mmol), and potassium carbonate (40 mg, 0.29 mmol) in DMF (1 mL) was heated to 80 °C for 6 h. EtOAc (5 mL) was added and the reaction mixture filtered through an Isolute filter cartridge, then concentrated to dryness. HCl/dioxane (4 M, 1 mL) was then added. After 1 h, the reaction mixture was concentrated to dryness under vacuum, and the resulting residue was purified by preparative HPLC (high pH) to afford the title compound (29 mg, 41%) as a light-yellow powder. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.16 (d, <i>J</i> = 8.6 Hz, 1H), 7.71–7.59 (m, 2H), 7.53 (d, <i>J</i> = 7.8 Hz, 2H), 7.48–7.34 (m, 2H), 4.79 (d, <i>J</i> = 16.5 Hz, 1H), 4.65 (d, <i>J</i> = 16.5 Hz, 1H), 4.47 (d, <i>J</i> = 13.8 Hz, 1H), 4.29–4.09 (m, 3H), 3.40 (ddt, <i>J</i> = 11.8, 7.4, 4.1 Hz, 1H), 3.26–3.15 (m, 3H), 2.73 (td, <i>J</i> = 13.3, 12.6, 2.8 Hz, 1H), 2.26 (s, 3H), 2.14 (d, <i>J</i> = 12.5 Hz, 1H), 2.04 (d, <i>J</i> = 12.5 Hz, 1H), 1.68 (qd, <i>J</i> = 11.8, 4.1 Hz, 1H), 1.46 (qd, <i>J</i> = 11.8, 4.1 Hz, 1H).</div></div><div id="sec5_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-[2-[(3<i>R</i>)-3-Amino-1-piperidyl]-2-oxo-ethyl]-4-cyano-<i>N</i>-(2-methylindazol-5-yl)benzenesulfonamide (<b>22</b>)</h4><div class="NLM_p last">Prepared in a manner analogous to compound <b>21a</b> using sulfonamide <b>19</b> and <b>SI1</b> to afford the title compound as a white powder, TFA salt (18 mg, 25%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.32 (m, 2H), 8.17 (s, 2H), 8.13–7.99 (m, 3H), 7.83 (t, <i>J</i> = 8.6 Hz, 2H), 7.59–7.45 (m, 2H), 7.01 (dd, <i>J</i> = 9.0, 2.1 Hz, 1H), 4.81–4.68 (m, 2H), 4.63 (d, <i>J</i> = 16.9 Hz, 1H), 4.14 (s, 3H), 3.67 (m, 1H), 3.15–3.05 (m, 1H), 3.02–2.83 (m, 1H), 1.93 (s, 1H), 1.80–1.28 (m, 2H).</div></div><div id="sec5_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 1-Acetyl-<i>N</i>-[2-(4-amino-1-piperidyl)-2-oxo-ethyl]-<i>N</i>-[4-(3,5-dimethylpyrazol-1-yl)-3-methoxy-phenyl]indoline-5-sulfonamide (<b>23</b>)</h4><div class="NLM_p last">Prepared in a manner analogous to compound <b>21b</b> using sulfonamide <b>20</b> and <b>SI2</b> to afford the title compound as a white powder (34 mg, 52%). <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.55 (s, 1H), 8.20 (d, <i>J</i> = 9.0 Hz, 1H), 7.60–7.49 (m, 2H), 7.21 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H), 7.07 (d, <i>J</i> = 2.2 Hz, 1H), 6.90 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 6.05–5.98 (m, 1H), 4.73 (d, <i>J</i> = 16.2 Hz, 1H), 4.62 (d, <i>J</i> = 16.2 Hz, 1H), 4.51 (d, <i>J</i> = 13.9 Hz, 1H), 4.20 (t, <i>J</i> = 8.7 Hz, 3H), 3.71 (s, 3H), 3.71 (s, 1H), 3.39 (td, <i>J</i> = 7.3, 3.6 Hz, 1H), 3.24 (t, <i>J</i> = 8.7 Hz, 3H), 2.82–2.64 (m, 1H), 2.27 (s, 3H), 2.22 (d, <i>J</i> = 1.6 Hz, 3H), 2.12 (d, <i>J</i> = 11.9 Hz, 1H), 2.06 (s, 3H), 1.73–1.55 (m, 1H), 1.54–1.37 (m, 1H).</div></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Preparation of Compounds <b>29</b>–<b>32</b></h3><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Route to Glycine Core</h4><div id="sec5_6_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> <i>tert</i>-Butyl <i>N</i>-[1-[2-(4-Cyanoanilino)acetyl]-4-piperidyl]carbamate (<b>25</b>)</h5><div class="NLM_p last">To a solution of <i>N</i>-(4-cyanophenyl)glycine (1 g, 5.7 mmol), COMU (2.95 g, 6.8 mmol), and 4-[(<i>tert</i>-butoxycarbonyl)amino]piperidine (1.36 g, 6.8 mmol) in DMF (10 mL) was added <i>N</i>,<i>N</i>-diisopropylethylamine (1.93 mL, 11.35 mmol). After 10 min, a white precipitate formed. Stirring was continued for 30 min, then water (50 mL) was added. The precipitate was filtered, washed with water (3 × 10 mL), and dried to afford the title compound (2.02 g, 99%) as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.65–7.50 (m, 2H), 6.86–6.73 (m, 2H), 6.62 (t, <i>J</i> = 5.1 Hz, 1H), 6.21 (d, <i>J</i> = 9.1 Hz, 1H), 4.10 (d, <i>J</i> = 5.1 Hz, 2H), 3.66–3.48 (m, 1H), 3.56–3.35 (m, 3H), 3.42–3.29 (m, 1H), 1.82–1.67 (m, 4H), 1.40 (s, 9H). LC-MS: (high pH) <i>t</i><sub>R</sub> 1.07 min, <i>m</i>/<i>z</i> 357.2 [M – H]<sup>−</sup>, 100% purity.</div></div><div id="sec5_6_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> <i>tert</i>-Butyl <i>N</i>-[[1-[2-(4-Cyanoanilino)acetyl]-4-piperidyl]methyl]carbamate (<b>26</b>)</h5><div class="NLM_p last">To a solution of <i>N</i>-(4-cyanophenyl)glycine (0.5 g, 2.8 mmol) and COMU (730 mg, 3.4 mmol) in DMF (10 mL) was added <i>N</i>,<i>N</i>-diisopropylethylamine (0.97 mL, 5.7 mmol). After 10 min, a white precipitate formed. Stirring was continued for 30 min, and then water (50 mL) was added. The resulting white precipitate was filtered, washed with water (3 × 10 mL), and dried to afford the title compound (1.04 g, 98%) as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.51–7.40 (m, 2H), 6.90 (t, <i>J</i> = 5.9 Hz, 1H), 6.82–6.68 (m, 2H), 6.63 (t, <i>J</i> = 5.1 Hz, 1H), 4.34 (d, <i>J</i> = 13.3 Hz, 1H), 3.98 (t, <i>J</i> = 5.1 Hz, 2H), 3.88 (d, <i>J</i> = 13.3 Hz, 1H), 2.97 (t, <i>J</i> = 12.8 Hz, 1H), 2.87–2.78 (m, 2H), 2.58 (d, <i>J</i> = 12.8 Hz, 1H), 1.64 (t, <i>J</i> = 10.8 Hz, 4H), 1.38 (s, 9H), 1.20–0.79 (m, 2H). LC-MS: (high pH) <i>t</i><sub>R</sub> 1.07 min, <i>m</i>/<i>z</i> 372.3 [M – H]<sup>−</sup>, 100% purity.</div></div><div id="sec5_6_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> <i>tert</i>-Butyl <i>N</i>-[[1-[2-(4-Cyanoanilino)acetyl]-4-fluoro-4-piperidyl]methyl]carbamate (<b>27</b>)</h5><div class="NLM_p last">Prepared in a manner analogous to compound <b>25</b> using <b>24</b> and <i>tert</i>-butyl <i>N</i>-[(4-fluoropiperidin-4-yl)methyl]carbamate to afford the title compound (356 mg, 87%) as a pink powder. This product was used in the next step without further purification.</div></div><div id="sec5_6_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> <i>tert</i>-Butyl 7-[2-(4-Cyanoanilino)acetyl]-2,7-diazaspiro[3.5]nonane-2-carboxylate (<b>28</b>)</h5><div class="NLM_p last">To a solution of <i>N</i>-(4-cyanophenyl)glycine (370 mg, 2.1 mmol), COMU (1.08 g, 2.5 mmol), and <i>tert</i>-butyl-2,7-diazaspiro[3.5]nonane-2-carboxylate (500 mg, 2.2 mmol) in DMF (5 mL) at 0 °C was added <i>N</i>,<i>N</i>-diisopropylethylamine (0.71 mL, 4.2 mmol). After 10 min, a white precipitate formed. Stirring was continued for 30 min, then water (50 mL) was added. The precipitate was filtered, washed with water (3 × 10 mL), and recrystallized from ethyl acetate (30 mL) to afford the title compound (598 mg, 74%) as an off-white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.50–7.41 (m, 2H), 6.82–6.70 (m, 2H), 6.65 (t, <i>J</i> = 5.0 Hz, 1H), 3.99 (d, <i>J</i> = 5.0 Hz, 2H), 3.59 (br s, 4H), 3.40 (br s, 4H), 1.71 (t, <i>J</i> = 5.5 Hz, 2H), 1.61 (t, <i>J</i> = 5.5 Hz, 2H), 1.38 (s, 9H). LC-MS: (high pH) <i>t</i><sub>R</sub> 1.11 min, <i>m</i>/<i>z</i> 383.3 [M – H]<sup>−</sup>, 98% purity.</div></div><div id="sec5_6_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> 4-[[2-(4-Amino-1-piperidyl)-2-oxo-ethyl]-(<i>p</i>-tolylmethyl)amino]benzonitrile (<b>29a</b>)</h5><div class="NLM_p last">A stirred suspension of <i>tert</i>-butyl <i>N</i>-[1-[2-(4-cyanoanilino)acetyl]-4-piperidyl]carbamate (50 mg, 0.14 mmol), 4-methylbenzyl bromide (31 mg, 0.17 mmol), and potassium carbonate (48 mg, 0.35 mmol) in DMF (500 μL) was heated to 80 °C for 1 h, then concentrated to dryness. HCl in dioxane (4 M, 1 mL) was added and the reaction mixture stirred for 1 h, then concentrated to dryness and purified by preparative HPLC (high pH) to afford the title compound (17 mg, 34%) as a white powder. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.53–7.32 (m, 2H), 7.16 (s, 4H), 6.76–6.62 (m, 2H), 4.63 (s, 2H), 4.56 (d, <i>J</i> = 8.4 Hz, 1H), 4.48 (d, <i>J</i> = 4.5 Hz, 2H), 4.03 (d, <i>J</i> = 14.1 Hz, 1H), 3.47–3.33 (m, 1H), 3.30–3.14 (m, 1H), 2.79 (t, <i>J</i> = 12.3 Hz, 1H), 2.32 (s, 3H), 2.12–2.05 (m, 2H), 1.65 (qd, <i>J</i> = 12.3, 4.2 Hz, 1H), 1.51 (qd, <i>J</i> = 12.3, 4.2 Hz, 1H).</div></div><div id="sec5_6_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> 4-[(<i>N</i>-[2-(4-Amino-1-piperidyl)-2-oxo-ethyl]-4-cyano-anilino)methyl]-2-fluoro-benzonitrile (<b>29b</b>)</h5><div class="NLM_p last">Prepared in a manner analogous to compound <b>29a</b> using 4-cyano-3-fluorobenzyl bromide to afford the title compound (17 mg, 15%) as a white powder. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.74 (dd, <i>J</i> = 8.2, 6.7 Hz, 1H), 7.51–7.44 (m, 2H), 7.42–7.31 (m, 2H), 6.72–6.60 (m, 2H), 4.78 (s, 2H), 4.58 (d, <i>J</i> = 9.1 Hz, 2H), 4.06 (d, <i>J</i> = 14.3 Hz, 1H), 3.51–3.34 (m, 2H), 3.30–3.17 (m, 1H), 2.81 (t, <i>J</i> = 13.2 Hz, 1H), 2.10 (t, <i>J</i> = 13.2 Hz, 2H), 1.65 (qd, <i>J</i> = 12.3, 4.2 Hz, 1H), 1.51 (qd, <i>J</i> = 12.3, 4.2 Hz, 1H).</div></div><div id="sec5_6_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> 4-[[2-(4-Amino-1-piperidyl)-2-oxo-ethyl]-[(3-fluoro-4-methoxy-phenyl)methyl]amino]benzonitrile (<b>29c</b>)</h5><div class="NLM_p last">Prepared in a manner analogous to compound <b>29a</b> using 3-fluoro-4-methoxybenzyl bromide to afford the title compound (17 mg, 31%) as a white powder. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.55–7.36 (m, 2H), 7.15–6.94 (m, 4H), 6.78–6.64 (m, 2H), 4.61 (s, 3H), 4.51 (d, <i>J</i> = 6.0 Hz, 2H), 4.04 (d, <i>J</i> = 14.2 Hz, 1H), 3.86 (s, 3H), 3.23 (t, <i>J</i> = 12.8 Hz, 1H), 2.80 (t, <i>J</i> = 12.8 Hz, 1H), 2.09 (t, <i>J</i> = 11.9 Hz, 2H), 1.65 (m, 1H), 1.50 (m, 1H). <sup>19</sup>F NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ −135.7. <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>) δ 168.6, 154.0 (d, <i>J</i> = 245 Hz), 153.2, 148.9, 133.8, 131.0 (d, <i>J</i> = 5.4 Hz), 122.5 (d, <i>J</i> = 3.6 Hz), 120.7, 115.8 (d, <i>J</i> = 18.8 Hz), 114.5, 113.4, 99.1, 86.4, 58.2, 56.1, 54.7, 49.2, 43.4, 33.0. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>26</sub>O<sub>2</sub>N<sub>4</sub>F 397.2034, found 397.2022.</div></div><div id="sec5_6_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 4-[[2-(4-Amino-1-piperidyl)-2-oxo-ethyl]-benzyl-amino]benzonitrile (<b>29d</b>)</h5><div class="NLM_p last">Prepared in a manner analogous to <b>29a</b> using benzyl bromide to afford the title compound (12 mg, 25%) as a white powder. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.51–7.39 (m, 2H), 7.41–7.21 (m, 5H), 6.77–6.65 (m, 2H), 4.68 (s, 2H), 4.64–4.41 (m, 3H), 4.03 (d, <i>J</i> = 14.0 Hz, 1H), 3.43–3.27 (m, 1H), 3.21 (t, <i>J</i> = 13.0 Hz, 1H), 2.79 (t, <i>J</i> = 13.0 Hz, 1H), 2.17–1.95 (m, 2H), 1.70–1.55 (m, 1H), 1.58–1.39 (m, 1H).</div></div><div id="sec5_6_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> 4-[[2-(4-Amino-1-piperidyl)-2-oxo-ethyl]-[(1-methylindazol-5-yl)methyl]amino]benzonitrile (<b>29e</b>)</h5><div class="NLM_p last">Prepared in a manner analogous to <b>29a</b> using 5-(bromomethyl)-1-methyl-1<i>H</i>-indazole hydrobromide to afford the title compound (13 mg, 21%) as a white powder. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.93 (d, <i>J</i> = 0.9 Hz, 1H), 7.65 (dd, <i>J</i> = 1.7, 0.9 Hz, 1H), 7.56 (dt, <i>J</i> = 8.6, 0.9 Hz, 1H), 7.50–7.35 (m, 3H), 6.80–6.69 (m, 2H), 4.79 (s, 2H), 4.61 (s, 1H), 4.54 (d, <i>J</i> = 6.0 Hz, 2H), 4.06 (s, 3H), 4.01 (s, 1H), 3.46–3.28 (m, 1H), 3.22 (t, <i>J</i> = 13.0 Hz, 1H), 2.80 (q, <i>J</i> = 12.1, 11.7 Hz, 1H), 2.13–2.01 (m, 2H), 1.71–1.45 (m, 2H).</div></div><div id="sec5_6_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> 4-[[2-[4-(Aminomethyl)-1-piperidyl]-2-oxo-ethyl]-(<i>p</i>-tolylmethyl)amino]benzonitrile (<b>30a</b>)</h5><div class="NLM_p last">Prepared in a manner analogous to <b>30b</b> (see below), affording the title compound (25 mg, 47%) as a white powder, bis-hydrochloride salt. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.50–7.38 (m, 2H), 7.16 (s, 4H), 6.78–6.66 (m, 2H), 4.62 (s, 2H), 4.55 (d, <i>J</i> = 13.7 Hz, 1H), 4.45 (s, 2H), 3.96 (d, <i>J</i> = 14.0 Hz, 1H), 3.15 (q, <i>J</i> = 11.1, 9.4 Hz, 1H), 2.95–2.84 (m, 2H), 2.72 (t, <i>J</i> = 13.1 Hz, 1H), 2.32 (s, 3H), 1.97 (tt, <i>J</i> = 7.3, 3.8 Hz, 1H), 1.86 (d, <i>J</i> = 13.4 Hz, 2H), 1.40–1.15 (m, 2H). <sup>13</sup>C NMR (75 MHz, methanol-<i>d</i><sub>4</sub>) δ 168.9, 153.7, 138.1, 135.7, 134.3, 130.5, 127.8, 121.3, 113.7, 99.0, 56.4, 52.9, 45.4, 42.9, 35.6, 30.1, 21.1. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>29</sub>ON<sub>4</sub> 377.2336, found 377.2320.</div></div><div id="sec5_6_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> 4-[[2-[4-(Aminomethyl)-1-piperidyl]-2-oxo-ethyl]-[(4-chlorophenyl)methyl]amino]benzonitrile (<b>30b</b>)</h5><div class="NLM_p last">A stirred suspension of <i>tert</i>-butyl <i>N</i>-[[1-[2-(4-cyanoanilino)acetyl]-4-piperidyl]methyl]carbamate (50. mg, 0.14 mmol), 4-chlorobenzyl bromide (43 mg, 0.21 mmol), and potassium carbonate (48 mg, 0.35 mmol) in DMF (0.5 mL) was heated to 80 °C for 1 h, then purified by HPLC (high pH). HCl in dioxane (4 M, 1 mL) was added and the reaction mixture concentrated to dryness to afford the title compound (27 mg, 37%) as a white powder, bis-hydrochloride salt. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.42–7.29 (m, 2H), 7.35–7.13 (m, 6H), 6.58 (dd, <i>J</i> = 9.8, 2.8 Hz, 2H), 4.78 (d, <i>J</i> = 1.1 Hz, 2H), 4.55 (d, <i>J</i> = 7.0 Hz, 3H), 3.87 (d, <i>J</i> = 14.1 Hz, 1H), 3.14–2.98 (m, 1H), 2.79 (dd, <i>J</i> = 7.2, 2.9 Hz, 2H), 1.76 (s, 2H), 1.43–1.01 (m, 3H).</div></div><div id="sec5_6_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> 4-[[2-[4-(Aminomethyl)-1-piperidyl]-2-oxo-ethyl]-[(4-fluorophenyl)methyl]amino]benzonitrile (<b>30c</b>)</h5><div class="NLM_p last">Prepared in a manner analogous to <b>30b</b> using 4-fluorobenzyl bromide to afford the title compound (13 mg, 21%) as a white powder, bis-hydrochloride salt. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.40–7.28 (m, 2H), 7.28–7.14 (m, 2H), 7.04–6.89 (m, 2H), 6.66–6.54 (m, 2H), 4.55 (s, 2H), 4.44 (d, <i>J</i> = 13.2 Hz, 1H), 4.37 (s, 2H), 3.88 (d, <i>J</i> = 13.9 Hz, 1H), 3.70–3.54 (m, 1H), 3.06 (t, <i>J</i> = 13.0 Hz, 1H), 2.90–2.71 (m, 2H), 2.62 (td, <i>J</i> = 13.0, 2.7 Hz, 1H), 1.97–1.66 (m, 3H), 1.35 (d, <i>J</i> = 13.0 Hz, 1H), 1.30–1.00 (m, 2H).</div></div><div id="sec5_6_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> 3-[(<i>N</i>-[2-[4-(Aminomethyl)-1-piperidyl]-2-oxo-ethyl]-4-cyano-anilino)methyl]benzamide (<b>30d</b>)</h5><div class="NLM_p last">Prepared in a manner analogous to <b>30b</b> using 3-(chloromethyl)benzamide to afford the title compound (14 mg, 22%) as a white powder, bis-hydrochloride salt. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.76–7.62 (m, 2H), 7.49–7.29 (m, 4H), 6.67–6.55 (m, 2H), 4.63 (d, <i>J</i> = 1.8 Hz, 2H), 4.42 (s, 3H), 3.89 (d, <i>J</i> = 13.8 Hz, 1H), 3.21 (t, <i>J</i> = 1.8 Hz, 1H), 3.06 (t, <i>J</i> = 12.9 Hz, 1H), 2.84–2.74 (m, 2H), 2.71–2.53 (m, 1H), 1.87 (tt, <i>J</i> = 7.3, 3.8 Hz, 2H), 1.76 (m, 3H), 1.30–1.00 (m, 2H).</div></div><div id="sec5_6_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> 4-[(<i>N</i>-[2-[4-(Aminomethyl)-1-piperidyl]-2-oxo-ethyl]-4-cyano-anilino)methyl]benzamide (<b>30e</b>)</h5><div class="NLM_p last">Prepared in a manner analogous to <b>30b</b> using 4-(chloromethyl)benzamide to afford the title compound (12 mg, 18%) as a white powder, bis-hydrochloride salt. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.81–7.70 (m, 2H), 7.39–7.33 (m, 2H), 7.33–7.25 (m, 2H), 6.59 (d, <i>J</i> = 9.0 Hz, 2H), 4.64 (s, 2H), 4.49–4.42 (m, 1H), 4.40 (s, 2H), 3.88 (d, <i>J</i> = 14.1 Hz, 1H), 3.68–3.53 (m, 4H), 3.06 (t, <i>J</i> = 12.7 Hz, 1H), 2.78 (dd, <i>J</i> = 6.9, 4.1 Hz, 2H), 2.62 (t, <i>J</i> = 12.6 Hz, 1H), 2.00–1.62 (m, 2H), 1.44–1.00 (m, 1H).</div></div><div id="sec5_6_1_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> 4-[[2-[4-(Aminomethyl)-1-piperidyl]-2-oxo-ethyl]-[(3-fluoro-4-methoxy-phenyl)methyl]amino]benzonitrile (<b>30f</b>)</h5><div class="NLM_p last">Prepared in a manner analogous to <b>30b</b> using 3-fluoro-4-methoxybenzyl bromide to afford the title compound (23 mg, 40%) as a white powder, bis-hydrochloride salt. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.42–7.29 (m, 2H), 7.03–6.89 (m, 3H), 6.67–6.55 (m, 2H), 4.50 (s, 2H), 4.43 (d, <i>J</i> = 14.7 Hz, 1H), 4.36 (s, 2H), 3.89 (d, <i>J</i> = 14.7 Hz, 1H), 3.76 (s, 3H), 3.06 (t, <i>J</i> = 12.8 Hz, 1H), 2.79 (dd, <i>J</i> = 6.8, 3.7 Hz, 2H), 2.62 (t, <i>J</i> = 12.8 Hz, 1H), 1.96–1.53 (m, 3H), 1.26–1.04 (m, 2H). <sup>13</sup>C NMR (75 MHz, MeOD) δ 169.0, 153.9 (d, <i>J</i> = 247 Hz), 153.5, 148.4, 134.1, 131.9 (d, <i>J</i> = 5.4 Hz), 124.2 (d, <i>J</i> = 3.6 Hz), 121.0, 115.9, 114.5 (d, <i>J</i> = 18.9 Hz), 114.2, 99.7, 56.8, 55.9, 53.1, 45.2, 42.9, 35.6, 30.1. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>28</sub>O<sub>2</sub>N<sub>4</sub>F 411.2191, found 411.2175.</div></div><div id="sec5_6_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> 4-[[2-[4-(Aminomethyl)-4-fluoro-1-piperidyl]-2-oxo-ethyl]-[(3-fluoro-4-methoxy-phenyl)methyl]amino]benzonitrile (<b>31</b>)</h5><div class="NLM_p last">Prepared in a manner analogous to <b>30b</b> using acid <b>27</b> as a starting material to afford the title compound as a white powder (9 mg, 17%), bis-hydrochloride salt. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.45 (dd, <i>J</i> = 8.9, 4.0 Hz, 2H), 7.22–6.93 (m, 2H), 6.83–6.62 (m, 2H), 4.68–4.34 (m, 4H), 3.88 (s, 3H), 3.86–3.54 (m, 2H), 3.67 (s, 1H), 3.45 (t, <i>J</i> = 12.5 Hz, 1H), 3.28 (d, <i>J</i> = 3.0 Hz, 1H), 3.22 (s, 1H), 3.05 (t, <i>J</i> = 12.8 Hz, 1H), 2.17–1.57 (m, 8H). <sup>19</sup>F NMR (282 MHz, methanol-<i>d</i><sub>4</sub>) δ −136.50 (m), −169.24 (dddt, <i>J</i> = 38.0, 29.5, 20.2, 10.0 Hz).</div></div><div id="sec5_6_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> 4-[[2-(2,7-Diazaspiro[3.5]nonan-7-yl)-2-oxo-ethyl]-[(3-fluoro-4-methoxy-phenyl)methyl]amino]benzonitrile (<b>32</b>)</h5><div class="NLM_p last">A stirred suspension of <b>28</b> (330 mg, 0.64 mmol), 4-(bromomethyl)-2-fluoro-1-methoxybenzene (282 mg, 1.3 mmol), and potassium carbonate (222 mg, 1.6 mmol) in DMF (3 mL) was heated to 120 °C by microwave irradiation for 0.5 h. The reaction mixture was adsorbed onto silica then purified by automated column chromatography (0–70% EtOAc in isohexane). HCl/dioxane (4 M, 1 mL) was added and the mixture stirred for 1 h, then concentrated to dryness. The resulting residue was purified by preparative HPLC (high pH) to afford the title compound (33 mg, 12%) as a white powder. <sup>1</sup>H{<sup>19</sup>F} NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ, <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.58 (s, 1H), 7.51–7.39 (m, 2H), 7.13–6.99 (m, 3H), 6.76–6.65 (m, 2H), 4.60 (s, 2H), 4.46 (s, 2H), 3.86 (s, 3H), 3.57 (br m, 2H), 3.50 (br m, 3H), 3.36 (s, 1H), 1.93 (br m, 2H), 1.86 (br m, 2H). <sup>19</sup>F NMR (282 MHz, methanol-<i>d</i><sub>4</sub>) δ −136.57 (m). <sup>13</sup>C NMR (75 MHz, MeOD) δ 168.8, 153.8 (d, <i>J</i><sub>C,F</sub><i>=</i> 247 Hz), 153.3, 148.2, 134.2, 131.9 (d, <i>J</i><sub>C,F</sub><i>=</i> 5.4 Hz), 123.8 (d, <i>J</i><sub>C,F</sub><i>=</i> 3.6 Hz), 121.3, 115.5 (d, <i>J</i><sub>C,F</sub><i>=</i> 18.9 Hz), 115.0, 113.8, 99.2, 86.4, 56.8, 56.3, 52.9, 49.9, 42.4, 40.0, 38.2, 35.3. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>28</sub>O<sub>2</sub>N<sub>4</sub>F 423.2191, found 423.2181.</div></div></div></div><div id="sec5_6_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> LSD1 Enzymatic Assay</h3><div class="NLM_p last">Assays were performed in Corning 384-well low-flange white flat-bottom polystyrene (no. 3574) microplates in a 10 μL reaction volume consisting of 50 mM TrisHCl, 50 mM NaCl, 1 mM DTT, 0.01% Tween-20, and 1% DMSO with or without compound in a 10-point, 3-fold dilution series, 0.2 μM histone H3(1–21)K4(Me1) biotin peptide substrate (AnaSpec Inc., Freemont, CA) and 1 nM LSD1 (Enzo Life Sciences, New York, NY). The reaction was allowed to proceed for 30 min at 25 °C before stopping the reaction with the addition of 0.3 mM tranylcypromine in LANCE detection buffer and quantifying the level of demethylated peptide by the addition of 1 nM europium-α-unmodified H3K4 antibody and 25 nM ULight streptavidin (both from PerkinElmer, Waltham, MA), also in LANCE detection buffer. Following a further 60 min incubation period, the TR-FRET signal was read on a PHERAstar FS plate reader (BMG LabTech, Ortenberg, DE) with excitation at 340 nm and emission at 665 nm.</div></div><div id="sec5_6_1_18_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> SPR Binding Assay</h3><div class="NLM_p last">Direct binding between compounds and LSD1 was assessed by SPR using Biacore T200, S200, and S51 instruments (GE Healthcare, Uppsala, Sweden). LSD1 was immobilized to CM5 or CM7 chips using amine coupling. Interaction experiments were performed at 15 °C in 10 mM HEPES, pH 7.4, 150 mM NaCl, 1% DMSO, 0.05% Tween, at a flow rate of 30 mL/min. Compounds were diluted in the buffer and injected for 15–25 s at increasing concentrations over the prepared surfaces. Sensorgrams were double-referenced by subtracting signals from untreated reference channel and responses from blank injections. Affinities were derived by either dose–response analysis of steady-state responses or regressions analysis of whole sensorgrams (1:1 interaction model including a term for mass transport limitation) using the T200 evaluation software 3.0 (GE Healthcare).</div></div><div id="sec5_6_1_18_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Cell Lines</h3><div class="NLM_p last">THP1 and MV4-11 cell lines were obtained from DSMZ (Braunschweig, Germany). All cell lines were cultured in RPMI supplemented with 10% FBS and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Sigma-Aldrich, Poole, UK).</div></div><div id="sec5_6_1_18_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Clonogenic Assays</h3><div class="NLM_p last">Clonogenic assays of human leukemic cell lines were performed in methylcellulose medium (H4320, Stem Cell Technologies, Vancouver, BC) with no supplemental growth factors. Cells were seeded at 2.5 × 10<sup>3</sup> and colonies enumerated after 7 days in culture.</div></div><div id="sec5_6_1_18_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> CD86 and Apoptosis Assays</h3><div class="NLM_p last">For CD86 assays, leukemic cell lines were incubated in culture medium containing compounds or DMSO (vehicle control) for 48 h at a density of 1 × 10<sup>5</sup>/mL. Cells were pelleted, resuspended in 100 mL of SM buffer (Phenol red free RPMI, 5 mM EDTA, and 2% BSA (Sigma-Aldrich)) containing 0.25 μL of CD86-PerCP EF710 (Clone IT2.2, eBioscience, Thermo Fisher Scientific) and incubated at 4 °C for 10 min. Cells were washed, resuspended in SM buffer, and analyzed by flow cytometry. To determine the effects of compounds on apoptosis, leukemic cell lines were incubated with 10 μM compound or vehicle for 4 days. Apoptosis was assessed using a BD Pharmingen PerCP-Cy5.5 annexin V/7-AAD Kit (BD Biosciences) according to manufacturer’s instructions. All FACS analyses were performed using either an LSR model II (BD Biosciences, Oxford, UK) or NovoCyte (ACEA Biosciences) flow cytometer or FACSArray bioanalyzer (BD Biosciences).</div></div><div id="sec5_6_1_18_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Glide Docking</h3><div class="NLM_p last">Docking into the active site of LSD1 was carried out for each of the synthesized ligands. Molecules were docked in their predicted charged form at pH 7.4. Compounds were docked into the crystal structure of tetrahydrofolate bound to LSD1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KUM">4KUM</a>) with all structural waters removed. Docking was performed in Glide 6.7 in standard precision mode and without further minimization. Glidescore was used for conformation scoring of each ligand.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00462">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02611" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02611" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00462" class="ext-link">10.1021/acs.jmedchem.7b00462</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">SPR sensorgrams for selected compounds; LC-MS methods and solvent gradients; preparative HPLC instrument and solvent gradients; summary of purity data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00462/suppl_file/jm7b00462_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00462/suppl_file/jm7b00462_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00462/suppl_file/jm7b00462_si_001.pdf">jm7b00462_si_001.pdf (360.62 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00462/suppl_file/jm7b00462_si_002.csv">jm7b00462_si_002.csv (2.46 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00462" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75684" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75684" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allan M. Jordan</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Unit,
Cancer Research UK Manchester Institute, University of Manchester, Wilmslow Road, Manchester, M20 4BX, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3449-3993" title="Orcid link">http://orcid.org/0000-0003-3449-3993</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3958555558571753564b5d5857795a4b4c52175458575a515c4a4d5c4b17585a174c52"><span class="__cf_email__" data-cfemail="afcec3c3cec181c5c0ddcbcec1efccdddac481c2cec1ccc7cadcdbcadd81cecc81dac4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel P. Mould</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Unit,
Cancer Research UK Manchester Institute, University of Manchester, Wilmslow Road, Manchester, M20 4BX, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6501-4938" title="Orcid link">http://orcid.org/0000-0001-6501-4938</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Alli</span> - <span class="hlFld-Affiliation affiliation">CRT Discovery Laboratories, Babraham Campus, Babraham, Cambridgeshire CB22 3AT, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulf Bremberg</span> - <span class="hlFld-Affiliation affiliation">Beactica
AB, Uppsala Business
Park, Virdings allé 2, 75450, Uppsala, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sharon Cartic</span> - <span class="hlFld-Affiliation affiliation">CRT Discovery Laboratories, Babraham Campus, Babraham, Cambridgeshire CB22 3AT, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthis Geitmann</span> - <span class="hlFld-Affiliation affiliation">Beactica
AB, Uppsala Business
Park, Virdings allé 2, 75450, Uppsala, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alba Maiques-Diaz</span> - <span class="hlFld-Affiliation affiliation">Leukaemia
Biology Laboratory, Cancer Research UK Manchester Institute, University of Manchester, Wilmslow Road, Manchester, M20 4BX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alison E. McGonagle</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Unit,
Cancer Research UK Manchester Institute, University of Manchester, Wilmslow Road, Manchester, M20 4BX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tim C. P. Somervaille</span> - <span class="hlFld-Affiliation affiliation">Leukaemia
Biology Laboratory, Cancer Research UK Manchester Institute, University of Manchester, Wilmslow Road, Manchester, M20 4BX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary J. Spencer</span> - <span class="hlFld-Affiliation affiliation">Leukaemia
Biology Laboratory, Cancer Research UK Manchester Institute, University of Manchester, Wilmslow Road, Manchester, M20 4BX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrice Turlais</span> - <span class="hlFld-Affiliation affiliation">CRT Discovery Laboratories, Babraham Campus, Babraham, Cambridgeshire CB22 3AT, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald Ogilvie</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Unit,
Cancer Research UK Manchester Institute, University of Manchester, Wilmslow Road, Manchester, M20 4BX, U.K.</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Tim Somervaille has ongoing research collaborations with Oryzon Genomics and consults for Imago Biosciences. The other authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d189e3718-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53865" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53865" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by Cancer Research UK (grants C5759/A12328, C480/A11411, C5759/A17098, and C5759/A02901). Additional support was provided to DPM by the Society of Chemical Industry through a Messel Scholarship. HRMS spectra were generated by Gareth Smith, School of Chemistry, University of Manchester, Manchester, UK. Assistance with Glide docking was kindly provided by Bohdan Waszkowycz. In vitro pharmacokinetic and hERG data was provided by Cyprotex Discovery, Macclesfield, UK. JChem for Excel was used for structure property prediction and calculation and general data handling (JChem for Excel, version 15.6.2900, 2008–2015, ChemAxon (<a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>)). Ligand interaction diagrams in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a> were generated within Maestro (Schrödinger, LLC, New York, NY), and images of protein–ligand complexes within the PyMOL Molecular Graphics System, version 1.7.6.2. (Schrödinger, LLC, New York, NY).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i77" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i77"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i78" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i78"> Abbreviations Used</h2><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">APL</td><td class="NLM_def"><p class="first last">acute promyelocytic leukemia</p></td></tr><tr><td class="NLM_term">ATRA</td><td class="NLM_def"><p class="first last">all-<i>trans</i> retinoic acid</p></td></tr><tr><td class="NLM_term">COMU</td><td class="NLM_def"><p class="first last">1-cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino-carbenium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">GFI</td><td class="NLM_def"><p class="first last">growth factor independence</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>d</sub></td><td class="NLM_def"><p class="first last">dissociation constant</p></td></tr><tr><td class="NLM_term">LSD1</td><td class="NLM_def"><p class="first last">lysine specific demethylase 1</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">MLL</td><td class="NLM_def"><p class="first last">mixed lineage leukemia</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">time-resolved fluorescence resonance energy transfer</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 42 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whetstine, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casero, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Histone demethylation mediated by the nuclear amine oxidase homolog LSD1</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">953</span><span class="refDoi"> DOI: 10.1016/j.cell.2004.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.cell.2004.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=15620353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2004&pages=941-953&author=Y.+Shiauthor=F.+Lanauthor=C.+Matsonauthor=P.+Mulliganauthor=J.+R.+Whetstineauthor=P.+A.+Coleauthor=R.+A.+Caseroauthor=Y.+Shi&title=Histone+demethylation+mediated+by+the+nuclear+amine+oxidase+homolog+LSD1&doi=10.1016%2Fj.cell.2004.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Histone demethylation mediated by the nuclear amine oxidase homolog LSD1</span></div><div class="casAuthors">Shi, Yujiang; Lan, Fei; Matson, Caitlin; Mulligan, Peter; Whetstine, Johnathan R.; Cole, Philip A.; Casero, Robert A.; Shi, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">941-953</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Posttranslational modifications of histone N-terminal tails impact chromatin structure and gene transcription.  While the extent of histone acetylation is detd. by both acetyltransferases and deacetylases, it has been unclear whether histone methylation is also regulated by enzymes with opposing activities.  Here, we provide evidence that LSD1 (KIAA0601), a nuclear homolog of amine oxidases, functions as a histone demethylase and transcriptional corepressor.  LSD1 specifically demethylates histone H3 lysine 4, which is linked to active transcription.  Lysine demethylation occurs via an oxidn. reaction that generates formaldehyde.  Importantly, RNAi inhibition of LSD1 causes an increase in H3 lysine 4 methylation and concomitant derepression of target genes, suggesting that LSD1 represses transcription via histone demethylation.  The results thus identify a histone demethylase conserved from S. pombe to human and reveal dynamic regulation of histone methylation by both histone methylases and demethylases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXHr-8kwGdXrVg90H21EOLACvtfcHk0ljltpM0M1cJLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlSitg%253D%253D&md5=3474569204255e90a832667ba654748b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2004.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2004.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.%26aulast%3DLan%26aufirst%3DF.%26aulast%3DMatson%26aufirst%3DC.%26aulast%3DMulligan%26aufirst%3DP.%26aulast%3DWhetstine%26aufirst%3DJ.%2BR.%26aulast%3DCole%26aufirst%3DP.%2BA.%26aulast%3DCasero%26aufirst%3DR.%2BA.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DHistone%2520demethylation%2520mediated%2520by%2520the%2520nuclear%2520amine%2520oxidase%2520homolog%2520LSD1%26jtitle%3DCell%26date%3D2004%26volume%3D119%26spage%3D941%26epage%3D953%26doi%3D10.1016%2Fj.cell.2004.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Amente, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lania, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majello, B.</span><span> </span><span class="NLM_article-title">The histone LSD1 demethylase in stemness and cancer transcription programs</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Gene Regul. Mech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1829</span><span class="NLM_x">, </span> <span class="NLM_fpage">981</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span><span class="refDoi"> DOI: 10.1016/j.bbagrm.2013.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.bbagrm.2013.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=23684752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCls7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1829&publication_year=2013&pages=981-986&author=S.+Amenteauthor=L.+Laniaauthor=B.+Majello&title=The+histone+LSD1+demethylase+in+stemness+and+cancer+transcription+programs&doi=10.1016%2Fj.bbagrm.2013.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The histone LSD1 demethylase in stemness and cancer transcription programs</span></div><div class="casAuthors">Amente, Stefano; Lania, Luigi; Majello, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Gene Regulatory Mechanisms</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1829</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">981-986</span>CODEN:
                <span class="NLM_cas:coden">BBAGC6</span>;
        ISSN:<span class="NLM_cas:issn">1874-9399</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  DNA and histone chromatin modifying enzymes play a crucial role in chromatin remodeling in several biol. processes.  Lysine-specific demethylase 1 (LSD1), the first identified histone demethylase, is a relevant player in the regulation of a broad spectrum of biol. processes including development, cellular differentiation, embryonic pluripotency and cancer.  Here, we review recent insights on the role of LSD1 activity in chromatin regulatory complexes, its functional role in the epigenetic changes during embryonic development, in the establishment and maintenance of stemness and during cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbcvNabWazwbVg90H21EOLACvtfcHk0ljltpM0M1cJLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCls7fF&md5=ea0ef4256c790ff25251b16cbb2880a5</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagrm.2013.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagrm.2013.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DAmente%26aufirst%3DS.%26aulast%3DLania%26aufirst%3DL.%26aulast%3DMajello%26aufirst%3DB.%26atitle%3DThe%2520histone%2520LSD1%2520demethylase%2520in%2520stemness%2520and%2520cancer%2520transcription%2520programs%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gene%2520Regul.%2520Mech.%26date%3D2013%26volume%3D1829%26spage%3D981%26epage%3D986%26doi%3D10.1016%2Fj.bbagrm.2013.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Shi, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwase, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Regulation of LSD1 histone demethylase activity by its associated factors</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">864</span><span class="refDoi"> DOI: 10.1016/j.molcel.2005.08.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.molcel.2005.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=16140033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVyhtbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=857-864&author=Y.-J.+Shiauthor=C.+Matsonauthor=F.+Lanauthor=S.+Iwaseauthor=T.+Babaauthor=Y.+Shi&title=Regulation+of+LSD1+histone+demethylase+activity+by+its+associated+factors&doi=10.1016%2Fj.molcel.2005.08.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of LSD1 histone demethylase activity by its associated factors</span></div><div class="casAuthors">Shi, Yu-Jiang; Matson, Caitlin; Lan, Fei; Iwase, Shigeki; Baba, Tadashi; Shi, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">857-864</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">LSD1 is a recently identified human lysine (K)-specific histone demethylase.  LSD1 is assocd. with HDAC1/2, with CoREST, a SANT domain-contg. corepressor, and with BHC80, a PHD domain-contg. protein, among others.  We show that CoREST confers on LSD1 the ability to demethylate nucleosomal substrates and that it protects LSD1 from proteasomal degrdn. in vivo.  We find hyperacetylated nucleosomes less susceptible to CoREST/LSD1-mediated demethylation, suggesting that hypoacetylated nucleosomes may be the preferred physiol. substrates.  This raises the possibility that histone deacetylases and LSD1 may collaborate to generate a repressive chromatin environment.  Consistent with this model, TSA treatment results in derepression of LSD1 target genes.  While CoREST pos. regulates LSD1 function, BHC80 inhibits CoREST/LSD1-mediated demethylation in vitro and may therefore confer neg. regulation.  Taken together, these findings suggest that LSD1-mediated histone demethylation is regulated dynamically in vivo.  This is expected to have profound effects on gene expression under both physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraharVnxcaMLVg90H21EOLACvtfcHk0lj1Z3yO5rz01Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyhtbzK&md5=34ba238112151c6596dd6f6c7caa043e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.08.027%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.-J.%26aulast%3DMatson%26aufirst%3DC.%26aulast%3DLan%26aufirst%3DF.%26aulast%3DIwase%26aufirst%3DS.%26aulast%3DBaba%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DRegulation%2520of%2520LSD1%2520histone%2520demethylase%2520activity%2520by%2520its%2520associated%2520factors%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D19%26spage%3D857%26epage%3D864%26doi%3D10.1016%2Fj.molcel.2005.08.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Laurent, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruitu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hempel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">A specific LSD1/KDM1A isoform regulates neuronal differentiation through H3K9 demethylation</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">957</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span><span class="refDoi"> DOI: 10.1016/j.molcel.2015.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.molcel.2015.01.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2015&pages=957-970&author=B.+Laurentauthor=L.+Ruituauthor=J.+Murnauthor=K.+Hempelauthor=R.+Ferraoauthor=Y.+Xiangauthor=S.+Liuauthor=B.+A.+Garciaauthor=H.+Wuauthor=F.+Wuauthor=H.+Steenauthor=Y.+Shi&title=A+specific+LSD1%2FKDM1A+isoform+regulates+neuronal+differentiation+through+H3K9+demethylation&doi=10.1016%2Fj.molcel.2015.01.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2015.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2015.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DLaurent%26aufirst%3DB.%26aulast%3DRuitu%26aufirst%3DL.%26aulast%3DMurn%26aufirst%3DJ.%26aulast%3DHempel%26aufirst%3DK.%26aulast%3DFerrao%26aufirst%3DR.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DGarcia%26aufirst%3DB.%2BA.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DSteen%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DA%2520specific%2520LSD1%252FKDM1A%2520isoform%2520regulates%2520neuronal%2520differentiation%2520through%2520H3K9%2520demethylation%26jtitle%3DMol.%2520Cell%26date%3D2015%26volume%3D57%26spage%3D957%26epage%3D970%26doi%3D10.1016%2Fj.molcel.2015.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Yang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gocke, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomchick, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span> </span><span class="NLM_article-title">Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1016/j.molcel.2006.07.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.molcel.2006.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=16885027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVWlu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=377-387&author=M.+Yangauthor=C.+B.+Gockeauthor=X.+Luoauthor=D.+Borekauthor=D.+R.+Tomchickauthor=M.+Machiusauthor=Z.+Otwinowskiauthor=H.+Yu&title=Structural+basis+for+CoREST-dependent+demethylation+of+nucleosomes+by+the+human+LSD1+histone+demethylase&doi=10.1016%2Fj.molcel.2006.07.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase</span></div><div class="casAuthors">Yang, Maojun; Gocke, Christian B.; Luo, Xuelian; Borek, Dominika; Tomchick, Diana R.; Machius, Mischa; Otwinowski, Zbyszek; Yu, Hongtao</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-387</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone methylation regulates diverse chromatin-templated processes, including transcription.  Many transcriptional corepressor complexes contain lysine-specific demethylase 1 (LSD1) and CoREST that collaborate to demethylate mono- and dimethylated H3-K4 of nucleosomes.  Here, we report the crystal structure of the LSD1-CoREST complex.  LSD1-CoREST forms an elongated structure with a long stalk connecting the catalytic domain of LSD1 and the CoREST SANT2 domain.  LSD1 recognizes a large segment of the H3 tail through a deep, neg. charged pocket at the active site and possibly a shallow groove on its surface.  CoREST SANT2 interacts with DNA.  Disruption of the SANT2-DNA interaction diminishes CoREST-dependent demethylation of nucleosomes by LSD1.  The shape and dimension of LSD1-CoREST suggest its bivalent binding to nucleosomes, allowing efficient H3-K4 demethylation.  This spatially sepd., multivalent nucleosome binding mode may apply to other chromatin-modifying enzymes that generally contain multiple nucleosome binding modules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon5vOAvWkcXrVg90H21EOLACvtfcHk0lj1Z3yO5rz01Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVWlu74%253D&md5=32aa853fd60a8a562900defa70d658c0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2006.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2006.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DM.%26aulast%3DGocke%26aufirst%3DC.%2BB.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DBorek%26aufirst%3DD.%26aulast%3DTomchick%26aufirst%3DD.%2BR.%26aulast%3DMachius%26aufirst%3DM.%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DH.%26atitle%3DStructural%2520basis%2520for%2520CoREST-dependent%2520demethylation%2520of%2520nucleosomes%2520by%2520the%2520human%2520LSD1%2520histone%2520demethylase%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D23%26spage%3D377%26epage%3D387%26doi%3D10.1016%2Fj.molcel.2006.07.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Saleque, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooke, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orkin, S. H.</span><span> </span><span class="NLM_article-title">Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span><span class="refDoi"> DOI: 10.1016/j.molcel.2007.06.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.molcel.2007.06.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=562-572&author=S.+Salequeauthor=J.+Kimauthor=H.+M.+Rookeauthor=S.+H.+Orkin&title=Epigenetic+regulation+of+hematopoietic+differentiation+by+Gfi-1+and+Gfi-1b+is+mediated+by+the+cofactors+CoREST+and+LSD1&doi=10.1016%2Fj.molcel.2007.06.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.06.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.06.039%26sid%3Dliteratum%253Aachs%26aulast%3DSaleque%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DRooke%26aufirst%3DH.%2BM.%26aulast%3DOrkin%26aufirst%3DS.%2BH.%26atitle%3DEpigenetic%2520regulation%2520of%2520hematopoietic%2520differentiation%2520by%2520Gfi-1%2520and%2520Gfi-1b%2520is%2520mediated%2520by%2520the%2520cofactors%2520CoREST%2520and%2520LSD1%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D27%26spage%3D562%26epage%3D572%26doi%3D10.1016%2Fj.molcel.2007.06.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyoshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazuhide, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairiki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hikichi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchida, K.</span><span> </span><span class="NLM_article-title">A novel LSD1 inihibitor T-3775440 disrupts GFI1B containing complex leading to transdifferentiation and imparied growth of AML cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-16-0471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1158%2F1535-7163.MCT-16-0471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=27903753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVertr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=273-284&author=Y.+Ishikawaauthor=K.+Gamoauthor=M.+Yabukiauthor=S.+Takagiauthor=K.+Toyoshimaauthor=N.+Kazuhideauthor=K.+Nakayamaauthor=A.+Nakayamaauthor=M.+Morimotoauthor=H.+Miyashitaauthor=R.+Dairikiauthor=Y.+Hikichiauthor=N.+Tomitaauthor=D.+Tomitaauthor=S.+Imamuraauthor=M.+Iwataniauthor=Y.+Kamadaauthor=S.+Matsumotoauthor=R.+Haraauthor=T.+Nomuraauthor=K.+Tsuchida&title=A+novel+LSD1+inihibitor+T-3775440+disrupts+GFI1B+containing+complex+leading+to+transdifferentiation+and+imparied+growth+of+AML+cells&doi=10.1158%2F1535-7163.MCT-16-0471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells</span></div><div class="casAuthors">Ishikawa, Yoshinori; Gamo, Kanae; Yabuki, Masato; Takagi, Shinji; Toyoshima, Kosei; Nakayama, Kazuhide; Nakayama, Akiko; Morimoto, Megumi; Miyashita, Hitoshi; Dairiki, Ryo; Hikichi, Yukiko; Tomita, Naoki; Tomita, Daisuke; Imamura, Shinichi; Iwatani, Misa; Kamada, Yusuke; Matsumoto, Satoru; Hara, Ryujiro; Nomura, Toshiyuki; Tsuchida, Ken; Nakamura, Kazuhide</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">273-284</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Dysregulation of lysine (K)-specific demethylase 1A (LSD1), also known as KDM1A, has been implicated in the development of various cancers, including leukemia.  Here, we describe the antileukemic activity and mechanism of action of T-3775440, a novel irreversible LSD1 inhibitor.  Cell growth anal. of leukemia cell lines revealed that acute erythroid leukemia (AEL) and acute megakaryoblastic leukemia cells (AMKL) were highly sensitive to this compd.  T-3775440 treatment enforced transdifferentiation of erythroid/megakaryocytic lineages into granulomonocytic-like lineage cells.  Mechanistically, T-3775440 disrupted the interaction between LSD1 and growth factor-independent 1B (GFI1B), a transcription factor crit. for the differentiation processes of erythroid and megakaryocytic lineage cells.  Knockdown of LSD1 and GFI1B recapitulated T-3775440-induced transdifferentiation and cell growth suppression, highlighting the significance of LSD1-GFI1B axis inhibition with regard to the anti-AML effects of T-3775440.  Moreover, T-3775440 exhibited significant antitumor efficacy in AEL and AMKL xenograft models.  Our findings provide a rationale for evaluating LSD1 inhibitors as potential treatments and indicate a novel mechanism of action against AML, particularly AEL and AMKL.  Mol Cancer Ther; 16(2); 273-84. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomcxpsluqnf7Vg90H21EOLACvtfcHk0lj1Z3yO5rz01Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVertr4%253D&md5=2335343b4d5e7bbc197a1d5aec54e3af</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-16-0471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-16-0471%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DGamo%26aufirst%3DK.%26aulast%3DYabuki%26aufirst%3DM.%26aulast%3DTakagi%26aufirst%3DS.%26aulast%3DToyoshima%26aufirst%3DK.%26aulast%3DKazuhide%26aufirst%3DN.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DA.%26aulast%3DMorimoto%26aufirst%3DM.%26aulast%3DMiyashita%26aufirst%3DH.%26aulast%3DDairiki%26aufirst%3DR.%26aulast%3DHikichi%26aufirst%3DY.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DTomita%26aufirst%3DD.%26aulast%3DImamura%26aufirst%3DS.%26aulast%3DIwatani%26aufirst%3DM.%26aulast%3DKamada%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DS.%26aulast%3DHara%26aufirst%3DR.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DTsuchida%26aufirst%3DK.%26atitle%3DA%2520novel%2520LSD1%2520inihibitor%2520T-3775440%2520disrupts%2520GFI1B%2520containing%2520complex%2520leading%2520to%2520transdifferentiation%2520and%2520imparied%2520growth%2520of%2520AML%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2017%26volume%3D16%26spage%3D273%26epage%3D284%26doi%3D10.1158%2F1535-7163.MCT-16-0471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Velinder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bareyan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meznarich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracy, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulcher, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClellan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucente, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, M. E.</span><span> </span><span class="NLM_article-title">GFI1 functions in transcriptional control and cell fate determination require SNAG domain methylation to recruit LSD1</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">473</span><span class="NLM_x">, </span> <span class="NLM_fpage">3355</span><span class="refDoi"> DOI: 10.1042/BCJ20160558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1042%2FBCJ20160558" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=473&publication_year=2016&pages=3355&author=M.+Velinderauthor=J.+Singerauthor=D.+Bareyanauthor=J.+Meznarichauthor=C.+M.+Tracyauthor=J.+M.+Fulcherauthor=D.+McClellanauthor=H.+Lucenteauthor=S.+Franklinauthor=S.+Sharmaauthor=M.+E.+Engel&title=GFI1+functions+in+transcriptional+control+and+cell+fate+determination+require+SNAG+domain+methylation+to+recruit+LSD1&doi=10.1042%2FBCJ20160558"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1042%2FBCJ20160558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBCJ20160558%26sid%3Dliteratum%253Aachs%26aulast%3DVelinder%26aufirst%3DM.%26aulast%3DSinger%26aufirst%3DJ.%26aulast%3DBareyan%26aufirst%3DD.%26aulast%3DMeznarich%26aufirst%3DJ.%26aulast%3DTracy%26aufirst%3DC.%2BM.%26aulast%3DFulcher%26aufirst%3DJ.%2BM.%26aulast%3DMcClellan%26aufirst%3DD.%26aulast%3DLucente%26aufirst%3DH.%26aulast%3DFranklin%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DEngel%26aufirst%3DM.%2BE.%26atitle%3DGFI1%2520functions%2520in%2520transcriptional%2520control%2520and%2520cell%2520fate%2520determination%2520require%2520SNAG%2520domain%2520methylation%2520to%2520recruit%2520LSD1%26jtitle%3DBiochem.%2520J.%26date%3D2016%26volume%3D473%26spage%3D3355%26doi%3D10.1042%2FBCJ20160558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Velinder, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meznarich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theisen, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulcher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, M. E.</span><span> </span><span class="NLM_article-title">GFI1 snag domain methylation directs LSD1 recruitment to control transcription and cell fate determination in hematopoiesis</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=46&author=M.+E.+Velinderauthor=J.+Singerauthor=J.+Meznarichauthor=E.+R.+Theisenauthor=J.+Fulcherauthor=C.+Tracyauthor=S.+Franklinauthor=S.+Sharmaauthor=M.+E.+Engel&title=GFI1+snag+domain+methylation+directs+LSD1+recruitment+to+control+transcription+and+cell+fate+determination+in+hematopoiesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVelinder%26aufirst%3DM.%2BE.%26aulast%3DSinger%26aufirst%3DJ.%26aulast%3DMeznarich%26aufirst%3DJ.%26aulast%3DTheisen%26aufirst%3DE.%2BR.%26aulast%3DFulcher%26aufirst%3DJ.%26aulast%3DTracy%26aufirst%3DC.%26aulast%3DFranklin%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DEngel%26aufirst%3DM.%2BE.%26atitle%3DGFI1%2520snag%2520domain%2520methylation%2520directs%2520LSD1%2520recruitment%2520to%2520control%2520transcription%2520and%2520cell%2520fate%2520determination%2520in%2520hematopoiesis%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26spage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Harris, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaser, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greystoke, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somervaille, T. C. P.</span><span> </span><span class="NLM_article-title">The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">487</span><span class="refDoi"> DOI: 10.1016/j.ccr.2012.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.ccr.2012.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=22464800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFyqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=473-487&author=W.+J.+Harrisauthor=X.+Huangauthor=J.+T.+Lynchauthor=G.+J.+Spencerauthor=J.+R.+Hitchinauthor=Y.+Liauthor=F.+Ciceriauthor=J.+G.+Blaserauthor=B.+F.+Greystokeauthor=A.+M.+Jordanauthor=C.+J.+Millerauthor=D.+J.+Ogilvieauthor=T.+C.+P.+Somervaille&title=The+histone+demethylase+KDM1A+sustains+the+oncogenic+potential+of+MLL-AF9+leukemia+stem+cells&doi=10.1016%2Fj.ccr.2012.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells</span></div><div class="casAuthors">Harris, William J.; Huang, Xu; Lynch, James T.; Spencer, Gary J.; Hitchin, James R.; Li, Yaoyong; Ciceri, Filippo; Blaser, Julian G.; Greystoke, Brigit F.; Jordan, Allan M.; Miller, Crispin J.; Ogilvie, Donald J.; Somervaille, Tim C. P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">473-487</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Using a mouse model of human MLL-AF9 leukemia, we identified the lysine-specific demethylase KDM1A (LSD1 or AOF2) as an essential regulator of leukemia stem cell (LSC) potential.  KDM1A acts at genomic loci bound by MLL-AF9 to sustain expression of the assocd. oncogenic program, thus preventing differentiation and apoptosis.  In vitro and in vivo pharmacol. targeting of KDM1A using tranylcypromine analogs active in the nanomolar range phenocopied Kdm1a knockdown in both murine and primary human AML cells exhibiting MLL translocations.  By contrast, the clonogenic and repopulating potential of normal hematopoietic stem and progenitor cells was spared.  These data establish KDM1A as a key effector of the differentiation block in MLL leukemia, which may be selectively targeted to therapeutic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiZ65foej58rVg90H21EOLACvtfcHk0liVCUDJi7Darg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFyqsrc%253D&md5=3227f2ac24a884a8ebadbce71198830c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DW.%2BJ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLynch%26aufirst%3DJ.%2BT.%26aulast%3DSpencer%26aufirst%3DG.%2BJ.%26aulast%3DHitchin%26aufirst%3DJ.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCiceri%26aufirst%3DF.%26aulast%3DBlaser%26aufirst%3DJ.%2BG.%26aulast%3DGreystoke%26aufirst%3DB.%2BF.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DMiller%26aufirst%3DC.%2BJ.%26aulast%3DOgilvie%26aufirst%3DD.%2BJ.%26aulast%3DSomervaille%26aufirst%3DT.%2BC.%2BP.%26atitle%3DThe%2520histone%2520demethylase%2520KDM1A%2520sustains%2520the%2520oncogenic%2520potential%2520of%2520MLL-AF9%2520leukemia%2520stem%2520cells%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D21%26spage%3D473%26epage%3D487%26doi%3D10.1016%2Fj.ccr.2012.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Döhner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estey, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appelbaum, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büchner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombret, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenaux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwade, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo-Coco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niederwieser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ossenkoppele, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sierra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallman, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löwenberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloomfield, C. D.</span><span> </span><span class="NLM_article-title">Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1182/blood-2009-07-235358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1182%2Fblood-2009-07-235358" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=453-474&author=H.+D%C3%B6hnerauthor=E.+H.+Esteyauthor=S.+Amadoriauthor=F.+R.+Appelbaumauthor=T.+B%C3%BCchnerauthor=A.+K.+Burnettauthor=H.+Dombretauthor=P.+Fenauxauthor=D.+Grimwadeauthor=R.+A.+Larsonauthor=F.+Lo-Cocoauthor=T.+Naoeauthor=D.+Niederwieserauthor=G.+J.+Ossenkoppeleauthor=M.+A.+Sanzauthor=J.+Sierraauthor=M.+S.+Tallmanauthor=B.+L%C3%B6wenbergauthor=C.+D.+Bloomfield&title=Diagnosis+and+management+of+acute+myeloid+leukemia+in+adults%3A+recommendations+from+an+international+expert+panel%2C+on+behalf+of+the+European+LeukemiaNet&doi=10.1182%2Fblood-2009-07-235358"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-07-235358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-07-235358%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25B6hner%26aufirst%3DH.%26aulast%3DEstey%26aufirst%3DE.%2BH.%26aulast%3DAmadori%26aufirst%3DS.%26aulast%3DAppelbaum%26aufirst%3DF.%2BR.%26aulast%3DB%25C3%25BCchner%26aufirst%3DT.%26aulast%3DBurnett%26aufirst%3DA.%2BK.%26aulast%3DDombret%26aufirst%3DH.%26aulast%3DFenaux%26aufirst%3DP.%26aulast%3DGrimwade%26aufirst%3DD.%26aulast%3DLarson%26aufirst%3DR.%2BA.%26aulast%3DLo-Coco%26aufirst%3DF.%26aulast%3DNaoe%26aufirst%3DT.%26aulast%3DNiederwieser%26aufirst%3DD.%26aulast%3DOssenkoppele%26aufirst%3DG.%2BJ.%26aulast%3DSanz%26aufirst%3DM.%2BA.%26aulast%3DSierra%26aufirst%3DJ.%26aulast%3DTallman%26aufirst%3DM.%2BS.%26aulast%3DL%25C3%25B6wenberg%26aufirst%3DB.%26aulast%3DBloomfield%26aufirst%3DC.%2BD.%26atitle%3DDiagnosis%2520and%2520management%2520of%2520acute%2520myeloid%2520leukemia%2520in%2520adults%253A%2520recommendations%2520from%2520an%2520international%2520expert%2520panel%252C%2520on%2520behalf%2520of%2520the%2520European%2520LeukemiaNet%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D453%26epage%3D474%26doi%3D10.1182%2Fblood-2009-07-235358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Mohammad, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smitheman, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamat, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federowicz, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneck, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butticello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnette, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degenhardt, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pappalardi, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasparec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDevitt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouthamel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Concha, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hann, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, R. G.</span><span> </span><span class="NLM_article-title">A DNA hypomethylation signature predicts antitumor activity of LSD1 inhibitors in SCLC</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span><span class="refDoi"> DOI: 10.1016/j.ccell.2015.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.ccell.2015.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=26175415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Grt7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=57-69&author=H.+P.+Mohammadauthor=K.+N.+Smithemanauthor=C.+D.+Kamatauthor=D.+Soongauthor=K.+E.+Federowiczauthor=G.+S.+Van+Allerauthor=J.+L.+Schneckauthor=J.+D.+Carsonauthor=Y.+Liuauthor=M.+Butticelloauthor=W.+G.+Bonnetteauthor=S.+A.+Gormanauthor=Y.+Degenhardtauthor=Y.+Baiauthor=M.+T.+McCabeauthor=M.+B.+Pappalardiauthor=J.+Kasparecauthor=X.+Tianauthor=K.+C.+McNultyauthor=M.+Rouseauthor=P.+McDevittauthor=T.+Hoauthor=M.+Crouthamelauthor=T.+K.+Hartauthor=N.+O.+Conchaauthor=C.+F.+McHughauthor=W.+H.+Millerauthor=D.+Dhanakauthor=P.+J.+Tumminoauthor=C.+L.+Carpenterauthor=N.+W.+Johnsonauthor=C.+L.+Hannauthor=R.+G.+Kruger&title=A+DNA+hypomethylation+signature+predicts+antitumor+activity+of+LSD1+inhibitors+in+SCLC&doi=10.1016%2Fj.ccell.2015.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC</span></div><div class="casAuthors">Mohammad, Helai P.; Smitheman, Kimberly N.; Kamat, Chandrashekhar D.; Soong, David; Federowicz, Kelly E.; Van Aller, Glenn S.; Schneck, Jess L.; Carson, Jeffrey D.; Liu, Yan; Butticello, Michael; Bonnette, William G.; Gorman, Shelby A.; Degenhardt, Yan; Bai, Yuchen; McCabe, Michael T.; Pappalardi, Melissa B.; Kasparec, Jiri; Tian, Xinrong; McNulty, Kenneth C.; Rouse, Meagan; McDevitt, Patrick; Ho, Thau; Crouthamel, Michelle; Hart, Timothy K.; Concha, Nestor O.; McHugh, Charles F.; Miller, William H.; Dhanak, Dashyant; Tummino, Peter J.; Carpenter, Christopher L.; Johnson, Neil W.; Hann, Christine L.; Kruger, Ryan G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-69</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Epigenetic dysregulation has emerged as an important mechanism in cancer.  Alterations in epigenetic machinery have become a major focus for targeted therapies.  The current report describes the discovery and biol. activity of a cyclopropylamine contg. inhibitor of Lysine Demethylase 1 (LSD1), GSK2879552.  This small mol. is a potent, selective, orally bioavailable, mechanism-based irreversible inactivator of LSD1.  A proliferation screen of cell lines representing a no. of tumor types indicated that small cell lung carcinoma (SCLC) is sensitive to LSD1 inhibition.  The subset of SCLC lines and primary samples that undergo growth inhibition in response to GSK2879552 exhibit DNA hypomethylation of a signature set of probes, suggesting this may be used as a predictive biomarker of activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppluiM41UspbVg90H21EOLACvtfcHk0liV5vyKpy3ZMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Grt7fJ&md5=863924e99fa3576dc1c67824b45462f8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2015.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2015.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DMohammad%26aufirst%3DH.%2BP.%26aulast%3DSmitheman%26aufirst%3DK.%2BN.%26aulast%3DKamat%26aufirst%3DC.%2BD.%26aulast%3DSoong%26aufirst%3DD.%26aulast%3DFederowicz%26aufirst%3DK.%2BE.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DSchneck%26aufirst%3DJ.%2BL.%26aulast%3DCarson%26aufirst%3DJ.%2BD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DButticello%26aufirst%3DM.%26aulast%3DBonnette%26aufirst%3DW.%2BG.%26aulast%3DGorman%26aufirst%3DS.%2BA.%26aulast%3DDegenhardt%26aufirst%3DY.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DPappalardi%26aufirst%3DM.%2BB.%26aulast%3DKasparec%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DMcNulty%26aufirst%3DK.%2BC.%26aulast%3DRouse%26aufirst%3DM.%26aulast%3DMcDevitt%26aufirst%3DP.%26aulast%3DHo%26aufirst%3DT.%26aulast%3DCrouthamel%26aufirst%3DM.%26aulast%3DHart%26aufirst%3DT.%2BK.%26aulast%3DConcha%26aufirst%3DN.%2BO.%26aulast%3DMcHugh%26aufirst%3DC.%2BF.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCarpenter%26aufirst%3DC.%2BL.%26aulast%3DJohnson%26aufirst%3DN.%2BW.%26aulast%3DHann%26aufirst%3DC.%2BL.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26atitle%3DA%2520DNA%2520hypomethylation%2520signature%2520predicts%2520antitumor%2520activity%2520of%2520LSD1%2520inhibitors%2520in%2520SCLC%26jtitle%3DCancer%2520Cell%26date%3D2015%26volume%3D28%26spage%3D57%26epage%3D69%26doi%3D10.1016%2Fj.ccell.2015.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hill, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quenelle, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardin, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosch-Marce, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raja, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristie, T. M.</span><span> </span><span class="NLM_article-title">Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomes</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">265ra169</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3010643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1126%2Fscitranslmed.3010643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=25473037" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=265ra169&author=J.+M.+Hillauthor=D.+C.+Quenelleauthor=R.+D.+Cardinauthor=J.+L.+Vogelauthor=C.+Clementauthor=F.+J.+Bravoauthor=T.+P.+Fosterauthor=M.+Bosch-Marceauthor=P.+Rajaauthor=J.+S.+Leeauthor=D.+I.+Bernsteinauthor=P.+R.+Krauseauthor=D.+M.+Knipeauthor=T.+M.+Kristie&title=Inhibition+of+LSD1+reduces+herpesvirus+infection%2C+shedding%2C+and+recurrence+by+promoting+epigenetic+suppression+of+viral+genomes&doi=10.1126%2Fscitranslmed.3010643"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3010643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3010643%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DJ.%2BM.%26aulast%3DQuenelle%26aufirst%3DD.%2BC.%26aulast%3DCardin%26aufirst%3DR.%2BD.%26aulast%3DVogel%26aufirst%3DJ.%2BL.%26aulast%3DClement%26aufirst%3DC.%26aulast%3DBravo%26aufirst%3DF.%2BJ.%26aulast%3DFoster%26aufirst%3DT.%2BP.%26aulast%3DBosch-Marce%26aufirst%3DM.%26aulast%3DRaja%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DBernstein%26aufirst%3DD.%2BI.%26aulast%3DKrause%26aufirst%3DP.%2BR.%26aulast%3DKnipe%26aufirst%3DD.%2BM.%26aulast%3DKristie%26aufirst%3DT.%2BM.%26atitle%3DInhibition%2520of%2520LSD1%2520reduces%2520herpesvirus%2520infection%252C%2520shedding%252C%2520and%2520recurrence%2520by%2520promoting%2520epigenetic%2520suppression%2520of%2520viral%2520genomes%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D265ra169%26doi%3D10.1126%2Fscitranslmed.3010643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quenelle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascaro, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristie, T. M.</span><span> </span><span class="NLM_article-title">A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency</span> <span class="citation_source-journal">mBio</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e00558-12</span><span class="refDoi"> DOI: 10.1128/mBio.00558-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1128%2FmBio.00558-12" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=e00558-12&author=Y.+Liangauthor=D.+Quenelleauthor=J.+L.+Vogelauthor=C.+Mascaroauthor=A.+Ortegaauthor=T.+M.+Kristie&title=A+novel+selective+LSD1%2FKDM1A+inhibitor+epigenetically+blocks+herpes+simplex+virus+lytic+replication+and+reactivation+from+latency&doi=10.1128%2FmBio.00558-12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FmBio.00558-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.00558-12%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DQuenelle%26aufirst%3DD.%26aulast%3DVogel%26aufirst%3DJ.%2BL.%26aulast%3DMascaro%26aufirst%3DC.%26aulast%3DOrtega%26aufirst%3DA.%26aulast%3DKristie%26aufirst%3DT.%2BM.%26atitle%3DA%2520novel%2520selective%2520LSD1%252FKDM1A%2520inhibitor%2520epigenetically%2520blocks%2520herpes%2520simplex%2520virus%2520lytic%2520replication%2520and%2520reactivation%2520from%2520latency%26jtitle%3DmBio%26date%3D2013%26volume%3D4%26spage%3De00558-12%26doi%3D10.1128%2FmBio.00558-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Buesa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascaró, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotllant, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griñan-Ferré, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallàs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, T.</span><span> </span><span class="NLM_article-title">The dual LSD1/MAO-B inhibitor ORY2001 prevents the development of the memory deficit in samp8 mice through induction of neuronal plasticity and reduction of neuroinflammation</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">P905</span><span class="refDoi"> DOI: 10.1016/j.jalz.2015.08.146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.jalz.2015.08.146" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=P905&author=C.+Buesaauthor=C.+Mascar%C3%B3author=D.+Rotllantauthor=C.+Gri%C3%B1an-Ferr%C3%A9author=M.+Pall%C3%A0sauthor=T.+Maes&title=The+dual+LSD1%2FMAO-B+inhibitor+ORY2001+prevents+the+development+of+the+memory+deficit+in+samp8+mice+through+induction+of+neuronal+plasticity+and+reduction+of+neuroinflammation&doi=10.1016%2Fj.jalz.2015.08.146"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2015.08.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2015.08.146%26sid%3Dliteratum%253Aachs%26aulast%3DBuesa%26aufirst%3DC.%26aulast%3DMascar%25C3%25B3%26aufirst%3DC.%26aulast%3DRotllant%26aufirst%3DD.%26aulast%3DGri%25C3%25B1an-Ferr%25C3%25A9%26aufirst%3DC.%26aulast%3DPall%25C3%25A0s%26aufirst%3DM.%26aulast%3DMaes%26aufirst%3DT.%26atitle%3DThe%2520dual%2520LSD1%252FMAO-B%2520inhibitor%2520ORY2001%2520prevents%2520the%2520development%2520of%2520the%2520memory%2520deficit%2520in%2520samp8%2520mice%2520through%2520induction%2520of%2520neuronal%2520plasticity%2520and%2520reduction%2520of%2520neuroinflammation%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2015%26volume%3D11%26spage%3DP905%26doi%3D10.1016%2Fj.jalz.2015.08.146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Maes, T.; Arjol, C. B.</span><span> </span><span class="NLM_article-title">Selective LSD1 and dual LSD1/MAO-B inhibitors for modulating diseases associated with alterations in protein conformation</span>. U.S. Pat. Appl. 20160081947,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=T.+Maes&author=C.+B.+Arjol&title=Selective+LSD1+and+dual+LSD1%2FMAO-B+inhibitors+for+modulating+diseases+associated+with+alterations+in+protein+conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMaes%26aufirst%3DT.%26atitle%3DSelective%2520LSD1%2520and%2520dual%2520LSD1%252FMAO-B%2520inhibitors%2520for%2520modulating%2520diseases%2520associated%2520with%2520alterations%2520in%2520protein%2520conformation%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Guibourt, N.; Munoz, A. O.; Laria, J. C.-P.</span><span> </span><span class="NLM_article-title">Phenylcyclopropylamine derivatives and their medical use</span>. U.S, Pat. 8,993,808,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=N.+Guibourt&author=A.+O.+Munoz&author=J.+C.-P.+Laria&title=Phenylcyclopropylamine+derivatives+and+their+medical+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGuibourt%26aufirst%3DN.%26atitle%3DPhenylcyclopropylamine%2520derivatives%2520and%2520their%2520medical%2520use%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Somervaille, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salamero, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montesinos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willekens, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez Simon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pigneux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinero, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascaro, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosch, F.</span><span> </span><span class="NLM_article-title">Safety, phamacokinetics (PK), pharmacodynamics (PD) and preliminary activity in acute leukemia of ORY-1001, a first-in-class inhibitor of lysine-specific histone demethylase 1A (LSD1/KDM1A): initial results from a first-in-human phase 1 study</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">4060</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=4060&author=T.+Somervailleauthor=O.+Salameroauthor=P.+Montesinosauthor=C.+Willekensauthor=J.+A.+Perez+Simonauthor=A.+Pigneuxauthor=C.+Recherauthor=R.+Popatauthor=C.+Molineroauthor=C.+Mascaroauthor=T.+Maesauthor=F.+Bosch&title=Safety%2C+phamacokinetics+%28PK%29%2C+pharmacodynamics+%28PD%29+and+preliminary+activity+in+acute+leukemia+of+ORY-1001%2C+a+first-in-class+inhibitor+of+lysine-specific+histone+demethylase+1A+%28LSD1%2FKDM1A%29%3A+initial+results+from+a+first-in-human+phase+1+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSomervaille%26aufirst%3DT.%26aulast%3DSalamero%26aufirst%3DO.%26aulast%3DMontesinos%26aufirst%3DP.%26aulast%3DWillekens%26aufirst%3DC.%26aulast%3DPerez%2BSimon%26aufirst%3DJ.%2BA.%26aulast%3DPigneux%26aufirst%3DA.%26aulast%3DRecher%26aufirst%3DC.%26aulast%3DPopat%26aufirst%3DR.%26aulast%3DMolinero%26aufirst%3DC.%26aulast%3DMascaro%26aufirst%3DC.%26aulast%3DMaes%26aufirst%3DT.%26aulast%3DBosch%26aufirst%3DF.%26atitle%3DSafety%252C%2520phamacokinetics%2520%2528PK%2529%252C%2520pharmacodynamics%2520%2528PD%2529%2520and%2520preliminary%2520activity%2520in%2520acute%2520leukemia%2520of%2520ORY-1001%252C%2520a%2520first-in-class%2520inhibitor%2520of%2520lysine-specific%2520histone%2520demethylase%25201A%2520%2528LSD1%252FKDM1A%2529%253A%2520initial%2520results%2520from%2520a%2520first-in-human%2520phase%25201%2520study%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26spage%3D4060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Johnson, N. W.; Kasparec, J.; Rouse, M. B.; Tian, X.; Miller, W. H.; Suarez, D.</span><span> </span><span class="NLM_article-title">Cyclopropylamines as LSD1 inhibitors</span>. U.S. Pat. 9346840,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=N.+W.+Johnson&author=J.+Kasparec&author=M.+B.+Rouse&author=X.+Tian&author=W.+H.+Miller&author=D.+Suarez&title=Cyclopropylamines+as+LSD1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DN.%2BW.%26atitle%3DCyclopropylamines%2520as%2520LSD1%2520inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Yongchun, P.; Han, W.; Cao, G.; Frietze, W.; Zhongjiang, J.; Sharief, V.; Zhou, J.; Li, Q.</span><span> </span><span class="NLM_article-title">Salts of an LSD1 inhibitor</span>. U.S. Pat. Appl. 201700440101,<span class="NLM_x"> </span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=P.+Yongchun&author=W.+Han&author=G.+Cao&author=W.+Frietze&author=J.+Zhongjiang&author=V.+Sharief&author=J.+Zhou&author=Q.+Li&title=Salts+of+an+LSD1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYongchun%26aufirst%3DP.%26atitle%3DSalts%2520of%2520an%2520LSD1%2520inhibitor%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Schenk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gollner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebestreit, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, H.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popescu, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casero, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woster, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller-Tidow, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelent, A.</span><span> </span><span class="NLM_article-title">Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span><span class="refDoi"> DOI: 10.1038/nm.2661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1038%2Fnm.2661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=22406747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1WhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=605-611&author=T.+Schenkauthor=W.+C.+Chenauthor=S.+Gollnerauthor=L.+Howellauthor=L.+Jinauthor=K.+Hebestreitauthor=H.-U.+Kleinauthor=A.+C.+Popescuauthor=A.+Burnettauthor=K.+Millsauthor=R.+A.+Caseroauthor=L.+Martonauthor=P.+Wosterauthor=M.+D.+Mindenauthor=M.+Dugasauthor=J.+C.+Y.+Wangauthor=J.+E.+Dickauthor=C.+Muller-Tidowauthor=K.+Petrieauthor=A.+Zelent&title=Inhibition+of+the+LSD1+%28KDM1A%29+demethylase+reactivates+the+all-trans-retinoic+acid+differentiation+pathway+in+acute+myeloid+leukemia&doi=10.1038%2Fnm.2661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia</span></div><div class="casAuthors">Schenk, Tino; Chen, Weihsu Claire; Goellner, Stefanie; Howell, Louise; Jin, Liqing; Hebestreit, Katja; Klein, Hans-Ulrich; Popescu, Andreea C.; Burnett, Alan; Mills, Ken; Casero, Robert A.; Marton, Laurence; Woster, Patrick; Minden, Mark D.; Dugas, Martin; Wang, Jean C. Y.; Dick, John E.; Mueller-Tidow, Carsten; Petrie, Kevin; Zelent, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">605-611</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acute promyelocytic leukemia (APL), a cytogenetically distinct subtype of acute myeloid leukemia (AML), characterized by the t(15;17)-assocd. PML-RARA fusion, has been successfully treated with therapy utilizing all-trans-retinoic acid (ATRA) to differentiate leukemic blasts.  However, among patients with non-APL AML, ATRA-based treatment has not been effective.  Here we show that, through epigenetic reprogramming, inhibitors of lysine-specific demethylase 1 (LSD1, also called KDM1A), including tranylcypromine (TCP), unlocked the ATRA-driven therapeutic response in non-APL AML.  LSD1 inhibition did not lead to a large-scale increase in histone 3 Lys4 dimethylation (H3K4me2) across the genome, but it did increase H3K4me2 and expression of myeloid-differentiation-assocd. genes.  Notably, treatment with ATRA plus TCP markedly diminished the engraftment of primary human AML cells in vivo in nonobese diabetic (NOD)-severe combined immunodeficient (SCID) mice, suggesting that ATRA in combination with TCP may target leukemia-initiating cells.  Furthermore, initiation of ATRA plus TCP treatment 15 d after engraftment of human AML cells in NOD-SCID γ (with interleukin-2 (IL-2) receptor γ chain deficiency) mice also revealed the ATRA plus TCP drug combination to have a potent anti-leukemic effect that was superior to treatment with either drug alone.  These data identify LSD1 as a therapeutic target and strongly suggest that it may contribute to AML pathogenesis by inhibiting the normal pro-differentiative function of ATRA, paving the way for new combinatorial therapies for AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU7ebz8Ar4AbVg90H21EOLACvtfcHk0ljk8yEw8usi3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1WhtL8%253D&md5=57d968de189123149a2714df0208725f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnm.2661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2661%26sid%3Dliteratum%253Aachs%26aulast%3DSchenk%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DW.%2BC.%26aulast%3DGollner%26aufirst%3DS.%26aulast%3DHowell%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DHebestreit%26aufirst%3DK.%26aulast%3DKlein%26aufirst%3DH.-U.%26aulast%3DPopescu%26aufirst%3DA.%2BC.%26aulast%3DBurnett%26aufirst%3DA.%26aulast%3DMills%26aufirst%3DK.%26aulast%3DCasero%26aufirst%3DR.%2BA.%26aulast%3DMarton%26aufirst%3DL.%26aulast%3DWoster%26aufirst%3DP.%26aulast%3DMinden%26aufirst%3DM.%2BD.%26aulast%3DDugas%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%2BC.%2BY.%26aulast%3DDick%26aufirst%3DJ.%2BE.%26aulast%3DMuller-Tidow%26aufirst%3DC.%26aulast%3DPetrie%26aufirst%3DK.%26aulast%3DZelent%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520the%2520LSD1%2520%2528KDM1A%2529%2520demethylase%2520reactivates%2520the%2520all-trans-retinoic%2520acid%2520differentiation%2520pathway%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D605%26epage%3D611%26doi%3D10.1038%2Fnm.2661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubbs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dostalik, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. H.</span><span> </span><span class="NLM_article-title">Abstract 4702: Combination of BET inhibitor INCB054329 and LSD1 inhibitor INCB059872 is synergistic for the treatment of AML in vitro and in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">4702</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2016-4702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1158%2F1538-7445.AM2016-4702" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=4702&author=X.+Liuauthor=M.+Stubbsauthor=M.+Yeauthor=R.+Collinsauthor=M.+Favataauthor=G.+Yangauthor=M.+Diamondauthor=V.+Dostalikauthor=Y.+Loauthor=C.+Heauthor=L.+Wuauthor=A.+Combsauthor=W.+Yaoauthor=G.+Hollisauthor=R.+Huberauthor=P.+Scherleauthor=B.+Ruggeriauthor=P.+Liuauthor=S.+H.+Lee&title=Abstract+4702%3A+Combination+of+BET+inhibitor+INCB054329+and+LSD1+inhibitor+INCB059872+is+synergistic+for+the+treatment+of+AML+in+vitro+and+in+vivo&doi=10.1158%2F1538-7445.AM2016-4702"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2016-4702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2016-4702%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStubbs%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DFavata%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DDiamond%26aufirst%3DM.%26aulast%3DDostalik%26aufirst%3DV.%26aulast%3DLo%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DCombs%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DHollis%26aufirst%3DG.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DScherle%26aufirst%3DP.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DS.%2BH.%26atitle%3DAbstract%25204702%253A%2520Combination%2520of%2520BET%2520inhibitor%2520INCB054329%2520and%2520LSD1%2520inhibitor%2520INCB059872%2520is%2520synergistic%2520for%2520the%2520treatment%2520of%2520AML%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D4702%26doi%3D10.1158%2F1538-7445.AM2016-4702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Vasilatos, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oesterreich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1196</span><span class="NLM_x">–</span> <span class="NLM_lpage">1207</span><span class="refDoi"> DOI: 10.1093/carcin/bgt033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1093%2Fcarcin%2Fbgt033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1196-1207&author=S.+N.+Vasilatosauthor=T.+A.+Katzauthor=S.+Oesterreichauthor=Y.+Wanauthor=N.+E.+Davidsonauthor=Y.+Huang&title=Crosstalk+between+lysine-specific+demethylase+1+%28LSD1%29+and+histone+deacetylases+mediates+antineoplastic+efficacy+of+HDAC+inhibitors+in+human+breast+cancer+cells&doi=10.1093%2Fcarcin%2Fbgt033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgt033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgt033%26sid%3Dliteratum%253Aachs%26aulast%3DVasilatos%26aufirst%3DS.%2BN.%26aulast%3DKatz%26aufirst%3DT.%2BA.%26aulast%3DOesterreich%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DDavidson%26aufirst%3DN.%2BE.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DCrosstalk%2520between%2520lysine-specific%2520demethylase%25201%2520%2528LSD1%2529%2520and%2520histone%2520deacetylases%2520mediates%2520antineoplastic%2520efficacy%2520of%2520HDAC%2520inhibitors%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DCarcinogenesis%26date%3D2013%26volume%3D34%26spage%3D1196%26epage%3D1207%26doi%3D10.1093%2Fcarcin%2Fbgt033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Mould, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGonagle, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiseman, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span> </span><span class="NLM_article-title">Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: clinical significance and progress to date</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">586</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span><span class="refDoi"> DOI: 10.1002/med.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1002%2Fmed.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=25418875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvFSju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=586-618&author=D.+P.+Mouldauthor=A.+E.+McGonagleauthor=D.+H.+Wisemanauthor=E.+L.+Williamsauthor=A.+M.+Jordan&title=Reversible+inhibitors+of+LSD1+as+therapeutic+agents+in+acute+myeloid+leukemia%3A+clinical+significance+and+progress+to+date&doi=10.1002%2Fmed.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible Inhibitors of LSD1 as Therapeutic Agents in Acute Myeloid Leukemia: Clinical Significance and Progress to Date</span></div><div class="casAuthors">Mould, Daniel P.; McGonagle, Alison E.; Wiseman, Daniel H.; Williams, Emma L.; Jordan, Allan M.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">586-618</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">In the 10 years since the discovery of lysine-specific demethylase 1 (LSD1), this epigenetic eraser has emerged as an important target of interest in oncol.  More specifically, research has demonstrated that it plays an essential role in the self-renewal of leukemic stem cells in acute myeloid leukemia (AML).  This review will cover clin. aspects of AML, the role of epigenetics in the disease, and discuss the research that led to the first irreversible inhibitors of LSD1 entering clin. trials for the treatment of AML in 2014.  We also review recent achievements and progress in the development of potent and selective reversible inhibitors of LSD1.  These compds. differ in their mode of action from tranylcypromine derivs. and could facilitate novel biochem. studies to probe the pathways mediated by LSD1.  In this review, we will critically evaluate the strengths and weaknesses of published series of reversible LSD1 inhibitors.  Overall, while the development of reversible inhibitors to date has been less fruitful than that of irreversible inhibitors, there is still the possibility for their use to facilitate further research into the roles and functions of LSD1 and to expand the therapeutic applications of LSD1 inhibitors in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTFqxWxhZyUrVg90H21EOLACvtfcHk0lg06GLYRSoQBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvFSju7c%253D&md5=b669a61231659817709013572e8fdcf7</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fmed.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21334%26sid%3Dliteratum%253Aachs%26aulast%3DMould%26aufirst%3DD.%2BP.%26aulast%3DMcGonagle%26aufirst%3DA.%2BE.%26aulast%3DWiseman%26aufirst%3DD.%2BH.%26aulast%3DWilliams%26aufirst%3DE.%2BL.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26atitle%3DReversible%2520inhibitors%2520of%2520LSD1%2520as%2520therapeutic%2520agents%2520in%2520acute%2520myeloid%2520leukemia%253A%2520clinical%2520significance%2520and%2520progress%2520to%2520date%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2015%26volume%3D35%26spage%3D586%26epage%3D618%26doi%3D10.1002%2Fmed.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Hitchin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairweather, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAndrew, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mould, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waddell, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, D. J.</span><span> </span><span class="NLM_article-title">Development and evaluation of selective, reversible LSD1 inhibitors derived from fragments</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1513</span><span class="NLM_x">–</span> <span class="NLM_lpage">1522</span><span class="refDoi"> DOI: 10.1039/c3md00226h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1039%2Fc3md00226h" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1OrsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1513-1522&author=J.+R.+Hitchinauthor=J.+Blaggauthor=R.+Burkeauthor=S.+Burnsauthor=M.+J.+Cockerillauthor=E.+E.+Fairweatherauthor=C.+Huttonauthor=A.+M.+Jordanauthor=C.+McAndrewauthor=A.+Mirzaauthor=D.+Mouldauthor=G.+J.+Thomsonauthor=I.+Waddellauthor=D.+J.+Ogilvie&title=Development+and+evaluation+of+selective%2C+reversible+LSD1+inhibitors+derived+from+fragments&doi=10.1039%2Fc3md00226h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Development and evaluation of selective, reversible LSD1 inhibitors derived from fragments</span></div><div class="casAuthors">Hitchin, James R.; Blagg, Julian; Burke, Rosemary; Burns, Samantha; Cockerill, Mark J.; Fairweather, Emma E.; Hutton, Colin; Jordan, Allan M.; McAndrew, Craig; Mirza, Amin; Mould, Daniel; Thomson, Graeme J.; Waddell, Ian; Ogilvie, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1513-1522</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Two series of aminothiazoles have been developed as reversible inhibitors of lysine specific demethylase 1 (LSD1) through the expansion of a hit derived from a high concn. biochem. fragment based screen of 2466 compds.  The potency of the initial fragment hit was increased 32-fold through synthesis, with one series of compds. showing clear structure-activity relationships and inhibitory activities in the range of 7 to 187 μM in a biochem. assay.  This series also showed selectivity against the related FAD-dependent enzyme mono-amine oxidase A (MAO-A).  Although a wide range of irreversible inhibitors of LSD1 have been reported with activities in the low nanomolar range, this work represents one of the first reported examples of a reversible small mol. inhibitor of LSD1 with clear SAR and selectivity against MAO-A, and could provide a platform for the development of more potent reversible inhibitors.  Herein, we also report the use of a recently developed cell-based assay for profiling LSD1 inhibitors, and present results on our own compds. as well as a selection of recently described reversible LSD1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUgrL8DOIuDbVg90H21EOLACvtfcHk0ljUu2P-3e0NBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1OrsrvK&md5=bec441bbb94f970eab94b96026db7fbe</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2Fc3md00226h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00226h%26sid%3Dliteratum%253Aachs%26aulast%3DHitchin%26aufirst%3DJ.%2BR.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DBurns%26aufirst%3DS.%26aulast%3DCockerill%26aufirst%3DM.%2BJ.%26aulast%3DFairweather%26aufirst%3DE.%2BE.%26aulast%3DHutton%26aufirst%3DC.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DMcAndrew%26aufirst%3DC.%26aulast%3DMirza%26aufirst%3DA.%26aulast%3DMould%26aufirst%3DD.%26aulast%3DThomson%26aufirst%3DG.%2BJ.%26aulast%3DWaddell%26aufirst%3DI.%26aulast%3DOgilvie%26aufirst%3DD.%2BJ.%26atitle%3DDevelopment%2520and%2520evaluation%2520of%2520selective%252C%2520reversible%2520LSD1%2520inhibitors%2520derived%2520from%2520fragments%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D1513%26epage%3D1522%26doi%3D10.1039%2Fc3md00226h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Johnson, N. W.</span><span> </span><span class="NLM_article-title">The identification of GSK2879552, a mechanism based irreversible inhibitor of the histone lysine demethylase LSD1</span>. Presented at XXIV EFMC International Symposium on Medicinal Chemistry, Manchester, UK, August 28September 1,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=N.+W.+Johnson&title=The+identification+of+GSK2879552%2C+a+mechanism+based+irreversible+inhibitor+of+the+histone+lysine+demethylase+LSD1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DN.%2BW.%26atitle%3DThe%2520identification%2520of%2520GSK2879552%252C%2520a%2520mechanism%2520based%2520irreversible%2520inhibitor%2520of%2520the%2520histone%2520lysine%2520demethylase%2520LSD1%26jtitle%3DXXIV%2520EFMC%2520International%2520Symposium%2520on%2520Medicinal%2520Chemistry%252C%2520Manchester%252C%2520UK%252C%2520August%252028September%25201%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Chen, Y. K.; Kanouni, T.; Nie, Z.; Stafford, J. A.; Veal, J. M.; Sung, L. M.</span><span> </span><span class="NLM_article-title">Inhibitors of lysine specific demethylase-1</span>. W.O. Pat. Appl. 2016004105,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Y.+K.+Chen&author=T.+Kanouni&author=Z.+Nie&author=J.+A.+Stafford&author=J.+M.+Veal&author=L.+M.+Sung&title=Inhibitors+of+lysine+specific+demethylase-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BK.%26atitle%3DInhibitors%2520of%2520lysine%2520specific%2520demethylase-1%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Chen, Y. K.; Kanouni, T.; Kaldor, S. W.; Stafford, J. A.; Veal, J. M.</span><span> </span><span class="NLM_article-title">Inhibitors of lysine specific demethylase-1</span>. W.O. Pat. Appl. 2015089192,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Y.+K.+Chen&author=T.+Kanouni&author=S.+W.+Kaldor&author=J.+A.+Stafford&author=J.+M.+Veal&title=Inhibitors+of+lysine+specific+demethylase-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BK.%26atitle%3DInhibitors%2520of%2520lysine%2520specific%2520demethylase-1%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Chen, Y. K.; Kanouni, T.; Nie, Z.; Stafford, J. A.; Veal, J. M.; Sung, L. M.</span><span> </span><span class="NLM_article-title">Inhibitors of lysine specific demethylase-1</span>. W.O. Pat. Appl. 2016003917,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Y.+K.+Chen&author=T.+Kanouni&author=Z.+Nie&author=J.+A.+Stafford&author=J.+M.+Veal&author=L.+M.+Sung&title=Inhibitors+of+lysine+specific+demethylase-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BK.%26atitle%3DInhibitors%2520of%2520lysine%2520specific%2520demethylase-1%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Liangxing, W.; Courter, J. R.; Chunhong, H.; Jingwei, L.; Liang, L.; Yaping, S.; Xiaozhao, W.; Wenqing, Y.; Zhang, C.; Jincong, Z.</span><span> </span><span class="NLM_article-title">Imidazopyrazines as LSD1 inhibitors</span>. U.S. Pat. Appl. 20160009720,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=W.+Liangxing&author=J.+R.+Courter&author=H.+Chunhong&author=L.+Jingwei&author=L.+Liang&author=S.+Yaping&author=W.+Xiaozhao&author=Y.+Wenqing&author=C.+Zhang&author=Z.+Jincong&title=Imidazopyrazines+as+LSD1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiangxing%26aufirst%3DW.%26atitle%3DImidazopyrazines%2520as%2520LSD1%2520inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Liangxing, W.; Konkol, L. C.; Lajkiewicz, N.; Liang, L.; Meizhong, X.; Wenqing, Y.; Zhang, C.</span>; <span> </span><span class="NLM_article-title">Chunhong He. Imidazopyridines and imidazopyrazines as LSD1 inhibitors</span>. U.S. Pat. Appl. 20160009712,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=W.+Liangxing&author=L.+C.+Konkol&author=N.+Lajkiewicz&author=L.+Liang&author=X.+Meizhong&author=Y.+Wenqing&author=C.+Zhang&title=Chunhong+He.+Imidazopyridines+and+imidazopyrazines+as+LSD1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiangxing%26aufirst%3DW.%26atitle%3DChunhong%2520He.%2520Imidazopyridines%2520and%2520imidazopyrazines%2520as%2520LSD1%2520inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Liangxing, W.; Xiaozhao, W.; Wenqing, Y.; Zhang, C.</span><span> </span><span class="NLM_article-title">Triazolopyridines and triazolopyrazines as LSD1 Inhibitors</span>. U.S. Pat. Appl. 20160009711,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=W.+Liangxing&author=W.+Xiaozhao&author=Y.+Wenqing&author=C.+Zhang&title=Triazolopyridines+and+triazolopyrazines+as+LSD1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiangxing%26aufirst%3DW.%26atitle%3DTriazolopyridines%2520and%2520triazolopyrazines%2520as%2520LSD1%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Sartori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amigoni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagá, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fattori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legnaghi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meroni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecatiello, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasqualato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romussi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trifiró, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vultaggio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botrugno, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dessanti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minucci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagarrí, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carettoni, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iuzzolino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, P.</span><span> </span><span class="NLM_article-title">Thieno[3,2-b]pyrrole-5-carboxamides as new reversible inhibitors of histone lysine demethylase KDM1A/LSD1. Part 1: high throughput screening and preliminary exploration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1673</span><span class="NLM_x">–</span> <span class="NLM_lpage">1692</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1673-1692&author=L.+Sartoriauthor=C.+Mercurioauthor=F.+Amigoniauthor=A.+Cappaauthor=G.+Fag%C3%A1author=R.+Fattoriauthor=E.+Legnaghiauthor=G.+Ciossaniauthor=A.+Matteviauthor=G.+Meroniauthor=L.+Morettiauthor=V.+Cecatielloauthor=S.+Pasqualatoauthor=A.+Romussiauthor=F.+Thalerauthor=P.+Trifir%C3%B3author=M.+Villaauthor=S.+Vultaggioauthor=O.+A.+Botrugnoauthor=P.+Dessantiauthor=S.+Minucciauthor=E.+Zagarr%C3%ADauthor=D.+Carettoniauthor=L.+Iuzzolinoauthor=M.+Varasiauthor=P.+Vianello&title=Thieno%5B3%2C2-b%5Dpyrrole-5-carboxamides+as+new+reversible+inhibitors+of+histone+lysine+demethylase+KDM1A%2FLSD1.+Part+1%3A+high+throughput+screening+and+preliminary+exploration&doi=10.1021%2Facs.jmedchem.6b01018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01018%26sid%3Dliteratum%253Aachs%26aulast%3DSartori%26aufirst%3DL.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DAmigoni%26aufirst%3DF.%26aulast%3DCappa%26aufirst%3DA.%26aulast%3DFag%25C3%25A1%26aufirst%3DG.%26aulast%3DFattori%26aufirst%3DR.%26aulast%3DLegnaghi%26aufirst%3DE.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DMeroni%26aufirst%3DG.%26aulast%3DMoretti%26aufirst%3DL.%26aulast%3DCecatiello%26aufirst%3DV.%26aulast%3DPasqualato%26aufirst%3DS.%26aulast%3DRomussi%26aufirst%3DA.%26aulast%3DThaler%26aufirst%3DF.%26aulast%3DTrifir%25C3%25B3%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DVultaggio%26aufirst%3DS.%26aulast%3DBotrugno%26aufirst%3DO.%2BA.%26aulast%3DDessanti%26aufirst%3DP.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DZagarr%25C3%25AD%26aufirst%3DE.%26aulast%3DCarettoni%26aufirst%3DD.%26aulast%3DIuzzolino%26aufirst%3DL.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DVianello%26aufirst%3DP.%26atitle%3DThieno%255B3%252C2-b%255Dpyrrole-5-carboxamides%2520as%2520new%2520reversible%2520inhibitors%2520of%2520histone%2520lysine%2520demethylase%2520KDM1A%252FLSD1.%2520Part%25201%253A%2520high%2520throughput%2520screening%2520and%2520preliminary%2520exploration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1673%26epage%3D1692%26doi%3D10.1021%2Facs.jmedchem.6b01018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Vianello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amigoni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagá, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fattori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legnaghi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meroni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecatiello, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasqualato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romussi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trifiró, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botrugno, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dessanti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minucci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vultaggio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagarrí, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, C.</span><span> </span><span class="NLM_article-title">Thieno[3,2-b]pyrrole-5-carboxamides as new reversible inhibitors of histone lysine demethylase KDM1A/LSD1. Part 2: structure based drug design and structure-activity relationship</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1693</span><span class="NLM_x">–</span> <span class="NLM_lpage">1715</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1693-1715&author=P.+Vianelloauthor=L.+Sartoriauthor=F.+Amigoniauthor=A.+Cappaauthor=G.+Fag%C3%A1author=R.+Fattoriauthor=E.+Legnaghiauthor=G.+Ciossaniauthor=A.+Matteviauthor=G.+Meroniauthor=L.+Morettiauthor=V.+Cecatielloauthor=S.+Pasqualatoauthor=A.+Romussiauthor=F.+Thalerauthor=P.+Trifir%C3%B3author=O.+A.+Botrugnoauthor=M.+Villaauthor=P.+Dessantiauthor=S.+Minucciauthor=S.+Vultaggioauthor=E.+Zagarr%C3%ADauthor=M.+Varasiauthor=C.+Mercurio&title=Thieno%5B3%2C2-b%5Dpyrrole-5-carboxamides+as+new+reversible+inhibitors+of+histone+lysine+demethylase+KDM1A%2FLSD1.+Part+2%3A+structure+based+drug+design+and+structure-activity+relationship&doi=10.1021%2Facs.jmedchem.6b01019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01019%26sid%3Dliteratum%253Aachs%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DSartori%26aufirst%3DL.%26aulast%3DAmigoni%26aufirst%3DF.%26aulast%3DCappa%26aufirst%3DA.%26aulast%3DFag%25C3%25A1%26aufirst%3DG.%26aulast%3DFattori%26aufirst%3DR.%26aulast%3DLegnaghi%26aufirst%3DE.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DMeroni%26aufirst%3DG.%26aulast%3DMoretti%26aufirst%3DL.%26aulast%3DCecatiello%26aufirst%3DV.%26aulast%3DPasqualato%26aufirst%3DS.%26aulast%3DRomussi%26aufirst%3DA.%26aulast%3DThaler%26aufirst%3DF.%26aulast%3DTrifir%25C3%25B3%26aufirst%3DP.%26aulast%3DBotrugno%26aufirst%3DO.%2BA.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DDessanti%26aufirst%3DP.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DVultaggio%26aufirst%3DS.%26aulast%3DZagarr%25C3%25AD%26aufirst%3DE.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DMercurio%26aufirst%3DC.%26atitle%3DThieno%255B3%252C2-b%255Dpyrrole-5-carboxamides%2520as%2520new%2520reversible%2520inhibitors%2520of%2520histone%2520lysine%2520demethylase%2520KDM1A%252FLSD1.%2520Part%25202%253A%2520structure%2520based%2520drug%2520design%2520and%2520structure-activity%2520relationship%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1693%26epage%3D1715%26doi%3D10.1021%2Facs.jmedchem.6b01019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Speranzini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotili, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilotto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrocco, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgione, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucidi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forneris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehdipour, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velankar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Polymyxins and quinazolines are LSD1/KDM1A inhibitors with unusual structural features</span> <span class="citation_source-journal">Sci. Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">e1601017</span><span class="refDoi"> DOI: 10.1126/sciadv.1601017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1126%2Fsciadv.1601017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=27626075" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=e1601017&issue=9&author=V.+Speranziniauthor=D.+Rotiliauthor=G.+Ciossaniauthor=S.+Pilottoauthor=B.+Marroccoauthor=M.+Forgioneauthor=A.+Lucidiauthor=F.+Fornerisauthor=P.+Mehdipourauthor=S.+Velankarauthor=A.+Maiauthor=A.+Mattevi&title=Polymyxins+and+quinazolines+are+LSD1%2FKDM1A+inhibitors+with+unusual+structural+features&doi=10.1126%2Fsciadv.1601017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.1601017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.1601017%26sid%3Dliteratum%253Aachs%26aulast%3DSperanzini%26aufirst%3DV.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DPilotto%26aufirst%3DS.%26aulast%3DMarrocco%26aufirst%3DB.%26aulast%3DForgione%26aufirst%3DM.%26aulast%3DLucidi%26aufirst%3DA.%26aulast%3DForneris%26aufirst%3DF.%26aulast%3DMehdipour%26aufirst%3DP.%26aulast%3DVelankar%26aufirst%3DS.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DPolymyxins%2520and%2520quinazolines%2520are%2520LSD1%252FKDM1A%2520inhibitors%2520with%2520unusual%2520structural%2520features%26jtitle%3DSci.%2520Adv.%26date%3D2016%26volume%3D2%26issue%3D9%26spage%3De1601017%26doi%3D10.1126%2Fsciadv.1601017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, C.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span> </span><span class="NLM_article-title">Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluation</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.03.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.ejmech.2016.03.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=27043267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVWkurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=13-26&author=Y.+Songauthor=X.+Xueauthor=X.+Wuauthor=R.+Wangauthor=Y.+Xingauthor=W.+Yanauthor=Y.+Zhouauthor=C.-N.+Qianauthor=Y.+Zhangauthor=Y.+Xu&title=Identification+of+N-phenyl-2-%28N-phenylphenylsulfonamido%29acetamides+as+new+ROR%CE%B3+inverse+agonists%3A+Virtual+screening%2C+structure-based+optimization%2C+and+biological+evaluation&doi=10.1016%2Fj.ejmech.2016.03.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluation</span></div><div class="casAuthors">Song, Yu; Xue, Xiaoqian; Wu, Xishan; Wang, Rui; Xing, Yanli; Yan, Weiqun; Zhou, Yulai; Qian, Chao-Nan; Zhang, Yan; Xu, Yong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-26</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Retinoic acid receptor-related orphan receptors (RORs) are ligand-dependent transcriptional factors and members of the nuclear receptor superfamily.  RORs regulate inflammation, metabolic disorders and circadian rhythm.  RORγ is a promising therapeutic drug target for treating Th17-mediated autoimmune diseases.  In the authors' study, the authors performed structure-based virtual screening and ligand-based virtual screening targeting the RORγ ligand-binding domain and successfully identified N-phenyl-2-(N-phenylphenylsulfonamido) acetamides as a type of RORγ inverse agonist.  Among the 28 purchased compds., C11 (I) was confirmed to be active with micromolar IC50 values in both an AlphaScreen assay (62.58 μM) and a cell-based reporter gene assay (4.54 μM).  Structure-guided optimization of the compd. C11 led to the identification of compd. N-(4-cyanophenyl)-2-(N-(3,4-dichlorophenyl)-4-methylphenylsulfonamido)acetamide (39), which significantly enhanced RORγ inhibition with an IC50 value of 630 nM.  The RORγ antagonism of (39) was 7-fold higher than that of hit compd. C11.  These results represent a promising starting point for developing potent small mol. RORγ inverse agonists for the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaA4dGfyShVLVg90H21EOLACvtfcHk0liT7yFYq-QCBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVWkurY%253D&md5=609fd2e8fabad02c0a96262d6d829deb</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.052%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DXing%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DQian%26aufirst%3DC.-N.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DIdentification%2520of%2520N-phenyl-2-%2528N-phenylphenylsulfonamido%2529acetamides%2520as%2520new%2520ROR%25CE%25B3%2520inverse%2520agonists%253A%2520Virtual%2520screening%252C%2520structure-based%2520optimization%252C%2520and%2520biological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D116%26spage%3D13%26epage%3D26%26doi%3D10.1016%2Fj.ejmech.2016.03.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Lynch, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiseman, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somervaille, T. C. P.</span><span> </span><span class="NLM_article-title">CD86 expression as a surrogate cellular biomarker for pharmacological inhibition of the histone demethylase lysine-specific demethylase 1</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">442</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1016/j.ab.2013.07.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.ab.2013.07.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=442&publication_year=2013&pages=104-106&author=J.+T.+Lynchauthor=M.+J.+Cockerillauthor=J.+R.+Hitchinauthor=D.+H.+Wisemanauthor=T.+C.+P.+Somervaille&title=CD86+expression+as+a+surrogate+cellular+biomarker+for+pharmacological+inhibition+of+the+histone+demethylase+lysine-specific+demethylase+1&doi=10.1016%2Fj.ab.2013.07.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2013.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2013.07.032%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DJ.%2BT.%26aulast%3DCockerill%26aufirst%3DM.%2BJ.%26aulast%3DHitchin%26aufirst%3DJ.%2BR.%26aulast%3DWiseman%26aufirst%3DD.%2BH.%26aulast%3DSomervaille%26aufirst%3DT.%2BC.%2BP.%26atitle%3DCD86%2520expression%2520as%2520a%2520surrogate%2520cellular%2520biomarker%2520for%2520pharmacological%2520inhibition%2520of%2520the%2520histone%2520demethylase%2520lysine-specific%2520demethylase%25201%26jtitle%3DAnal.%2520Biochem.%26date%3D2013%26volume%3D442%26spage%3D104%26epage%3D106%26doi%3D10.1016%2Fj.ab.2013.07.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Wu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">3-(Piperidin-4-ylmethoxy)pyridine containing compounds are potent inhibitors of lysine specific demethylase 1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01361</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01361" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFylu77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=253-263&author=F.+Wuauthor=C.+Zhouauthor=Y.+Yaoauthor=L.+Weiauthor=Z.+Fengauthor=L.+Dengauthor=Y.+Song&title=3-%28Piperidin-4-ylmethoxy%29pyridine+containing+compounds+are+potent+inhibitors+of+lysine+specific+demethylase+1&doi=10.1021%2Facs.jmedchem.5b01361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1</span></div><div class="casAuthors">Wu, Fangrui; Zhou, Chao; Yao, Yuan; Wei, Liping; Feng, Zizhen; Deng, Lisheng; Song, Yongcheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">253-263</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Methylation of histone lysine residues plays important roles in gene expression regulation as well as cancer initiation.  Lysine specific demethylase 1 (LSD1) is responsible for maintaining balanced methylation levels at histone H3 lysine 4 (H3K4).  LSD1 is a drug target for certain cancers, due to important functions of methylated H3K4 or LSD1 overexpression.  We report the design, synthesis, and structure-activity relationships of 3-(piperidin-4-ylmethoxy)pyridine contg. compds. as potent LSD1 inhibitors with Ki values as low as 29 nM.  These compds. exhibited high selectivity (>160×) against related monoamine oxidase A and B.  Enzyme kinetics and docking studies suggested they are competitive inhibitors against a dimethylated H3K4 substrate and provided a possible binding mode.  The potent LSD1 inhibitors can increase cellular H3K4 methylation and strongly inhibit proliferation of several leukemia and solid tumor cells with EC50 values as low as 280 nM, while they had negligible effects on normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKAqQdCeodaLVg90H21EOLACvtfcHk0liT7yFYq-QCBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFylu77N&md5=2c74e06ed3c755826d25917d02cb845f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01361%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DC.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DY.%26atitle%3D3-%2528Piperidin-4-ylmethoxy%2529pyridine%2520containing%2520compounds%2520are%2520potent%2520inhibitors%2520of%2520lysine%2520specific%2520demethylase%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D253%26epage%3D263%26doi%3D10.1021%2Facs.jmedchem.5b01361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Cheeseright, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melville, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinter, J. G.</span><span> </span><span class="NLM_article-title">FieldScreen: virtual screening using molecular fields. Application to the DUD data set</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2108</span><span class="NLM_x">–</span> <span class="NLM_lpage">2117</span><span class="refDoi"> DOI: 10.1021/ci800110p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci800110p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlCrs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=2108-2117&author=T.+J.+Cheeserightauthor=M.+D.+Mackeyauthor=J.+L.+Melvilleauthor=J.+G.+Vinter&title=FieldScreen%3A+virtual+screening+using+molecular+fields.+Application+to+the+DUD+data+set&doi=10.1021%2Fci800110p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">FieldScreen: Virtual Screening Using Molecular Fields. Application to the DUD Data Set</span></div><div class="casAuthors">Cheeseright, Timothy J.; Mackey, Mark D.; Melville, James L.; Vinter, Jeremy G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2108-2117</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">FieldScreen, a ligand-based Virtual Screening (VS) method, is described.  Its use of 3D mol. fields makes it particularly suitable for scaffold hopping, and we have rigorously validated it for this purpose using a clustered version of the Directory of Useful Decoys (DUD).  Using thirteen pharmaceutically relevant targets, we demonstrate that FieldScreen produces superior early chemotype enrichments, compared to DOCK.  Addnl., hits retrieved by FieldScreen are consistently lower in mol. wt. than those retrieved by docking.  Where no X-ray protein structures are available, FieldScreen searches are more robust than docking into homol. models or apo structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql1Ac_qCT-T7Vg90H21EOLACvtfcHk0liT7yFYq-QCBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlCrs7fK&md5=01485c82f1801e5df5ad1b142a7c80c8</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fci800110p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci800110p%26sid%3Dliteratum%253Aachs%26aulast%3DCheeseright%26aufirst%3DT.%2BJ.%26aulast%3DMackey%26aufirst%3DM.%2BD.%26aulast%3DMelville%26aufirst%3DJ.%2BL.%26aulast%3DVinter%26aufirst%3DJ.%2BG.%26atitle%3DFieldScreen%253A%2520virtual%2520screening%2520using%2520molecular%2520fields.%2520Application%2520to%2520the%2520DUD%2520data%2520set%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D2108%26epage%3D2117%26doi%3D10.1021%2Fci800110p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Park, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boobis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldring, C. E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenna, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laverty, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naisbitt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweedie, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeulen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Managing the challenge of chemically reactive metabolites in drug development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span><span class="refDoi"> DOI: 10.1038/nrd3408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1038%2Fnrd3408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=21455238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=292-306&author=B.+K.+Parkauthor=A.+Boobisauthor=S.+Clarkeauthor=C.+E.+P.+Goldringauthor=D.+Jonesauthor=J.+G.+Kennaauthor=C.+Lambertauthor=H.+G.+Lavertyauthor=D.+J.+Naisbittauthor=S.+Nelsonauthor=D.+A.+Nicoll-Griffithauthor=R.+S.+Obachauthor=P.+Routledgeauthor=D.+A.+Smithauthor=D.+J.+Tweedieauthor=N.+Vermeulenauthor=D.+P.+Williamsauthor=I.+D.+Wilsonauthor=T.+A.+Baillie&title=Managing+the+challenge+of+chemically+reactive+metabolites+in+drug+development&doi=10.1038%2Fnrd3408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Managing the challenge of chemically reactive metabolites in drug development</span></div><div class="casAuthors">Park, B. Kevin; Boobis, Alan; Clarke, Stephen; Goldring, Chris E. P.; Jones, David; Kenna, J. Gerry; Lambert, Craig; Laverty, Hugh G.; Naisbitt, Dean J.; Nelson, Sidney; Nicoll-Griffith, Deborah A.; Obach, R. Scott; Routledge, Philip; Smith, Dennis A.; Tweedie, Donald J.; Vermeulen, Nico; Williams, Dominic P.; Wilson, Ian D.; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">292-306</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The normal metab. of drugs can generate metabolites that have intrinsic chem. reactivity towards cellular mols., and therefore have the potential to alter biol. function and initiate serious adverse drug reactions.  Here, we present an assessment of the current approaches used for the evaluation of chem. reactive metabolites.  We also describe how these approaches are being used within the pharmaceutical industry to assess and minimize the potential of drug candidates to cause toxicity.  At early stages of drug discovery, iteration between medicinal chem. and drug metab. can eliminate perceived reactive metabolite-mediated chem. liabilities without compromising pharmacol. activity or the need for extensive safety evaluation beyond std. practices.  In the future, reactive metabolite evaluation may also be useful during clin. development for improving clin. risk assessment and risk management.  Currently, there remains a huge gap in our understanding of the basic mechanisms that underlie chem. stress-mediated adverse reactions in humans.  This Review summarizes our views on this complex topic, and includes insights into practices considered by the pharmaceutical industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBv41vr7ZlNLVg90H21EOLACvtfcHk0lh51XZ-OVH32Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGnu78%253D&md5=8f6865f17bbe50b51aa4282379e82a08</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnrd3408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3408%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DB.%2BK.%26aulast%3DBoobis%26aufirst%3DA.%26aulast%3DClarke%26aufirst%3DS.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%2BP.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26aulast%3DLambert%26aufirst%3DC.%26aulast%3DLaverty%26aufirst%3DH.%2BG.%26aulast%3DNaisbitt%26aufirst%3DD.%2BJ.%26aulast%3DNelson%26aufirst%3DS.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DRoutledge%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DTweedie%26aufirst%3DD.%2BJ.%26aulast%3DVermeulen%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26aulast%3DWilson%26aufirst%3DI.%2BD.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DManaging%2520the%2520challenge%2520of%2520chemically%2520reactive%2520metabolites%2520in%2520drug%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D292%26epage%3D306%26doi%3D10.1038%2Fnrd3408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Luka, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pakhomova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loukachevitch, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calcutt, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomer, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C.</span><span> </span><span class="NLM_article-title">Crystal structure of the histone lysine specific demethylase LSD1 complexed with tetrahydrofolate</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">998</span><span class="refDoi"> DOI: 10.1002/pro.2469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1002%2Fpro.2469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=24715612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=993-998&author=Z.+Lukaauthor=S.+Pakhomovaauthor=L.+V.+Loukachevitchauthor=M.+W.+Calcuttauthor=M.+E.+Newcomerauthor=C.+Wagner&title=Crystal+structure+of+the+histone+lysine+specific+demethylase+LSD1+complexed+with+tetrahydrofolate&doi=10.1002%2Fpro.2469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the histone lysine specific demethylase LSD1 complexed with tetrahydrofolate</span></div><div class="casAuthors">Luka, Zigmund; Pakhomova, Svetlana; Loukachevitch, Lioudmila V.; Calcutt, M. Wade; Newcomer, Marcia E.; Wagner, Conrad</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">993-998</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">An important epigenetic modification is the methylation/demethylation of histone lysine residues.  The first histone demethylase to be discovered was a lysine-specific demethylase 1, LSD1, a flavin contg. enzyme which carries out the demethylation of di- and monomethyllysine 4 in histone H3.  The removed Me groups are oxidized to formaldehyde.  This reaction is similar to those performed by dimethylglycine dehydrogenase and sarcosine dehydrogenase, in which protein-bound tetrahydrofolate (THF) was proposed to serve as an acceptor of the generated formaldehyde.  The authors showed earlier that LSD1 binds THF with high affinity which suggests its possible participation in the histone demethylation reaction.  In the cell, LSD1 interacts with co-repressor for repressor element 1 silencing transcription factor (CoREST).  In order to elucidate the role of folate in the demethylating reaction the authors solved the crystal structure of the LSD1-CoREST-THF complex.  In the complex, the folate-binding site is located in the active center in close proximity to FAD.  This position of the folate suggests that the bound THF accepts the formaldehyde generated in the course of histone demethylation to form 5,10-methylene-THF.  The authors also show the formation of 5,10-methylene-THF during the course of the enzymic reaction in the presence of THF by mass spectrometry.  Prodn. of this form of folate could act to prevent accumulation of potentially toxic formaldehyde in the cell.  These studies suggest that folate may play a role in the epigenetic control of gene expression in addn. to its traditional role in the transfer of one-carbon units in metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_2NE_odCJR7Vg90H21EOLACvtfcHk0lh51XZ-OVH32Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL%252FE&md5=d4330f49c208bee3e42b426c9f39680f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fpro.2469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.2469%26sid%3Dliteratum%253Aachs%26aulast%3DLuka%26aufirst%3DZ.%26aulast%3DPakhomova%26aufirst%3DS.%26aulast%3DLoukachevitch%26aufirst%3DL.%2BV.%26aulast%3DCalcutt%26aufirst%3DM.%2BW.%26aulast%3DNewcomer%26aufirst%3DM.%2BE.%26aulast%3DWagner%26aufirst%3DC.%26atitle%3DCrystal%2520structure%2520of%2520the%2520histone%2520lysine%2520specific%2520demethylase%2520LSD1%2520complexed%2520with%2520tetrahydrofolate%26jtitle%3DProtein%2520Sci.%26date%3D2014%26volume%3D23%26spage%3D993%26epage%3D998%26doi%3D10.1002%2Fpro.2469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1749</span><span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0liqVGeLOsK27w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 25 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xiaoyi Zhu, Ruibo Li, Hequan Yao, <span class="NLM_string-name hlFld-ContribAuthor">Aijun Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Allenamide Carbopalladation/Allylation with Active Methine Compounds. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (12)
                                     , 4630-4634. <a href="https://doi.org/10.1021/acs.orglett.1c01369" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c01369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c01369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c01369%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPalladium-Catalyzed%252BAllenamide%252BCarbopalladation%25252FAllylation%252Bwith%252BActive%252BMethine%252BCompounds%26aulast%3DZhu%26aufirst%3DXiaoyi%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D20042021%26date%3D28052021%26volume%3D23%26issue%3D12%26spage%3D4630%26epage%3D4634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xing-Jie Dai, Ying Liu, Lei-Peng Xue, Xiao-Peng Xiong, Ying Zhou, Yi-Chao Zheng, <span class="NLM_string-name hlFld-ContribAuthor">Hong-Min Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2466-2488. <a href="https://doi.org/10.1021/acs.jmedchem.0c02176" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02176%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DReversible%252BLysine%252BSpecific%252BDemethylase%252B1%252B%252528LSD1%252529%252BInhibitors%25253A%252BA%252BPromising%252BWrench%252Bto%252BImpair%252BLSD1%26aulast%3DDai%26aufirst%3DXing-Jie%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D16122020%26date%3D23022021%26volume%3D64%26issue%3D5%26spage%3D2466%26epage%3D2488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kerstin Hiesinger, Dmitry Dar’in, Ewgenij Proschak, <span class="NLM_string-name hlFld-ContribAuthor">Mikhail Krasavin</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 150-183. <a href="https://doi.org/10.1021/acs.jmedchem.0c01473" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01473%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BMedicinal%252BChemistry%26aulast%3DHiesinger%26aufirst%3DKerstin%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D24082020%26date%3D31122020%26volume%3D64%26issue%3D1%26spage%3D150%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Opportunities for Tapping into Three-Dimensional Chemical Space through a Quaternary Carbon. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13291-13315. <a href="https://doi.org/10.1021/acs.jmedchem.0c00829" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00829%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOpportunities%252Bfor%252BTapping%252Binto%252BThree-Dimensional%252BChemical%252BSpace%252Bthrough%252Ba%252BQuaternary%252BCarbon%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15052020%26date%3D31082020%26date%3D17082020%26volume%3D63%26issue%3D22%26spage%3D13291%26epage%3D13315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Screening for the Discovery of Enzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10742-10772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Throughput%252BScreening%252Bfor%252Bthe%252BDiscovery%252Bof%252BEnzyme%252BInhibitors%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30032020%26date%3D10062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10742%26epage%3D10772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alessia Romussi, Anna Cappa, Paola Vianello, Silvia Brambillasca, Maria Rosaria Cera, Roberto Dal Zuffo, Giovanni Fagà, Raimondo Fattori, Loris Moretti, Paolo Trifirò, Manuela Villa, Stefania Vultaggio, Valentina Cecatiello, Sebastiano Pasqualato, Giulio Dondio, Chi Wai Eric So, Saverio Minucci, Luca Sartori, Mario Varasi, <span class="NLM_string-name hlFld-ContribAuthor">Ciro Mercurio</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Reversible Inhibitors of KDM1A Efficacious in Acute Myeloid Leukemia Models. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 754-759. <a href="https://doi.org/10.1021/acsmedchemlett.9b00604" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00604</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00604%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BReversible%252BInhibitors%252Bof%252BKDM1A%252BEfficacious%252Bin%252BAcute%252BMyeloid%252BLeukemia%252BModels%26aulast%3DRomussi%26aufirst%3DAlessia%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D16122019%26date%3D13022020%26date%3D20022020%26date%3D13022020%26volume%3D11%26issue%3D5%26spage%3D754%26epage%3D759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malose J.  Mphahlele</span>, <span class="hlFld-ContribAuthor ">Marole M.  Maluleka</span>. </span><span class="cited-content_cbyCitation_article-title">A combined experimental and computational structural study of the N-(2-cyanophenyl)disulfonamides derived from 5-bromo- and 5-iodoanthranilamide. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1238 </em>, 130447. <a href="https://doi.org/10.1016/j.molstruc.2021.130447" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.130447</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.130447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.130447%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DA%252Bcombined%252Bexperimental%252Band%252Bcomputational%252Bstructural%252Bstudy%252Bof%252Bthe%252BN-%2525282-cyanophenyl%252529disulfonamides%252Bderived%252Bfrom%252B5-bromo-%252Band%252B5-iodoanthranilamide%26aulast%3DMphahlele%26aufirst%3DMalose%2BJ.%26date%3D2021%26volume%3D1238%26spage%3D130447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Hailan  Huang</span>, <span class="hlFld-ContribAuthor ">Ziheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiangkun  Yan</span>, <span class="hlFld-ContribAuthor ">Tianxiao  Wu</span>, <span class="hlFld-ContribAuthor ">Wenbo  Yin</span>, <span class="hlFld-ContribAuthor ">Yixiang  Sun</span>, <span class="hlFld-ContribAuthor ">Xinran  Wang</span>, <span class="hlFld-ContribAuthor ">Yanting  Gu</span>, <span class="hlFld-ContribAuthor ">Dongmei  Zhao</span>, <span class="hlFld-ContribAuthor ">Maosheng  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel benzofuran derivatives as potent LSD1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>220 </em>, 113501. <a href="https://doi.org/10.1016/j.ejmech.2021.113501" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113501%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bbenzofuran%252Bderivatives%252Bas%252Bpotent%252BLSD1%252Binhibitors%26aulast%3DZhang%26aufirst%3DXiangyu%26date%3D2021%26volume%3D220%26spage%3D113501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shujing  Zhang</span>, <span class="hlFld-ContribAuthor ">Menghan  Liu</span>, <span class="hlFld-ContribAuthor ">Yongfang  Yao</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Hongmin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting LSD1 for acute myeloid leukemia (AML) treatment. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>164 </em>, 105335. <a href="https://doi.org/10.1016/j.phrs.2020.105335" title="DOI URL">https://doi.org/10.1016/j.phrs.2020.105335</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2020.105335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2020.105335%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DTargeting%252BLSD1%252Bfor%252Bacute%252Bmyeloid%252Bleukemia%252B%252528AML%252529%252Btreatment%26aulast%3DZhang%26aufirst%3DShujing%26date%3D2021%26volume%3D164%26spage%3D105335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samir  Mehndiratta</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>. </span><span class="cited-content_cbyCitation_article-title">Histone lysine specific demethylase 1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (9)
                                     , 969-981. <a href="https://doi.org/10.1039/D0MD00141D" title="DOI URL">https://doi.org/10.1039/D0MD00141D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00141D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00141D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DHistone%252Blysine%252Bspecific%252Bdemethylase%252B1%252Binhibitors%26aulast%3DMehndiratta%26aufirst%3DSamir%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D9%26spage%3D969%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Roscales</span>, <span class="hlFld-ContribAuthor ">Aurelio G.  Csáky</span>. </span><span class="cited-content_cbyCitation_article-title">Transition‐Metal‐Free Three‐Component Synthesis of Tertiary Aryl Amines from Nitro Compounds, Boronic Acids, and Trialkyl Phosphites. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (1)
                                     , 111-117. <a href="https://doi.org/10.1002/adsc.201901009" title="DOI URL">https://doi.org/10.1002/adsc.201901009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201901009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201901009%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DTransition%2525E2%252580%252590Metal%2525E2%252580%252590Free%252BThree%2525E2%252580%252590Component%252BSynthesis%252Bof%252BTertiary%252BAryl%252BAmines%252Bfrom%252BNitro%252BCompounds%25252C%252BBoronic%252BAcids%25252C%252Band%252BTrialkyl%252BPhosphites%26aulast%3DRoscales%26aufirst%3DSilvia%26date%3D2020%26date%3D2019%26volume%3D362%26issue%3D1%26spage%3D111%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soraya  Alnabulsi</span>, <span class="hlFld-ContribAuthor ">Enas A.  Al-Hurani</span>, <span class="hlFld-ContribAuthor ">Nizar A.  Al-shar'i</span>, <span class="hlFld-ContribAuthor ">Tamam  El-Elimat</span>. </span><span class="cited-content_cbyCitation_article-title">Amino-carboxamide benzothiazoles as potential LSD1 hit inhibitors. Part I: Computational fragment-based drug design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2019,</strong> <em>93 </em>, 107440. <a href="https://doi.org/10.1016/j.jmgm.2019.107440" title="DOI URL">https://doi.org/10.1016/j.jmgm.2019.107440</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2019.107440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2019.107440%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DAmino-carboxamide%252Bbenzothiazoles%252Bas%252Bpotential%252BLSD1%252Bhit%252Binhibitors.%252BPart%252BI%25253A%252BComputational%252Bfragment-based%252Bdrug%252Bdesign%26aulast%3DAlnabulsi%26aufirst%3DSoraya%26date%3D2019%26volume%3D93%26spage%3D107440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu-Dong  Sun</span>, <span class="hlFld-ContribAuthor ">Yi-Chao  Zheng</span>, <span class="hlFld-ContribAuthor ">Chao-Ya  Ma</span>, <span class="hlFld-ContribAuthor ">Jing  Yang</span>, <span class="hlFld-ContribAuthor ">Qi-Bing  Gao</span>, <span class="hlFld-ContribAuthor ">Ying  Yan</span>, <span class="hlFld-ContribAuthor ">Zhi-Zheng  Wang</span>, <span class="hlFld-ContribAuthor ">Wen  Li</span>, <span class="hlFld-ContribAuthor ">Wen  Zhao</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>, <span class="hlFld-ContribAuthor ">Lina  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2019,</strong> <em>37 </em>
                                    (16)
                                     , 4200-4214. <a href="https://doi.org/10.1080/07391102.2018.1538903" title="DOI URL">https://doi.org/10.1080/07391102.2018.1538903</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2018.1538903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2018.1538903%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIdentifying%252Bthe%252Bnovel%252Binhibitors%252Bof%252Blysine-specific%252Bdemethylase%252B1%252B%252528LSD1%252529%252Bcombining%252Bpharmacophore-based%252Band%252Bstructure-based%252Bvirtual%252Bscreening%26aulast%3DSun%26aufirst%3DXu-Dong%26date%3D2019%26date%3D2018%26volume%3D37%26issue%3D16%26spage%3D4200%26epage%3D4214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhonghua  Li</span>, <span class="hlFld-ContribAuthor ">Lina  Ding</span>, <span class="hlFld-ContribAuthor ">Zhongrui  Li</span>, <span class="hlFld-ContribAuthor ">Zhizheng  Wang</span>, <span class="hlFld-ContribAuthor ">Fengzhi  Suo</span>, <span class="hlFld-ContribAuthor ">Dandan  Shen</span>, <span class="hlFld-ContribAuthor ">Taoqian  Zhao</span>, <span class="hlFld-ContribAuthor ">Xudong  Sun</span>, <span class="hlFld-ContribAuthor ">Junwei  Wang</span>, <span class="hlFld-ContribAuthor ">Ying  Liu</span>, <span class="hlFld-ContribAuthor ">Liying  Ma</span>, <span class="hlFld-ContribAuthor ">Bing  Zhao</span>, <span class="hlFld-ContribAuthor ">Pengfei  Geng</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Yichao  Zheng</span>, <span class="hlFld-ContribAuthor ">Hongmin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A). </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2019,</strong> <em>9 </em>
                                    (4)
                                     , 794-808. <a href="https://doi.org/10.1016/j.apsb.2019.01.001" title="DOI URL">https://doi.org/10.1016/j.apsb.2019.01.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2019.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2019.01.001%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDevelopment%252Bof%252Bthe%252Btriazole-fused%252Bpyrimidine%252Bderivatives%252Bas%252Bhighly%252Bpotent%252Band%252Breversible%252Binhibitors%252Bof%252Bhistone%252Blysine%252Bspecific%252Bdemethylase%252B1%252B%252528LSD1%25252FKDM1A%252529%26aulast%3DLi%26aufirst%3DZhonghua%26date%3D2019%26volume%3D9%26issue%3D4%26spage%3D794%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lambert</span>, <span class="hlFld-ContribAuthor ">Alioui</span>, <span class="hlFld-ContribAuthor ">Jambon</span>, <span class="hlFld-ContribAuthor ">Depauw</span>, <span class="hlFld-ContribAuthor ">Van Seuningen</span>, <span class="hlFld-ContribAuthor ">David-Cordonnier</span>. </span><span class="cited-content_cbyCitation_article-title">Direct and Indirect Targeting of HOXA9 Transcription Factor in Acute Myeloid Leukemia.. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (6)
                                     , 837. <a href="https://doi.org/10.3390/cancers11060837" title="DOI URL">https://doi.org/10.3390/cancers11060837</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11060837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11060837%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DDirect%252Band%252BIndirect%252BTargeting%252Bof%252BHOXA9%252BTranscription%252BFactor%252Bin%252BAcute%252BMyeloid%252BLeukemia.%26aulast%3DLambert%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D6%26spage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuai  Wang</span>, <span class="hlFld-ContribAuthor ">Zhong-Rui  Li</span>, <span class="hlFld-ContribAuthor ">Feng-Zhi  Suo</span>, <span class="hlFld-ContribAuthor ">Xiao-Han  Yuan</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, structure-activity relationship studies and biological characterization of new [1,2,4]triazolo[1,5-a]pyrimidine-based LSD1/KDM1A inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>167 </em>, 388-401. <a href="https://doi.org/10.1016/j.ejmech.2019.02.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bstructure-activity%252Brelationship%252Bstudies%252Band%252Bbiological%252Bcharacterization%252Bof%252Bnew%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-a%25255Dpyrimidine-based%252BLSD1%25252FKDM1A%252Binhibitors%26aulast%3DWang%26aufirst%3DShuai%26date%3D2019%26volume%3D167%26spage%3D388%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takayoshi  Suzuki</span>. </span><span class="cited-content_cbyCitation_article-title">Lysine-Specific Histone Demethylases 1/2 (LSD1/2) and Their Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 197-219. <a href="https://doi.org/10.1007/7355_2019_74" title="DOI URL">https://doi.org/10.1007/7355_2019_74</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2019_74&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2019_74%26sid%3Dliteratum%253Aachs%26atitle%3DLysine-Specific%252BHistone%252BDemethylases%252B1%25252F2%252B%252528LSD1%25252F2%252529%252Band%252BTheir%252BInhibitors%26aulast%3DSuzuki%26aufirst%3DTakayoshi%26date%3D2019%26date%3D2020%26spage%3D197%26epage%3D219%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DChemical%252BEpigenetics%26aulast%3DMai%26aufirst%3DAntonello%26date%3D2020%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dina  Robaa</span>, <span class="hlFld-ContribAuthor ">Jelena  Melesina</span>, <span class="hlFld-ContribAuthor ">Chiara  Luise</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Epigenetic Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 455-486. <a href="https://doi.org/10.1007/7355_2019_80" title="DOI URL">https://doi.org/10.1007/7355_2019_80</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2019_80&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2019_80%26sid%3Dliteratum%253Aachs%26atitle%3DStructure-Based%252BDesign%252Bof%252BEpigenetic%252BInhibitors%26aulast%3DRobaa%26aufirst%3DDina%26date%3D2019%26date%3D2019%26spage%3D455%26epage%3D486%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DChemical%252BEpigenetics%26aulast%3DMai%26aufirst%3DAntonello%26date%3D2020%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhe  Nie</span>, <span class="hlFld-ContribAuthor ">Lihong  Shi</span>, <span class="hlFld-ContribAuthor ">Chon  Lai</span>, <span class="hlFld-ContribAuthor ">Christophe  Severin</span>, <span class="hlFld-ContribAuthor ">Jiangchun  Xu</span>, <span class="hlFld-ContribAuthor ">Joselyn R.  Del Rosario</span>, <span class="hlFld-ContribAuthor ">Ryan K.  Stansfield</span>, <span class="hlFld-ContribAuthor ">Robert W.  Cho</span>, <span class="hlFld-ContribAuthor ">Toufike  Kanouni</span>, <span class="hlFld-ContribAuthor ">James M.  Veal</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Stafford</span>, <span class="hlFld-ContribAuthor ">Young K.  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design and discovery of potent and selective lysine-specific demethylase 1 (LSD1) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (1)
                                     , 103-106. <a href="https://doi.org/10.1016/j.bmcl.2018.11.001" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.11.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.11.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Bdesign%252Band%252Bdiscovery%252Bof%252Bpotent%252Band%252Bselective%252Blysine-specific%252Bdemethylase%252B1%252B%252528LSD1%252529%252Binhibitors%26aulast%3DNie%26aufirst%3DZhe%26date%3D2019%26volume%3D29%26issue%3D1%26spage%3D103%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Zheng  Wang</span>, <span class="hlFld-ContribAuthor ">Chao-Ya  Ma</span>, <span class="hlFld-ContribAuthor ">Jing  Yang</span>, <span class="hlFld-ContribAuthor ">Qi-Bing  Gao</span>, <span class="hlFld-ContribAuthor ">Xu-Dong  Sun</span>, <span class="hlFld-ContribAuthor ">Lina  Ding</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Investigating the binding mechanism of (4-Cyanophenyl)glycine derivatives as reversible LSD1 by 3D-QSAR, molecular docking and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2019,</strong> <em>1175 </em>, 698-707. <a href="https://doi.org/10.1016/j.molstruc.2018.08.029" title="DOI URL">https://doi.org/10.1016/j.molstruc.2018.08.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2018.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2018.08.029%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DInvestigating%252Bthe%252Bbinding%252Bmechanism%252Bof%252B%2525284-Cyanophenyl%252529glycine%252Bderivatives%252Bas%252Breversible%252BLSD1%252Bby%252B3D-QSAR%25252C%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DWang%26aufirst%3DZhi-Zheng%26date%3D2019%26volume%3D1175%26spage%3D698%26epage%3D707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yingchao  Duan</span>, <span class="hlFld-ContribAuthor ">Wenping  Qin</span>, <span class="hlFld-ContribAuthor ">Fengzhi  Suo</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhai</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Guan</span>, <span class="hlFld-ContribAuthor ">Xiaojuan  Wang</span>, <span class="hlFld-ContribAuthor ">Yichao  Zheng</span>, <span class="hlFld-ContribAuthor ">Hongmin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (23-24)
                                     , 6000-6014. <a href="https://doi.org/10.1016/j.bmc.2018.10.037" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.10.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.10.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bin%252Bvitro%252Bevaluation%252Bof%252Bstilbene%252Bderivatives%252Bas%252Bnovel%252BLSD1%252Binhibitors%252Bfor%252BAML%252Btherapy%26aulast%3DDuan%26aufirst%3DYingchao%26date%3D2018%26volume%3D26%26issue%3D23-24%26spage%3D6000%26epage%3D6014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veera Ganesh  Yerra</span>, <span class="hlFld-ContribAuthor ">Andrew  Advani</span>. </span><span class="cited-content_cbyCitation_article-title">Histones and heart failure in diabetes. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2018,</strong> <em>75 </em>
                                    (17)
                                     , 3193-3213. <a href="https://doi.org/10.1007/s00018-018-2857-1" title="DOI URL">https://doi.org/10.1007/s00018-018-2857-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-018-2857-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-018-2857-1%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DHistones%252Band%252Bheart%252Bfailure%252Bin%252Bdiabetes%26aulast%3DYerra%26aufirst%3DVeera%2BGanesh%26date%3D2018%26date%3D2018%26volume%3D75%26issue%3D17%26spage%3D3193%26epage%3D3213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiayue  Xi</span>, <span class="hlFld-ContribAuthor ">Siyuan  Xu</span>, <span class="hlFld-ContribAuthor ">Lulu  Zhang</span>, <span class="hlFld-ContribAuthor ">Xueyuan  Bi</span>, <span class="hlFld-ContribAuthor ">Yanshen  Ren</span>, <span class="hlFld-ContribAuthor ">Yu-Chih  Liu</span>, <span class="hlFld-ContribAuthor ">Yueqing  Gu</span>, <span class="hlFld-ContribAuthor ">Yungen  Xu</span>, <span class="hlFld-ContribAuthor ">Fei  Lan</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Zha</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological activity of 4-(4-benzyloxy)phenoxypiperidines as selective and reversible LSD1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>78 </em>, 7-16. <a href="https://doi.org/10.1016/j.bioorg.2018.02.016" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.02.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.02.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bactivity%252Bof%252B4-%2525284-benzyloxy%252529phenoxypiperidines%252Bas%252Bselective%252Band%252Breversible%252BLSD1%252Binhibitors%26aulast%3DXi%26aufirst%3DJiayue%26date%3D2018%26volume%3D78%26spage%3D7%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hideaki  Niwa</span>, <span class="hlFld-ContribAuthor ">Shin  Sato</span>, <span class="hlFld-ContribAuthor ">Tomoko  Hashimoto</span>, <span class="hlFld-ContribAuthor ">Kenji  Matsuno</span>, <span class="hlFld-ContribAuthor ">Takashi  Umehara</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal Structure of LSD1 in Complex with 4-[5-(Piperidin-4-ylmethoxy)-2-(p-tolyl)pyridin-3-yl]benzonitrile. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (7)
                                     , 1538. <a href="https://doi.org/10.3390/molecules23071538" title="DOI URL">https://doi.org/10.3390/molecules23071538</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23071538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23071538%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DCrystal%252BStructure%252Bof%252BLSD1%252Bin%252BComplex%252Bwith%252B4-%25255B5-%252528Piperidin-4-ylmethoxy%252529-2-%252528p-tolyl%252529pyridin-3-yl%25255Dbenzonitrile%26aulast%3DNiwa%26aufirst%3DHideaki%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D7%26spage%3D1538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alba  Maiques-Diaz</span>, <span class="hlFld-ContribAuthor ">Gary J.  Spencer</span>, <span class="hlFld-ContribAuthor ">James T.  Lynch</span>, <span class="hlFld-ContribAuthor ">Filippo  Ciceri</span>, <span class="hlFld-ContribAuthor ">Emma L.  Williams</span>, <span class="hlFld-ContribAuthor ">Fabio M.R.  Amaral</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Wiseman</span>, <span class="hlFld-ContribAuthor ">William J.  Harris</span>, <span class="hlFld-ContribAuthor ">Yaoyong  Li</span>, <span class="hlFld-ContribAuthor ">Sudhakar  Sahoo</span>, <span class="hlFld-ContribAuthor ">James R.  Hitchin</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Mould</span>, <span class="hlFld-ContribAuthor ">Emma E.  Fairweather</span>, <span class="hlFld-ContribAuthor ">Bohdan  Waszkowycz</span>, <span class="hlFld-ContribAuthor ">Allan M.  Jordan</span>, <span class="hlFld-ContribAuthor ">Duncan L.  Smith</span>, <span class="hlFld-ContribAuthor ">Tim C.P.  Somervaille</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid Leukemia. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2018,</strong> <em>22 </em>
                                    (13)
                                     , 3641-3659. <a href="https://doi.org/10.1016/j.celrep.2018.03.012" title="DOI URL">https://doi.org/10.1016/j.celrep.2018.03.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2018.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2018.03.012%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DEnhancer%252BActivation%252Bby%252BPharmacologic%252BDisplacement%252Bof%252BLSD1%252Bfrom%252BGFI1%252BInduces%252BDifferentiation%252Bin%252BAcute%252BMyeloid%252BLeukemia%26aulast%3DMaiques-Diaz%26aufirst%3DAlba%26date%3D2018%26volume%3D22%26issue%3D13%26spage%3D3641%26epage%3D3659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compound <b>1</b> and examples from several series disclosed by Quanticel Pharmaceuticals (<b>2</b>–<b>6</b>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>10a</b>–<b>b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 3,5-dimethylpyrazole, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 16 h, 99%; (ii) Zn, ammonium formate, MeOH, 40 °C, 16 h, 78%; (iii) appropriate sulfonyl chloride, pyridine, 100 °C, 1 h, 41–70%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>12</b> and <b>16a</b>–<b>m</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 4-acetamidobenzenesulfonyl chloride, DMAP, MeCN, μW, 100 °C, 1 h, 37%; (ii) 4-methylphenylsulfonyl, pyridine, MeCN, RT, 12 h, 89%; (iii) <i>tert</i>-butyl bromoacetate, K<sub>2</sub>CO<sub>3</sub>, DMF, 1 h, 96%; (iv) TFA, DCM, 1 h, 98%; (v) amine, DIPEA, COMU, DMF, then 4 M HCl/dioxane if Boc deprotection required, RT, 12–68%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>21a</b>–<b>b</b>, <b>22</b>, and <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 1-acetylindoline-5-sulfonyl chloride, pyridine, MeCN, RT, 12 h, 84%; (ii) (<b>21a</b>) <i>tert</i>-butyl <i>N</i>-[(3<i>R</i>)-1-(2-chloroacetyl)-3-piperidyl]carbamate, K<sub>2</sub>CO<sub>3</sub>, cat. KI, DMF, 80 °C, 3 h, then TFA, 1 h, rt, 42%; (<b>21b</b>) <i>tert</i>-butyl <i>N</i>-[1-(2-chloroacetyl)-4-piperidyl]carbamate, K<sub>2</sub>CO<sub>3</sub>, 80 °C, 6 h, then 4 M HCl/dioxane, 70%; (iii) 2-methyl-2<i>H</i>-indazol-5-amine, pyridine, MeCN, rt, 12 h, 54%; (iv) <i>tert</i>-butyl <i>N</i>-[(3<i>R</i>)-1-(2-chloroacetyl)-3-piperidyl]carbamate, K<sub>2</sub>CO<sub>3</sub>, cat. KI, DMF, 80 °C, 3 h; then TFA, 1 h, rt, 25%; (v) 1-acetylindoline-5-sulfonyl chloride, pyridine, MeCN, RT, 12 h, 54%; (vi) <i>tert</i>-butyl <i>N</i>-[1-(2-chloroacetyl)-4-piperidyl]carbamate, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 6 h, then 4 M HCl/dioxane, 1 h RT, 52%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>29a</b>–<b>e</b>, <b>30a</b>–<b>f</b>, <b>31</b>, and <b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Boc-protected diamine, DIPEA, COMU, DMF, rt, 1 h, 67–99%; (ii) substituted benzyl-bromide, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 1 h, then 4 M HCl/dioxane, rt, 1 h, 6–58%</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Development and characterization of compound <b>10b</b>. (A) Biochemical assay; (B) surrogate cellular biomarker assay; (C) surface plasmon resonance sensorgram of the interaction between LSD1 and <b>10b</b> in 2-fold dilution series (highest concentration indicated in the graph).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure of compound <b>12</b> with biochemical and SPR sensorgram indicating the highest tested concentration. <i>K</i><sub>d</sub> = 9.5 μM. <i>K</i><sub>d</sub> value was determined by SPR at 15 °C as the average of two experimental series (typically 10 concentrations).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cresset Torch alignment and structures of compound <b>1</b> (left) and <b>16g</b> (right). Similarity score 0.712. Blue field points (spheres) highlight energy minima for a positively charged probe, red for a negative probe. Yellow spheres represent an attractive van der Waals minimum for a neutral probe, and brown spheres represent hydrophobic regions. Oxygen atoms are shown in red, nitrogen in blue. The similarity score is based on the likeness of the field points in terms of their magnitude and position. A score of greater than 0.7 is considered a “good” score.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Top: Predicted binding mode of compound <b>30f</b> in the LSD1 active site (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KUM">4KUM</a>). Visualized using Maestro. Bottom: Protein–ligand interaction diagram with key hydrogen bond interactions highlighted (pink arrows).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. CD86 cell assay results for compounds <b>1</b>, <b>30f</b>, and <b>32</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Top: Colony formation assay for THP-1 and MV4-11 cells dosed with 10 μM of compounds <b>1</b> and <b>32</b> for 7 days. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, ****<i>P</i> < 0.0001, statistical significance calculated using a one-way ANOVA with Dunnett’s tests between vehicle treated and compound dosed cells. Bottom: representative images of colonies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/medium/jm-2017-00462b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Annexin V-perCP EF710/7AAD double staining experiments results with THP-1 cell dosed with vehicle, or 10 μM <b>1</b> or <b>32</b> for 4 days in liquid culture. Early apoptotic cells = annexin V<sup>pos</sup>7-AAD<sup>neg</sup>; apoptotic cells = annexin V<sup>pos</sup>7-AAD<sup>pos</sup>. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, ****<i>P</i> < 0.0001, statistical significance calculated using one-way ANOVA analysis with Dunnett’s tests.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00462/20171006/images/large/jm-2017-00462b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00462&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i79">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64620" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64620" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 42 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whetstine, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casero, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Histone demethylation mediated by the nuclear amine oxidase homolog LSD1</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">953</span><span class="refDoi"> DOI: 10.1016/j.cell.2004.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.cell.2004.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=15620353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2004&pages=941-953&author=Y.+Shiauthor=F.+Lanauthor=C.+Matsonauthor=P.+Mulliganauthor=J.+R.+Whetstineauthor=P.+A.+Coleauthor=R.+A.+Caseroauthor=Y.+Shi&title=Histone+demethylation+mediated+by+the+nuclear+amine+oxidase+homolog+LSD1&doi=10.1016%2Fj.cell.2004.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Histone demethylation mediated by the nuclear amine oxidase homolog LSD1</span></div><div class="casAuthors">Shi, Yujiang; Lan, Fei; Matson, Caitlin; Mulligan, Peter; Whetstine, Johnathan R.; Cole, Philip A.; Casero, Robert A.; Shi, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">941-953</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Posttranslational modifications of histone N-terminal tails impact chromatin structure and gene transcription.  While the extent of histone acetylation is detd. by both acetyltransferases and deacetylases, it has been unclear whether histone methylation is also regulated by enzymes with opposing activities.  Here, we provide evidence that LSD1 (KIAA0601), a nuclear homolog of amine oxidases, functions as a histone demethylase and transcriptional corepressor.  LSD1 specifically demethylates histone H3 lysine 4, which is linked to active transcription.  Lysine demethylation occurs via an oxidn. reaction that generates formaldehyde.  Importantly, RNAi inhibition of LSD1 causes an increase in H3 lysine 4 methylation and concomitant derepression of target genes, suggesting that LSD1 represses transcription via histone demethylation.  The results thus identify a histone demethylase conserved from S. pombe to human and reveal dynamic regulation of histone methylation by both histone methylases and demethylases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXHr-8kwGdXrVg90H21EOLACvtfcHk0liftEytqDFDzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlSitg%253D%253D&md5=3474569204255e90a832667ba654748b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2004.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2004.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.%26aulast%3DLan%26aufirst%3DF.%26aulast%3DMatson%26aufirst%3DC.%26aulast%3DMulligan%26aufirst%3DP.%26aulast%3DWhetstine%26aufirst%3DJ.%2BR.%26aulast%3DCole%26aufirst%3DP.%2BA.%26aulast%3DCasero%26aufirst%3DR.%2BA.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DHistone%2520demethylation%2520mediated%2520by%2520the%2520nuclear%2520amine%2520oxidase%2520homolog%2520LSD1%26jtitle%3DCell%26date%3D2004%26volume%3D119%26spage%3D941%26epage%3D953%26doi%3D10.1016%2Fj.cell.2004.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Amente, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lania, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majello, B.</span><span> </span><span class="NLM_article-title">The histone LSD1 demethylase in stemness and cancer transcription programs</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Gene Regul. Mech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1829</span><span class="NLM_x">, </span> <span class="NLM_fpage">981</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span><span class="refDoi"> DOI: 10.1016/j.bbagrm.2013.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.bbagrm.2013.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=23684752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCls7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1829&publication_year=2013&pages=981-986&author=S.+Amenteauthor=L.+Laniaauthor=B.+Majello&title=The+histone+LSD1+demethylase+in+stemness+and+cancer+transcription+programs&doi=10.1016%2Fj.bbagrm.2013.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The histone LSD1 demethylase in stemness and cancer transcription programs</span></div><div class="casAuthors">Amente, Stefano; Lania, Luigi; Majello, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Gene Regulatory Mechanisms</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1829</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">981-986</span>CODEN:
                <span class="NLM_cas:coden">BBAGC6</span>;
        ISSN:<span class="NLM_cas:issn">1874-9399</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  DNA and histone chromatin modifying enzymes play a crucial role in chromatin remodeling in several biol. processes.  Lysine-specific demethylase 1 (LSD1), the first identified histone demethylase, is a relevant player in the regulation of a broad spectrum of biol. processes including development, cellular differentiation, embryonic pluripotency and cancer.  Here, we review recent insights on the role of LSD1 activity in chromatin regulatory complexes, its functional role in the epigenetic changes during embryonic development, in the establishment and maintenance of stemness and during cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbcvNabWazwbVg90H21EOLACvtfcHk0liftEytqDFDzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCls7fF&md5=ea0ef4256c790ff25251b16cbb2880a5</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagrm.2013.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagrm.2013.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DAmente%26aufirst%3DS.%26aulast%3DLania%26aufirst%3DL.%26aulast%3DMajello%26aufirst%3DB.%26atitle%3DThe%2520histone%2520LSD1%2520demethylase%2520in%2520stemness%2520and%2520cancer%2520transcription%2520programs%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gene%2520Regul.%2520Mech.%26date%3D2013%26volume%3D1829%26spage%3D981%26epage%3D986%26doi%3D10.1016%2Fj.bbagrm.2013.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Shi, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwase, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Regulation of LSD1 histone demethylase activity by its associated factors</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">864</span><span class="refDoi"> DOI: 10.1016/j.molcel.2005.08.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.molcel.2005.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=16140033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVyhtbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=857-864&author=Y.-J.+Shiauthor=C.+Matsonauthor=F.+Lanauthor=S.+Iwaseauthor=T.+Babaauthor=Y.+Shi&title=Regulation+of+LSD1+histone+demethylase+activity+by+its+associated+factors&doi=10.1016%2Fj.molcel.2005.08.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of LSD1 histone demethylase activity by its associated factors</span></div><div class="casAuthors">Shi, Yu-Jiang; Matson, Caitlin; Lan, Fei; Iwase, Shigeki; Baba, Tadashi; Shi, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">857-864</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">LSD1 is a recently identified human lysine (K)-specific histone demethylase.  LSD1 is assocd. with HDAC1/2, with CoREST, a SANT domain-contg. corepressor, and with BHC80, a PHD domain-contg. protein, among others.  We show that CoREST confers on LSD1 the ability to demethylate nucleosomal substrates and that it protects LSD1 from proteasomal degrdn. in vivo.  We find hyperacetylated nucleosomes less susceptible to CoREST/LSD1-mediated demethylation, suggesting that hypoacetylated nucleosomes may be the preferred physiol. substrates.  This raises the possibility that histone deacetylases and LSD1 may collaborate to generate a repressive chromatin environment.  Consistent with this model, TSA treatment results in derepression of LSD1 target genes.  While CoREST pos. regulates LSD1 function, BHC80 inhibits CoREST/LSD1-mediated demethylation in vitro and may therefore confer neg. regulation.  Taken together, these findings suggest that LSD1-mediated histone demethylation is regulated dynamically in vivo.  This is expected to have profound effects on gene expression under both physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraharVnxcaMLVg90H21EOLACvtfcHk0liQnhwbA0SHSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyhtbzK&md5=34ba238112151c6596dd6f6c7caa043e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.08.027%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.-J.%26aulast%3DMatson%26aufirst%3DC.%26aulast%3DLan%26aufirst%3DF.%26aulast%3DIwase%26aufirst%3DS.%26aulast%3DBaba%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DRegulation%2520of%2520LSD1%2520histone%2520demethylase%2520activity%2520by%2520its%2520associated%2520factors%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D19%26spage%3D857%26epage%3D864%26doi%3D10.1016%2Fj.molcel.2005.08.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Laurent, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruitu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hempel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">A specific LSD1/KDM1A isoform regulates neuronal differentiation through H3K9 demethylation</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">957</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span><span class="refDoi"> DOI: 10.1016/j.molcel.2015.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.molcel.2015.01.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2015&pages=957-970&author=B.+Laurentauthor=L.+Ruituauthor=J.+Murnauthor=K.+Hempelauthor=R.+Ferraoauthor=Y.+Xiangauthor=S.+Liuauthor=B.+A.+Garciaauthor=H.+Wuauthor=F.+Wuauthor=H.+Steenauthor=Y.+Shi&title=A+specific+LSD1%2FKDM1A+isoform+regulates+neuronal+differentiation+through+H3K9+demethylation&doi=10.1016%2Fj.molcel.2015.01.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2015.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2015.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DLaurent%26aufirst%3DB.%26aulast%3DRuitu%26aufirst%3DL.%26aulast%3DMurn%26aufirst%3DJ.%26aulast%3DHempel%26aufirst%3DK.%26aulast%3DFerrao%26aufirst%3DR.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DGarcia%26aufirst%3DB.%2BA.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DSteen%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DA%2520specific%2520LSD1%252FKDM1A%2520isoform%2520regulates%2520neuronal%2520differentiation%2520through%2520H3K9%2520demethylation%26jtitle%3DMol.%2520Cell%26date%3D2015%26volume%3D57%26spage%3D957%26epage%3D970%26doi%3D10.1016%2Fj.molcel.2015.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Yang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gocke, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomchick, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span> </span><span class="NLM_article-title">Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1016/j.molcel.2006.07.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.molcel.2006.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=16885027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVWlu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=377-387&author=M.+Yangauthor=C.+B.+Gockeauthor=X.+Luoauthor=D.+Borekauthor=D.+R.+Tomchickauthor=M.+Machiusauthor=Z.+Otwinowskiauthor=H.+Yu&title=Structural+basis+for+CoREST-dependent+demethylation+of+nucleosomes+by+the+human+LSD1+histone+demethylase&doi=10.1016%2Fj.molcel.2006.07.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase</span></div><div class="casAuthors">Yang, Maojun; Gocke, Christian B.; Luo, Xuelian; Borek, Dominika; Tomchick, Diana R.; Machius, Mischa; Otwinowski, Zbyszek; Yu, Hongtao</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-387</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone methylation regulates diverse chromatin-templated processes, including transcription.  Many transcriptional corepressor complexes contain lysine-specific demethylase 1 (LSD1) and CoREST that collaborate to demethylate mono- and dimethylated H3-K4 of nucleosomes.  Here, we report the crystal structure of the LSD1-CoREST complex.  LSD1-CoREST forms an elongated structure with a long stalk connecting the catalytic domain of LSD1 and the CoREST SANT2 domain.  LSD1 recognizes a large segment of the H3 tail through a deep, neg. charged pocket at the active site and possibly a shallow groove on its surface.  CoREST SANT2 interacts with DNA.  Disruption of the SANT2-DNA interaction diminishes CoREST-dependent demethylation of nucleosomes by LSD1.  The shape and dimension of LSD1-CoREST suggest its bivalent binding to nucleosomes, allowing efficient H3-K4 demethylation.  This spatially sepd., multivalent nucleosome binding mode may apply to other chromatin-modifying enzymes that generally contain multiple nucleosome binding modules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon5vOAvWkcXrVg90H21EOLACvtfcHk0liQnhwbA0SHSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVWlu74%253D&md5=32aa853fd60a8a562900defa70d658c0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2006.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2006.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DM.%26aulast%3DGocke%26aufirst%3DC.%2BB.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DBorek%26aufirst%3DD.%26aulast%3DTomchick%26aufirst%3DD.%2BR.%26aulast%3DMachius%26aufirst%3DM.%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DH.%26atitle%3DStructural%2520basis%2520for%2520CoREST-dependent%2520demethylation%2520of%2520nucleosomes%2520by%2520the%2520human%2520LSD1%2520histone%2520demethylase%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D23%26spage%3D377%26epage%3D387%26doi%3D10.1016%2Fj.molcel.2006.07.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Saleque, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooke, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orkin, S. H.</span><span> </span><span class="NLM_article-title">Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span><span class="refDoi"> DOI: 10.1016/j.molcel.2007.06.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.molcel.2007.06.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=562-572&author=S.+Salequeauthor=J.+Kimauthor=H.+M.+Rookeauthor=S.+H.+Orkin&title=Epigenetic+regulation+of+hematopoietic+differentiation+by+Gfi-1+and+Gfi-1b+is+mediated+by+the+cofactors+CoREST+and+LSD1&doi=10.1016%2Fj.molcel.2007.06.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.06.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.06.039%26sid%3Dliteratum%253Aachs%26aulast%3DSaleque%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DRooke%26aufirst%3DH.%2BM.%26aulast%3DOrkin%26aufirst%3DS.%2BH.%26atitle%3DEpigenetic%2520regulation%2520of%2520hematopoietic%2520differentiation%2520by%2520Gfi-1%2520and%2520Gfi-1b%2520is%2520mediated%2520by%2520the%2520cofactors%2520CoREST%2520and%2520LSD1%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D27%26spage%3D562%26epage%3D572%26doi%3D10.1016%2Fj.molcel.2007.06.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyoshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazuhide, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairiki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hikichi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchida, K.</span><span> </span><span class="NLM_article-title">A novel LSD1 inihibitor T-3775440 disrupts GFI1B containing complex leading to transdifferentiation and imparied growth of AML cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-16-0471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1158%2F1535-7163.MCT-16-0471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=27903753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVertr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=273-284&author=Y.+Ishikawaauthor=K.+Gamoauthor=M.+Yabukiauthor=S.+Takagiauthor=K.+Toyoshimaauthor=N.+Kazuhideauthor=K.+Nakayamaauthor=A.+Nakayamaauthor=M.+Morimotoauthor=H.+Miyashitaauthor=R.+Dairikiauthor=Y.+Hikichiauthor=N.+Tomitaauthor=D.+Tomitaauthor=S.+Imamuraauthor=M.+Iwataniauthor=Y.+Kamadaauthor=S.+Matsumotoauthor=R.+Haraauthor=T.+Nomuraauthor=K.+Tsuchida&title=A+novel+LSD1+inihibitor+T-3775440+disrupts+GFI1B+containing+complex+leading+to+transdifferentiation+and+imparied+growth+of+AML+cells&doi=10.1158%2F1535-7163.MCT-16-0471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells</span></div><div class="casAuthors">Ishikawa, Yoshinori; Gamo, Kanae; Yabuki, Masato; Takagi, Shinji; Toyoshima, Kosei; Nakayama, Kazuhide; Nakayama, Akiko; Morimoto, Megumi; Miyashita, Hitoshi; Dairiki, Ryo; Hikichi, Yukiko; Tomita, Naoki; Tomita, Daisuke; Imamura, Shinichi; Iwatani, Misa; Kamada, Yusuke; Matsumoto, Satoru; Hara, Ryujiro; Nomura, Toshiyuki; Tsuchida, Ken; Nakamura, Kazuhide</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">273-284</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Dysregulation of lysine (K)-specific demethylase 1A (LSD1), also known as KDM1A, has been implicated in the development of various cancers, including leukemia.  Here, we describe the antileukemic activity and mechanism of action of T-3775440, a novel irreversible LSD1 inhibitor.  Cell growth anal. of leukemia cell lines revealed that acute erythroid leukemia (AEL) and acute megakaryoblastic leukemia cells (AMKL) were highly sensitive to this compd.  T-3775440 treatment enforced transdifferentiation of erythroid/megakaryocytic lineages into granulomonocytic-like lineage cells.  Mechanistically, T-3775440 disrupted the interaction between LSD1 and growth factor-independent 1B (GFI1B), a transcription factor crit. for the differentiation processes of erythroid and megakaryocytic lineage cells.  Knockdown of LSD1 and GFI1B recapitulated T-3775440-induced transdifferentiation and cell growth suppression, highlighting the significance of LSD1-GFI1B axis inhibition with regard to the anti-AML effects of T-3775440.  Moreover, T-3775440 exhibited significant antitumor efficacy in AEL and AMKL xenograft models.  Our findings provide a rationale for evaluating LSD1 inhibitors as potential treatments and indicate a novel mechanism of action against AML, particularly AEL and AMKL.  Mol Cancer Ther; 16(2); 273-84. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomcxpsluqnf7Vg90H21EOLACvtfcHk0lgOsu5gw0mVWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVertr4%253D&md5=2335343b4d5e7bbc197a1d5aec54e3af</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-16-0471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-16-0471%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DGamo%26aufirst%3DK.%26aulast%3DYabuki%26aufirst%3DM.%26aulast%3DTakagi%26aufirst%3DS.%26aulast%3DToyoshima%26aufirst%3DK.%26aulast%3DKazuhide%26aufirst%3DN.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DA.%26aulast%3DMorimoto%26aufirst%3DM.%26aulast%3DMiyashita%26aufirst%3DH.%26aulast%3DDairiki%26aufirst%3DR.%26aulast%3DHikichi%26aufirst%3DY.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DTomita%26aufirst%3DD.%26aulast%3DImamura%26aufirst%3DS.%26aulast%3DIwatani%26aufirst%3DM.%26aulast%3DKamada%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DS.%26aulast%3DHara%26aufirst%3DR.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DTsuchida%26aufirst%3DK.%26atitle%3DA%2520novel%2520LSD1%2520inihibitor%2520T-3775440%2520disrupts%2520GFI1B%2520containing%2520complex%2520leading%2520to%2520transdifferentiation%2520and%2520imparied%2520growth%2520of%2520AML%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2017%26volume%3D16%26spage%3D273%26epage%3D284%26doi%3D10.1158%2F1535-7163.MCT-16-0471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Velinder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bareyan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meznarich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracy, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulcher, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClellan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucente, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, M. E.</span><span> </span><span class="NLM_article-title">GFI1 functions in transcriptional control and cell fate determination require SNAG domain methylation to recruit LSD1</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">473</span><span class="NLM_x">, </span> <span class="NLM_fpage">3355</span><span class="refDoi"> DOI: 10.1042/BCJ20160558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1042%2FBCJ20160558" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=473&publication_year=2016&pages=3355&author=M.+Velinderauthor=J.+Singerauthor=D.+Bareyanauthor=J.+Meznarichauthor=C.+M.+Tracyauthor=J.+M.+Fulcherauthor=D.+McClellanauthor=H.+Lucenteauthor=S.+Franklinauthor=S.+Sharmaauthor=M.+E.+Engel&title=GFI1+functions+in+transcriptional+control+and+cell+fate+determination+require+SNAG+domain+methylation+to+recruit+LSD1&doi=10.1042%2FBCJ20160558"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1042%2FBCJ20160558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBCJ20160558%26sid%3Dliteratum%253Aachs%26aulast%3DVelinder%26aufirst%3DM.%26aulast%3DSinger%26aufirst%3DJ.%26aulast%3DBareyan%26aufirst%3DD.%26aulast%3DMeznarich%26aufirst%3DJ.%26aulast%3DTracy%26aufirst%3DC.%2BM.%26aulast%3DFulcher%26aufirst%3DJ.%2BM.%26aulast%3DMcClellan%26aufirst%3DD.%26aulast%3DLucente%26aufirst%3DH.%26aulast%3DFranklin%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DEngel%26aufirst%3DM.%2BE.%26atitle%3DGFI1%2520functions%2520in%2520transcriptional%2520control%2520and%2520cell%2520fate%2520determination%2520require%2520SNAG%2520domain%2520methylation%2520to%2520recruit%2520LSD1%26jtitle%3DBiochem.%2520J.%26date%3D2016%26volume%3D473%26spage%3D3355%26doi%3D10.1042%2FBCJ20160558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Velinder, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meznarich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theisen, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulcher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, M. E.</span><span> </span><span class="NLM_article-title">GFI1 snag domain methylation directs LSD1 recruitment to control transcription and cell fate determination in hematopoiesis</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=46&author=M.+E.+Velinderauthor=J.+Singerauthor=J.+Meznarichauthor=E.+R.+Theisenauthor=J.+Fulcherauthor=C.+Tracyauthor=S.+Franklinauthor=S.+Sharmaauthor=M.+E.+Engel&title=GFI1+snag+domain+methylation+directs+LSD1+recruitment+to+control+transcription+and+cell+fate+determination+in+hematopoiesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVelinder%26aufirst%3DM.%2BE.%26aulast%3DSinger%26aufirst%3DJ.%26aulast%3DMeznarich%26aufirst%3DJ.%26aulast%3DTheisen%26aufirst%3DE.%2BR.%26aulast%3DFulcher%26aufirst%3DJ.%26aulast%3DTracy%26aufirst%3DC.%26aulast%3DFranklin%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DEngel%26aufirst%3DM.%2BE.%26atitle%3DGFI1%2520snag%2520domain%2520methylation%2520directs%2520LSD1%2520recruitment%2520to%2520control%2520transcription%2520and%2520cell%2520fate%2520determination%2520in%2520hematopoiesis%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26spage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Harris, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaser, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greystoke, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somervaille, T. C. P.</span><span> </span><span class="NLM_article-title">The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">487</span><span class="refDoi"> DOI: 10.1016/j.ccr.2012.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.ccr.2012.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=22464800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFyqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=473-487&author=W.+J.+Harrisauthor=X.+Huangauthor=J.+T.+Lynchauthor=G.+J.+Spencerauthor=J.+R.+Hitchinauthor=Y.+Liauthor=F.+Ciceriauthor=J.+G.+Blaserauthor=B.+F.+Greystokeauthor=A.+M.+Jordanauthor=C.+J.+Millerauthor=D.+J.+Ogilvieauthor=T.+C.+P.+Somervaille&title=The+histone+demethylase+KDM1A+sustains+the+oncogenic+potential+of+MLL-AF9+leukemia+stem+cells&doi=10.1016%2Fj.ccr.2012.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells</span></div><div class="casAuthors">Harris, William J.; Huang, Xu; Lynch, James T.; Spencer, Gary J.; Hitchin, James R.; Li, Yaoyong; Ciceri, Filippo; Blaser, Julian G.; Greystoke, Brigit F.; Jordan, Allan M.; Miller, Crispin J.; Ogilvie, Donald J.; Somervaille, Tim C. P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">473-487</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Using a mouse model of human MLL-AF9 leukemia, we identified the lysine-specific demethylase KDM1A (LSD1 or AOF2) as an essential regulator of leukemia stem cell (LSC) potential.  KDM1A acts at genomic loci bound by MLL-AF9 to sustain expression of the assocd. oncogenic program, thus preventing differentiation and apoptosis.  In vitro and in vivo pharmacol. targeting of KDM1A using tranylcypromine analogs active in the nanomolar range phenocopied Kdm1a knockdown in both murine and primary human AML cells exhibiting MLL translocations.  By contrast, the clonogenic and repopulating potential of normal hematopoietic stem and progenitor cells was spared.  These data establish KDM1A as a key effector of the differentiation block in MLL leukemia, which may be selectively targeted to therapeutic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiZ65foej58rVg90H21EOLACvtfcHk0lgOsu5gw0mVWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFyqsrc%253D&md5=3227f2ac24a884a8ebadbce71198830c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DW.%2BJ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLynch%26aufirst%3DJ.%2BT.%26aulast%3DSpencer%26aufirst%3DG.%2BJ.%26aulast%3DHitchin%26aufirst%3DJ.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCiceri%26aufirst%3DF.%26aulast%3DBlaser%26aufirst%3DJ.%2BG.%26aulast%3DGreystoke%26aufirst%3DB.%2BF.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DMiller%26aufirst%3DC.%2BJ.%26aulast%3DOgilvie%26aufirst%3DD.%2BJ.%26aulast%3DSomervaille%26aufirst%3DT.%2BC.%2BP.%26atitle%3DThe%2520histone%2520demethylase%2520KDM1A%2520sustains%2520the%2520oncogenic%2520potential%2520of%2520MLL-AF9%2520leukemia%2520stem%2520cells%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D21%26spage%3D473%26epage%3D487%26doi%3D10.1016%2Fj.ccr.2012.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Döhner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estey, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appelbaum, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büchner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombret, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenaux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwade, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo-Coco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niederwieser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ossenkoppele, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sierra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallman, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löwenberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloomfield, C. D.</span><span> </span><span class="NLM_article-title">Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1182/blood-2009-07-235358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1182%2Fblood-2009-07-235358" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=453-474&author=H.+D%C3%B6hnerauthor=E.+H.+Esteyauthor=S.+Amadoriauthor=F.+R.+Appelbaumauthor=T.+B%C3%BCchnerauthor=A.+K.+Burnettauthor=H.+Dombretauthor=P.+Fenauxauthor=D.+Grimwadeauthor=R.+A.+Larsonauthor=F.+Lo-Cocoauthor=T.+Naoeauthor=D.+Niederwieserauthor=G.+J.+Ossenkoppeleauthor=M.+A.+Sanzauthor=J.+Sierraauthor=M.+S.+Tallmanauthor=B.+L%C3%B6wenbergauthor=C.+D.+Bloomfield&title=Diagnosis+and+management+of+acute+myeloid+leukemia+in+adults%3A+recommendations+from+an+international+expert+panel%2C+on+behalf+of+the+European+LeukemiaNet&doi=10.1182%2Fblood-2009-07-235358"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-07-235358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-07-235358%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25B6hner%26aufirst%3DH.%26aulast%3DEstey%26aufirst%3DE.%2BH.%26aulast%3DAmadori%26aufirst%3DS.%26aulast%3DAppelbaum%26aufirst%3DF.%2BR.%26aulast%3DB%25C3%25BCchner%26aufirst%3DT.%26aulast%3DBurnett%26aufirst%3DA.%2BK.%26aulast%3DDombret%26aufirst%3DH.%26aulast%3DFenaux%26aufirst%3DP.%26aulast%3DGrimwade%26aufirst%3DD.%26aulast%3DLarson%26aufirst%3DR.%2BA.%26aulast%3DLo-Coco%26aufirst%3DF.%26aulast%3DNaoe%26aufirst%3DT.%26aulast%3DNiederwieser%26aufirst%3DD.%26aulast%3DOssenkoppele%26aufirst%3DG.%2BJ.%26aulast%3DSanz%26aufirst%3DM.%2BA.%26aulast%3DSierra%26aufirst%3DJ.%26aulast%3DTallman%26aufirst%3DM.%2BS.%26aulast%3DL%25C3%25B6wenberg%26aufirst%3DB.%26aulast%3DBloomfield%26aufirst%3DC.%2BD.%26atitle%3DDiagnosis%2520and%2520management%2520of%2520acute%2520myeloid%2520leukemia%2520in%2520adults%253A%2520recommendations%2520from%2520an%2520international%2520expert%2520panel%252C%2520on%2520behalf%2520of%2520the%2520European%2520LeukemiaNet%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D453%26epage%3D474%26doi%3D10.1182%2Fblood-2009-07-235358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Mohammad, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smitheman, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamat, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federowicz, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneck, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butticello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnette, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degenhardt, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pappalardi, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasparec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDevitt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouthamel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Concha, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hann, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, R. G.</span><span> </span><span class="NLM_article-title">A DNA hypomethylation signature predicts antitumor activity of LSD1 inhibitors in SCLC</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span><span class="refDoi"> DOI: 10.1016/j.ccell.2015.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.ccell.2015.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=26175415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Grt7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=57-69&author=H.+P.+Mohammadauthor=K.+N.+Smithemanauthor=C.+D.+Kamatauthor=D.+Soongauthor=K.+E.+Federowiczauthor=G.+S.+Van+Allerauthor=J.+L.+Schneckauthor=J.+D.+Carsonauthor=Y.+Liuauthor=M.+Butticelloauthor=W.+G.+Bonnetteauthor=S.+A.+Gormanauthor=Y.+Degenhardtauthor=Y.+Baiauthor=M.+T.+McCabeauthor=M.+B.+Pappalardiauthor=J.+Kasparecauthor=X.+Tianauthor=K.+C.+McNultyauthor=M.+Rouseauthor=P.+McDevittauthor=T.+Hoauthor=M.+Crouthamelauthor=T.+K.+Hartauthor=N.+O.+Conchaauthor=C.+F.+McHughauthor=W.+H.+Millerauthor=D.+Dhanakauthor=P.+J.+Tumminoauthor=C.+L.+Carpenterauthor=N.+W.+Johnsonauthor=C.+L.+Hannauthor=R.+G.+Kruger&title=A+DNA+hypomethylation+signature+predicts+antitumor+activity+of+LSD1+inhibitors+in+SCLC&doi=10.1016%2Fj.ccell.2015.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC</span></div><div class="casAuthors">Mohammad, Helai P.; Smitheman, Kimberly N.; Kamat, Chandrashekhar D.; Soong, David; Federowicz, Kelly E.; Van Aller, Glenn S.; Schneck, Jess L.; Carson, Jeffrey D.; Liu, Yan; Butticello, Michael; Bonnette, William G.; Gorman, Shelby A.; Degenhardt, Yan; Bai, Yuchen; McCabe, Michael T.; Pappalardi, Melissa B.; Kasparec, Jiri; Tian, Xinrong; McNulty, Kenneth C.; Rouse, Meagan; McDevitt, Patrick; Ho, Thau; Crouthamel, Michelle; Hart, Timothy K.; Concha, Nestor O.; McHugh, Charles F.; Miller, William H.; Dhanak, Dashyant; Tummino, Peter J.; Carpenter, Christopher L.; Johnson, Neil W.; Hann, Christine L.; Kruger, Ryan G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-69</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Epigenetic dysregulation has emerged as an important mechanism in cancer.  Alterations in epigenetic machinery have become a major focus for targeted therapies.  The current report describes the discovery and biol. activity of a cyclopropylamine contg. inhibitor of Lysine Demethylase 1 (LSD1), GSK2879552.  This small mol. is a potent, selective, orally bioavailable, mechanism-based irreversible inactivator of LSD1.  A proliferation screen of cell lines representing a no. of tumor types indicated that small cell lung carcinoma (SCLC) is sensitive to LSD1 inhibition.  The subset of SCLC lines and primary samples that undergo growth inhibition in response to GSK2879552 exhibit DNA hypomethylation of a signature set of probes, suggesting this may be used as a predictive biomarker of activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppluiM41UspbVg90H21EOLACvtfcHk0lhk_W48QGEVEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Grt7fJ&md5=863924e99fa3576dc1c67824b45462f8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2015.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2015.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DMohammad%26aufirst%3DH.%2BP.%26aulast%3DSmitheman%26aufirst%3DK.%2BN.%26aulast%3DKamat%26aufirst%3DC.%2BD.%26aulast%3DSoong%26aufirst%3DD.%26aulast%3DFederowicz%26aufirst%3DK.%2BE.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DSchneck%26aufirst%3DJ.%2BL.%26aulast%3DCarson%26aufirst%3DJ.%2BD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DButticello%26aufirst%3DM.%26aulast%3DBonnette%26aufirst%3DW.%2BG.%26aulast%3DGorman%26aufirst%3DS.%2BA.%26aulast%3DDegenhardt%26aufirst%3DY.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DPappalardi%26aufirst%3DM.%2BB.%26aulast%3DKasparec%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DMcNulty%26aufirst%3DK.%2BC.%26aulast%3DRouse%26aufirst%3DM.%26aulast%3DMcDevitt%26aufirst%3DP.%26aulast%3DHo%26aufirst%3DT.%26aulast%3DCrouthamel%26aufirst%3DM.%26aulast%3DHart%26aufirst%3DT.%2BK.%26aulast%3DConcha%26aufirst%3DN.%2BO.%26aulast%3DMcHugh%26aufirst%3DC.%2BF.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCarpenter%26aufirst%3DC.%2BL.%26aulast%3DJohnson%26aufirst%3DN.%2BW.%26aulast%3DHann%26aufirst%3DC.%2BL.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26atitle%3DA%2520DNA%2520hypomethylation%2520signature%2520predicts%2520antitumor%2520activity%2520of%2520LSD1%2520inhibitors%2520in%2520SCLC%26jtitle%3DCancer%2520Cell%26date%3D2015%26volume%3D28%26spage%3D57%26epage%3D69%26doi%3D10.1016%2Fj.ccell.2015.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hill, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quenelle, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardin, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosch-Marce, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raja, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristie, T. M.</span><span> </span><span class="NLM_article-title">Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomes</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">265ra169</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3010643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1126%2Fscitranslmed.3010643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=25473037" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=265ra169&author=J.+M.+Hillauthor=D.+C.+Quenelleauthor=R.+D.+Cardinauthor=J.+L.+Vogelauthor=C.+Clementauthor=F.+J.+Bravoauthor=T.+P.+Fosterauthor=M.+Bosch-Marceauthor=P.+Rajaauthor=J.+S.+Leeauthor=D.+I.+Bernsteinauthor=P.+R.+Krauseauthor=D.+M.+Knipeauthor=T.+M.+Kristie&title=Inhibition+of+LSD1+reduces+herpesvirus+infection%2C+shedding%2C+and+recurrence+by+promoting+epigenetic+suppression+of+viral+genomes&doi=10.1126%2Fscitranslmed.3010643"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3010643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3010643%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DJ.%2BM.%26aulast%3DQuenelle%26aufirst%3DD.%2BC.%26aulast%3DCardin%26aufirst%3DR.%2BD.%26aulast%3DVogel%26aufirst%3DJ.%2BL.%26aulast%3DClement%26aufirst%3DC.%26aulast%3DBravo%26aufirst%3DF.%2BJ.%26aulast%3DFoster%26aufirst%3DT.%2BP.%26aulast%3DBosch-Marce%26aufirst%3DM.%26aulast%3DRaja%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DBernstein%26aufirst%3DD.%2BI.%26aulast%3DKrause%26aufirst%3DP.%2BR.%26aulast%3DKnipe%26aufirst%3DD.%2BM.%26aulast%3DKristie%26aufirst%3DT.%2BM.%26atitle%3DInhibition%2520of%2520LSD1%2520reduces%2520herpesvirus%2520infection%252C%2520shedding%252C%2520and%2520recurrence%2520by%2520promoting%2520epigenetic%2520suppression%2520of%2520viral%2520genomes%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D265ra169%26doi%3D10.1126%2Fscitranslmed.3010643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quenelle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascaro, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristie, T. M.</span><span> </span><span class="NLM_article-title">A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency</span> <span class="citation_source-journal">mBio</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e00558-12</span><span class="refDoi"> DOI: 10.1128/mBio.00558-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1128%2FmBio.00558-12" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=e00558-12&author=Y.+Liangauthor=D.+Quenelleauthor=J.+L.+Vogelauthor=C.+Mascaroauthor=A.+Ortegaauthor=T.+M.+Kristie&title=A+novel+selective+LSD1%2FKDM1A+inhibitor+epigenetically+blocks+herpes+simplex+virus+lytic+replication+and+reactivation+from+latency&doi=10.1128%2FmBio.00558-12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FmBio.00558-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.00558-12%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DQuenelle%26aufirst%3DD.%26aulast%3DVogel%26aufirst%3DJ.%2BL.%26aulast%3DMascaro%26aufirst%3DC.%26aulast%3DOrtega%26aufirst%3DA.%26aulast%3DKristie%26aufirst%3DT.%2BM.%26atitle%3DA%2520novel%2520selective%2520LSD1%252FKDM1A%2520inhibitor%2520epigenetically%2520blocks%2520herpes%2520simplex%2520virus%2520lytic%2520replication%2520and%2520reactivation%2520from%2520latency%26jtitle%3DmBio%26date%3D2013%26volume%3D4%26spage%3De00558-12%26doi%3D10.1128%2FmBio.00558-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Buesa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascaró, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotllant, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griñan-Ferré, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallàs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, T.</span><span> </span><span class="NLM_article-title">The dual LSD1/MAO-B inhibitor ORY2001 prevents the development of the memory deficit in samp8 mice through induction of neuronal plasticity and reduction of neuroinflammation</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">P905</span><span class="refDoi"> DOI: 10.1016/j.jalz.2015.08.146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.jalz.2015.08.146" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=P905&author=C.+Buesaauthor=C.+Mascar%C3%B3author=D.+Rotllantauthor=C.+Gri%C3%B1an-Ferr%C3%A9author=M.+Pall%C3%A0sauthor=T.+Maes&title=The+dual+LSD1%2FMAO-B+inhibitor+ORY2001+prevents+the+development+of+the+memory+deficit+in+samp8+mice+through+induction+of+neuronal+plasticity+and+reduction+of+neuroinflammation&doi=10.1016%2Fj.jalz.2015.08.146"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2015.08.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2015.08.146%26sid%3Dliteratum%253Aachs%26aulast%3DBuesa%26aufirst%3DC.%26aulast%3DMascar%25C3%25B3%26aufirst%3DC.%26aulast%3DRotllant%26aufirst%3DD.%26aulast%3DGri%25C3%25B1an-Ferr%25C3%25A9%26aufirst%3DC.%26aulast%3DPall%25C3%25A0s%26aufirst%3DM.%26aulast%3DMaes%26aufirst%3DT.%26atitle%3DThe%2520dual%2520LSD1%252FMAO-B%2520inhibitor%2520ORY2001%2520prevents%2520the%2520development%2520of%2520the%2520memory%2520deficit%2520in%2520samp8%2520mice%2520through%2520induction%2520of%2520neuronal%2520plasticity%2520and%2520reduction%2520of%2520neuroinflammation%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2015%26volume%3D11%26spage%3DP905%26doi%3D10.1016%2Fj.jalz.2015.08.146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Maes, T.; Arjol, C. B.</span><span> </span><span class="NLM_article-title">Selective LSD1 and dual LSD1/MAO-B inhibitors for modulating diseases associated with alterations in protein conformation</span>. U.S. Pat. Appl. 20160081947,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=T.+Maes&author=C.+B.+Arjol&title=Selective+LSD1+and+dual+LSD1%2FMAO-B+inhibitors+for+modulating+diseases+associated+with+alterations+in+protein+conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMaes%26aufirst%3DT.%26atitle%3DSelective%2520LSD1%2520and%2520dual%2520LSD1%252FMAO-B%2520inhibitors%2520for%2520modulating%2520diseases%2520associated%2520with%2520alterations%2520in%2520protein%2520conformation%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Guibourt, N.; Munoz, A. O.; Laria, J. C.-P.</span><span> </span><span class="NLM_article-title">Phenylcyclopropylamine derivatives and their medical use</span>. U.S, Pat. 8,993,808,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=N.+Guibourt&author=A.+O.+Munoz&author=J.+C.-P.+Laria&title=Phenylcyclopropylamine+derivatives+and+their+medical+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGuibourt%26aufirst%3DN.%26atitle%3DPhenylcyclopropylamine%2520derivatives%2520and%2520their%2520medical%2520use%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Somervaille, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salamero, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montesinos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willekens, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez Simon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pigneux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinero, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascaro, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosch, F.</span><span> </span><span class="NLM_article-title">Safety, phamacokinetics (PK), pharmacodynamics (PD) and preliminary activity in acute leukemia of ORY-1001, a first-in-class inhibitor of lysine-specific histone demethylase 1A (LSD1/KDM1A): initial results from a first-in-human phase 1 study</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">4060</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=4060&author=T.+Somervailleauthor=O.+Salameroauthor=P.+Montesinosauthor=C.+Willekensauthor=J.+A.+Perez+Simonauthor=A.+Pigneuxauthor=C.+Recherauthor=R.+Popatauthor=C.+Molineroauthor=C.+Mascaroauthor=T.+Maesauthor=F.+Bosch&title=Safety%2C+phamacokinetics+%28PK%29%2C+pharmacodynamics+%28PD%29+and+preliminary+activity+in+acute+leukemia+of+ORY-1001%2C+a+first-in-class+inhibitor+of+lysine-specific+histone+demethylase+1A+%28LSD1%2FKDM1A%29%3A+initial+results+from+a+first-in-human+phase+1+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSomervaille%26aufirst%3DT.%26aulast%3DSalamero%26aufirst%3DO.%26aulast%3DMontesinos%26aufirst%3DP.%26aulast%3DWillekens%26aufirst%3DC.%26aulast%3DPerez%2BSimon%26aufirst%3DJ.%2BA.%26aulast%3DPigneux%26aufirst%3DA.%26aulast%3DRecher%26aufirst%3DC.%26aulast%3DPopat%26aufirst%3DR.%26aulast%3DMolinero%26aufirst%3DC.%26aulast%3DMascaro%26aufirst%3DC.%26aulast%3DMaes%26aufirst%3DT.%26aulast%3DBosch%26aufirst%3DF.%26atitle%3DSafety%252C%2520phamacokinetics%2520%2528PK%2529%252C%2520pharmacodynamics%2520%2528PD%2529%2520and%2520preliminary%2520activity%2520in%2520acute%2520leukemia%2520of%2520ORY-1001%252C%2520a%2520first-in-class%2520inhibitor%2520of%2520lysine-specific%2520histone%2520demethylase%25201A%2520%2528LSD1%252FKDM1A%2529%253A%2520initial%2520results%2520from%2520a%2520first-in-human%2520phase%25201%2520study%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26spage%3D4060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Johnson, N. W.; Kasparec, J.; Rouse, M. B.; Tian, X.; Miller, W. H.; Suarez, D.</span><span> </span><span class="NLM_article-title">Cyclopropylamines as LSD1 inhibitors</span>. U.S. Pat. 9346840,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=N.+W.+Johnson&author=J.+Kasparec&author=M.+B.+Rouse&author=X.+Tian&author=W.+H.+Miller&author=D.+Suarez&title=Cyclopropylamines+as+LSD1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DN.%2BW.%26atitle%3DCyclopropylamines%2520as%2520LSD1%2520inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Yongchun, P.; Han, W.; Cao, G.; Frietze, W.; Zhongjiang, J.; Sharief, V.; Zhou, J.; Li, Q.</span><span> </span><span class="NLM_article-title">Salts of an LSD1 inhibitor</span>. U.S. Pat. Appl. 201700440101,<span class="NLM_x"> </span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=P.+Yongchun&author=W.+Han&author=G.+Cao&author=W.+Frietze&author=J.+Zhongjiang&author=V.+Sharief&author=J.+Zhou&author=Q.+Li&title=Salts+of+an+LSD1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYongchun%26aufirst%3DP.%26atitle%3DSalts%2520of%2520an%2520LSD1%2520inhibitor%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Schenk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gollner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebestreit, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, H.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popescu, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casero, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woster, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller-Tidow, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelent, A.</span><span> </span><span class="NLM_article-title">Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span><span class="refDoi"> DOI: 10.1038/nm.2661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1038%2Fnm.2661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=22406747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1WhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=605-611&author=T.+Schenkauthor=W.+C.+Chenauthor=S.+Gollnerauthor=L.+Howellauthor=L.+Jinauthor=K.+Hebestreitauthor=H.-U.+Kleinauthor=A.+C.+Popescuauthor=A.+Burnettauthor=K.+Millsauthor=R.+A.+Caseroauthor=L.+Martonauthor=P.+Wosterauthor=M.+D.+Mindenauthor=M.+Dugasauthor=J.+C.+Y.+Wangauthor=J.+E.+Dickauthor=C.+Muller-Tidowauthor=K.+Petrieauthor=A.+Zelent&title=Inhibition+of+the+LSD1+%28KDM1A%29+demethylase+reactivates+the+all-trans-retinoic+acid+differentiation+pathway+in+acute+myeloid+leukemia&doi=10.1038%2Fnm.2661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia</span></div><div class="casAuthors">Schenk, Tino; Chen, Weihsu Claire; Goellner, Stefanie; Howell, Louise; Jin, Liqing; Hebestreit, Katja; Klein, Hans-Ulrich; Popescu, Andreea C.; Burnett, Alan; Mills, Ken; Casero, Robert A.; Marton, Laurence; Woster, Patrick; Minden, Mark D.; Dugas, Martin; Wang, Jean C. Y.; Dick, John E.; Mueller-Tidow, Carsten; Petrie, Kevin; Zelent, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">605-611</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acute promyelocytic leukemia (APL), a cytogenetically distinct subtype of acute myeloid leukemia (AML), characterized by the t(15;17)-assocd. PML-RARA fusion, has been successfully treated with therapy utilizing all-trans-retinoic acid (ATRA) to differentiate leukemic blasts.  However, among patients with non-APL AML, ATRA-based treatment has not been effective.  Here we show that, through epigenetic reprogramming, inhibitors of lysine-specific demethylase 1 (LSD1, also called KDM1A), including tranylcypromine (TCP), unlocked the ATRA-driven therapeutic response in non-APL AML.  LSD1 inhibition did not lead to a large-scale increase in histone 3 Lys4 dimethylation (H3K4me2) across the genome, but it did increase H3K4me2 and expression of myeloid-differentiation-assocd. genes.  Notably, treatment with ATRA plus TCP markedly diminished the engraftment of primary human AML cells in vivo in nonobese diabetic (NOD)-severe combined immunodeficient (SCID) mice, suggesting that ATRA in combination with TCP may target leukemia-initiating cells.  Furthermore, initiation of ATRA plus TCP treatment 15 d after engraftment of human AML cells in NOD-SCID γ (with interleukin-2 (IL-2) receptor γ chain deficiency) mice also revealed the ATRA plus TCP drug combination to have a potent anti-leukemic effect that was superior to treatment with either drug alone.  These data identify LSD1 as a therapeutic target and strongly suggest that it may contribute to AML pathogenesis by inhibiting the normal pro-differentiative function of ATRA, paving the way for new combinatorial therapies for AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU7ebz8Ar4AbVg90H21EOLACvtfcHk0lhuSm2IKavG9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1WhtL8%253D&md5=57d968de189123149a2714df0208725f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnm.2661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2661%26sid%3Dliteratum%253Aachs%26aulast%3DSchenk%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DW.%2BC.%26aulast%3DGollner%26aufirst%3DS.%26aulast%3DHowell%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DHebestreit%26aufirst%3DK.%26aulast%3DKlein%26aufirst%3DH.-U.%26aulast%3DPopescu%26aufirst%3DA.%2BC.%26aulast%3DBurnett%26aufirst%3DA.%26aulast%3DMills%26aufirst%3DK.%26aulast%3DCasero%26aufirst%3DR.%2BA.%26aulast%3DMarton%26aufirst%3DL.%26aulast%3DWoster%26aufirst%3DP.%26aulast%3DMinden%26aufirst%3DM.%2BD.%26aulast%3DDugas%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%2BC.%2BY.%26aulast%3DDick%26aufirst%3DJ.%2BE.%26aulast%3DMuller-Tidow%26aufirst%3DC.%26aulast%3DPetrie%26aufirst%3DK.%26aulast%3DZelent%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520the%2520LSD1%2520%2528KDM1A%2529%2520demethylase%2520reactivates%2520the%2520all-trans-retinoic%2520acid%2520differentiation%2520pathway%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D605%26epage%3D611%26doi%3D10.1038%2Fnm.2661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubbs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dostalik, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. H.</span><span> </span><span class="NLM_article-title">Abstract 4702: Combination of BET inhibitor INCB054329 and LSD1 inhibitor INCB059872 is synergistic for the treatment of AML in vitro and in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">4702</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2016-4702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1158%2F1538-7445.AM2016-4702" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=4702&author=X.+Liuauthor=M.+Stubbsauthor=M.+Yeauthor=R.+Collinsauthor=M.+Favataauthor=G.+Yangauthor=M.+Diamondauthor=V.+Dostalikauthor=Y.+Loauthor=C.+Heauthor=L.+Wuauthor=A.+Combsauthor=W.+Yaoauthor=G.+Hollisauthor=R.+Huberauthor=P.+Scherleauthor=B.+Ruggeriauthor=P.+Liuauthor=S.+H.+Lee&title=Abstract+4702%3A+Combination+of+BET+inhibitor+INCB054329+and+LSD1+inhibitor+INCB059872+is+synergistic+for+the+treatment+of+AML+in+vitro+and+in+vivo&doi=10.1158%2F1538-7445.AM2016-4702"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2016-4702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2016-4702%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStubbs%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DFavata%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DDiamond%26aufirst%3DM.%26aulast%3DDostalik%26aufirst%3DV.%26aulast%3DLo%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DCombs%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DHollis%26aufirst%3DG.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DScherle%26aufirst%3DP.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DS.%2BH.%26atitle%3DAbstract%25204702%253A%2520Combination%2520of%2520BET%2520inhibitor%2520INCB054329%2520and%2520LSD1%2520inhibitor%2520INCB059872%2520is%2520synergistic%2520for%2520the%2520treatment%2520of%2520AML%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D4702%26doi%3D10.1158%2F1538-7445.AM2016-4702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Vasilatos, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oesterreich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1196</span><span class="NLM_x">–</span> <span class="NLM_lpage">1207</span><span class="refDoi"> DOI: 10.1093/carcin/bgt033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1093%2Fcarcin%2Fbgt033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1196-1207&author=S.+N.+Vasilatosauthor=T.+A.+Katzauthor=S.+Oesterreichauthor=Y.+Wanauthor=N.+E.+Davidsonauthor=Y.+Huang&title=Crosstalk+between+lysine-specific+demethylase+1+%28LSD1%29+and+histone+deacetylases+mediates+antineoplastic+efficacy+of+HDAC+inhibitors+in+human+breast+cancer+cells&doi=10.1093%2Fcarcin%2Fbgt033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgt033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgt033%26sid%3Dliteratum%253Aachs%26aulast%3DVasilatos%26aufirst%3DS.%2BN.%26aulast%3DKatz%26aufirst%3DT.%2BA.%26aulast%3DOesterreich%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DDavidson%26aufirst%3DN.%2BE.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DCrosstalk%2520between%2520lysine-specific%2520demethylase%25201%2520%2528LSD1%2529%2520and%2520histone%2520deacetylases%2520mediates%2520antineoplastic%2520efficacy%2520of%2520HDAC%2520inhibitors%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DCarcinogenesis%26date%3D2013%26volume%3D34%26spage%3D1196%26epage%3D1207%26doi%3D10.1093%2Fcarcin%2Fbgt033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Mould, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGonagle, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiseman, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span> </span><span class="NLM_article-title">Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: clinical significance and progress to date</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">586</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span><span class="refDoi"> DOI: 10.1002/med.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1002%2Fmed.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=25418875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvFSju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=586-618&author=D.+P.+Mouldauthor=A.+E.+McGonagleauthor=D.+H.+Wisemanauthor=E.+L.+Williamsauthor=A.+M.+Jordan&title=Reversible+inhibitors+of+LSD1+as+therapeutic+agents+in+acute+myeloid+leukemia%3A+clinical+significance+and+progress+to+date&doi=10.1002%2Fmed.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible Inhibitors of LSD1 as Therapeutic Agents in Acute Myeloid Leukemia: Clinical Significance and Progress to Date</span></div><div class="casAuthors">Mould, Daniel P.; McGonagle, Alison E.; Wiseman, Daniel H.; Williams, Emma L.; Jordan, Allan M.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">586-618</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">In the 10 years since the discovery of lysine-specific demethylase 1 (LSD1), this epigenetic eraser has emerged as an important target of interest in oncol.  More specifically, research has demonstrated that it plays an essential role in the self-renewal of leukemic stem cells in acute myeloid leukemia (AML).  This review will cover clin. aspects of AML, the role of epigenetics in the disease, and discuss the research that led to the first irreversible inhibitors of LSD1 entering clin. trials for the treatment of AML in 2014.  We also review recent achievements and progress in the development of potent and selective reversible inhibitors of LSD1.  These compds. differ in their mode of action from tranylcypromine derivs. and could facilitate novel biochem. studies to probe the pathways mediated by LSD1.  In this review, we will critically evaluate the strengths and weaknesses of published series of reversible LSD1 inhibitors.  Overall, while the development of reversible inhibitors to date has been less fruitful than that of irreversible inhibitors, there is still the possibility for their use to facilitate further research into the roles and functions of LSD1 and to expand the therapeutic applications of LSD1 inhibitors in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTFqxWxhZyUrVg90H21EOLACvtfcHk0lhuSm2IKavG9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvFSju7c%253D&md5=b669a61231659817709013572e8fdcf7</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fmed.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21334%26sid%3Dliteratum%253Aachs%26aulast%3DMould%26aufirst%3DD.%2BP.%26aulast%3DMcGonagle%26aufirst%3DA.%2BE.%26aulast%3DWiseman%26aufirst%3DD.%2BH.%26aulast%3DWilliams%26aufirst%3DE.%2BL.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26atitle%3DReversible%2520inhibitors%2520of%2520LSD1%2520as%2520therapeutic%2520agents%2520in%2520acute%2520myeloid%2520leukemia%253A%2520clinical%2520significance%2520and%2520progress%2520to%2520date%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2015%26volume%3D35%26spage%3D586%26epage%3D618%26doi%3D10.1002%2Fmed.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Hitchin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairweather, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAndrew, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mould, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waddell, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, D. J.</span><span> </span><span class="NLM_article-title">Development and evaluation of selective, reversible LSD1 inhibitors derived from fragments</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1513</span><span class="NLM_x">–</span> <span class="NLM_lpage">1522</span><span class="refDoi"> DOI: 10.1039/c3md00226h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1039%2Fc3md00226h" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1OrsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1513-1522&author=J.+R.+Hitchinauthor=J.+Blaggauthor=R.+Burkeauthor=S.+Burnsauthor=M.+J.+Cockerillauthor=E.+E.+Fairweatherauthor=C.+Huttonauthor=A.+M.+Jordanauthor=C.+McAndrewauthor=A.+Mirzaauthor=D.+Mouldauthor=G.+J.+Thomsonauthor=I.+Waddellauthor=D.+J.+Ogilvie&title=Development+and+evaluation+of+selective%2C+reversible+LSD1+inhibitors+derived+from+fragments&doi=10.1039%2Fc3md00226h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Development and evaluation of selective, reversible LSD1 inhibitors derived from fragments</span></div><div class="casAuthors">Hitchin, James R.; Blagg, Julian; Burke, Rosemary; Burns, Samantha; Cockerill, Mark J.; Fairweather, Emma E.; Hutton, Colin; Jordan, Allan M.; McAndrew, Craig; Mirza, Amin; Mould, Daniel; Thomson, Graeme J.; Waddell, Ian; Ogilvie, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1513-1522</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Two series of aminothiazoles have been developed as reversible inhibitors of lysine specific demethylase 1 (LSD1) through the expansion of a hit derived from a high concn. biochem. fragment based screen of 2466 compds.  The potency of the initial fragment hit was increased 32-fold through synthesis, with one series of compds. showing clear structure-activity relationships and inhibitory activities in the range of 7 to 187 μM in a biochem. assay.  This series also showed selectivity against the related FAD-dependent enzyme mono-amine oxidase A (MAO-A).  Although a wide range of irreversible inhibitors of LSD1 have been reported with activities in the low nanomolar range, this work represents one of the first reported examples of a reversible small mol. inhibitor of LSD1 with clear SAR and selectivity against MAO-A, and could provide a platform for the development of more potent reversible inhibitors.  Herein, we also report the use of a recently developed cell-based assay for profiling LSD1 inhibitors, and present results on our own compds. as well as a selection of recently described reversible LSD1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUgrL8DOIuDbVg90H21EOLACvtfcHk0li0HP4slkjFQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1OrsrvK&md5=bec441bbb94f970eab94b96026db7fbe</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2Fc3md00226h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00226h%26sid%3Dliteratum%253Aachs%26aulast%3DHitchin%26aufirst%3DJ.%2BR.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DBurns%26aufirst%3DS.%26aulast%3DCockerill%26aufirst%3DM.%2BJ.%26aulast%3DFairweather%26aufirst%3DE.%2BE.%26aulast%3DHutton%26aufirst%3DC.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DMcAndrew%26aufirst%3DC.%26aulast%3DMirza%26aufirst%3DA.%26aulast%3DMould%26aufirst%3DD.%26aulast%3DThomson%26aufirst%3DG.%2BJ.%26aulast%3DWaddell%26aufirst%3DI.%26aulast%3DOgilvie%26aufirst%3DD.%2BJ.%26atitle%3DDevelopment%2520and%2520evaluation%2520of%2520selective%252C%2520reversible%2520LSD1%2520inhibitors%2520derived%2520from%2520fragments%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D1513%26epage%3D1522%26doi%3D10.1039%2Fc3md00226h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Johnson, N. W.</span><span> </span><span class="NLM_article-title">The identification of GSK2879552, a mechanism based irreversible inhibitor of the histone lysine demethylase LSD1</span>. Presented at XXIV EFMC International Symposium on Medicinal Chemistry, Manchester, UK, August 28September 1,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=N.+W.+Johnson&title=The+identification+of+GSK2879552%2C+a+mechanism+based+irreversible+inhibitor+of+the+histone+lysine+demethylase+LSD1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DN.%2BW.%26atitle%3DThe%2520identification%2520of%2520GSK2879552%252C%2520a%2520mechanism%2520based%2520irreversible%2520inhibitor%2520of%2520the%2520histone%2520lysine%2520demethylase%2520LSD1%26jtitle%3DXXIV%2520EFMC%2520International%2520Symposium%2520on%2520Medicinal%2520Chemistry%252C%2520Manchester%252C%2520UK%252C%2520August%252028September%25201%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Chen, Y. K.; Kanouni, T.; Nie, Z.; Stafford, J. A.; Veal, J. M.; Sung, L. M.</span><span> </span><span class="NLM_article-title">Inhibitors of lysine specific demethylase-1</span>. W.O. Pat. Appl. 2016004105,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Y.+K.+Chen&author=T.+Kanouni&author=Z.+Nie&author=J.+A.+Stafford&author=J.+M.+Veal&author=L.+M.+Sung&title=Inhibitors+of+lysine+specific+demethylase-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BK.%26atitle%3DInhibitors%2520of%2520lysine%2520specific%2520demethylase-1%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Chen, Y. K.; Kanouni, T.; Kaldor, S. W.; Stafford, J. A.; Veal, J. M.</span><span> </span><span class="NLM_article-title">Inhibitors of lysine specific demethylase-1</span>. W.O. Pat. Appl. 2015089192,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Y.+K.+Chen&author=T.+Kanouni&author=S.+W.+Kaldor&author=J.+A.+Stafford&author=J.+M.+Veal&title=Inhibitors+of+lysine+specific+demethylase-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BK.%26atitle%3DInhibitors%2520of%2520lysine%2520specific%2520demethylase-1%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Chen, Y. K.; Kanouni, T.; Nie, Z.; Stafford, J. A.; Veal, J. M.; Sung, L. M.</span><span> </span><span class="NLM_article-title">Inhibitors of lysine specific demethylase-1</span>. W.O. Pat. Appl. 2016003917,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Y.+K.+Chen&author=T.+Kanouni&author=Z.+Nie&author=J.+A.+Stafford&author=J.+M.+Veal&author=L.+M.+Sung&title=Inhibitors+of+lysine+specific+demethylase-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BK.%26atitle%3DInhibitors%2520of%2520lysine%2520specific%2520demethylase-1%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Liangxing, W.; Courter, J. R.; Chunhong, H.; Jingwei, L.; Liang, L.; Yaping, S.; Xiaozhao, W.; Wenqing, Y.; Zhang, C.; Jincong, Z.</span><span> </span><span class="NLM_article-title">Imidazopyrazines as LSD1 inhibitors</span>. U.S. Pat. Appl. 20160009720,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=W.+Liangxing&author=J.+R.+Courter&author=H.+Chunhong&author=L.+Jingwei&author=L.+Liang&author=S.+Yaping&author=W.+Xiaozhao&author=Y.+Wenqing&author=C.+Zhang&author=Z.+Jincong&title=Imidazopyrazines+as+LSD1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiangxing%26aufirst%3DW.%26atitle%3DImidazopyrazines%2520as%2520LSD1%2520inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Liangxing, W.; Konkol, L. C.; Lajkiewicz, N.; Liang, L.; Meizhong, X.; Wenqing, Y.; Zhang, C.</span>; <span> </span><span class="NLM_article-title">Chunhong He. Imidazopyridines and imidazopyrazines as LSD1 inhibitors</span>. U.S. Pat. Appl. 20160009712,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=W.+Liangxing&author=L.+C.+Konkol&author=N.+Lajkiewicz&author=L.+Liang&author=X.+Meizhong&author=Y.+Wenqing&author=C.+Zhang&title=Chunhong+He.+Imidazopyridines+and+imidazopyrazines+as+LSD1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiangxing%26aufirst%3DW.%26atitle%3DChunhong%2520He.%2520Imidazopyridines%2520and%2520imidazopyrazines%2520as%2520LSD1%2520inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Liangxing, W.; Xiaozhao, W.; Wenqing, Y.; Zhang, C.</span><span> </span><span class="NLM_article-title">Triazolopyridines and triazolopyrazines as LSD1 Inhibitors</span>. U.S. Pat. Appl. 20160009711,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=W.+Liangxing&author=W.+Xiaozhao&author=Y.+Wenqing&author=C.+Zhang&title=Triazolopyridines+and+triazolopyrazines+as+LSD1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiangxing%26aufirst%3DW.%26atitle%3DTriazolopyridines%2520and%2520triazolopyrazines%2520as%2520LSD1%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Sartori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amigoni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagá, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fattori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legnaghi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meroni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecatiello, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasqualato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romussi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trifiró, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vultaggio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botrugno, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dessanti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minucci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagarrí, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carettoni, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iuzzolino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, P.</span><span> </span><span class="NLM_article-title">Thieno[3,2-b]pyrrole-5-carboxamides as new reversible inhibitors of histone lysine demethylase KDM1A/LSD1. Part 1: high throughput screening and preliminary exploration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1673</span><span class="NLM_x">–</span> <span class="NLM_lpage">1692</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1673-1692&author=L.+Sartoriauthor=C.+Mercurioauthor=F.+Amigoniauthor=A.+Cappaauthor=G.+Fag%C3%A1author=R.+Fattoriauthor=E.+Legnaghiauthor=G.+Ciossaniauthor=A.+Matteviauthor=G.+Meroniauthor=L.+Morettiauthor=V.+Cecatielloauthor=S.+Pasqualatoauthor=A.+Romussiauthor=F.+Thalerauthor=P.+Trifir%C3%B3author=M.+Villaauthor=S.+Vultaggioauthor=O.+A.+Botrugnoauthor=P.+Dessantiauthor=S.+Minucciauthor=E.+Zagarr%C3%ADauthor=D.+Carettoniauthor=L.+Iuzzolinoauthor=M.+Varasiauthor=P.+Vianello&title=Thieno%5B3%2C2-b%5Dpyrrole-5-carboxamides+as+new+reversible+inhibitors+of+histone+lysine+demethylase+KDM1A%2FLSD1.+Part+1%3A+high+throughput+screening+and+preliminary+exploration&doi=10.1021%2Facs.jmedchem.6b01018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01018%26sid%3Dliteratum%253Aachs%26aulast%3DSartori%26aufirst%3DL.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DAmigoni%26aufirst%3DF.%26aulast%3DCappa%26aufirst%3DA.%26aulast%3DFag%25C3%25A1%26aufirst%3DG.%26aulast%3DFattori%26aufirst%3DR.%26aulast%3DLegnaghi%26aufirst%3DE.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DMeroni%26aufirst%3DG.%26aulast%3DMoretti%26aufirst%3DL.%26aulast%3DCecatiello%26aufirst%3DV.%26aulast%3DPasqualato%26aufirst%3DS.%26aulast%3DRomussi%26aufirst%3DA.%26aulast%3DThaler%26aufirst%3DF.%26aulast%3DTrifir%25C3%25B3%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DVultaggio%26aufirst%3DS.%26aulast%3DBotrugno%26aufirst%3DO.%2BA.%26aulast%3DDessanti%26aufirst%3DP.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DZagarr%25C3%25AD%26aufirst%3DE.%26aulast%3DCarettoni%26aufirst%3DD.%26aulast%3DIuzzolino%26aufirst%3DL.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DVianello%26aufirst%3DP.%26atitle%3DThieno%255B3%252C2-b%255Dpyrrole-5-carboxamides%2520as%2520new%2520reversible%2520inhibitors%2520of%2520histone%2520lysine%2520demethylase%2520KDM1A%252FLSD1.%2520Part%25201%253A%2520high%2520throughput%2520screening%2520and%2520preliminary%2520exploration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1673%26epage%3D1692%26doi%3D10.1021%2Facs.jmedchem.6b01018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Vianello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amigoni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagá, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fattori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legnaghi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meroni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecatiello, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasqualato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romussi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trifiró, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botrugno, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dessanti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minucci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vultaggio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagarrí, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, C.</span><span> </span><span class="NLM_article-title">Thieno[3,2-b]pyrrole-5-carboxamides as new reversible inhibitors of histone lysine demethylase KDM1A/LSD1. Part 2: structure based drug design and structure-activity relationship</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1693</span><span class="NLM_x">–</span> <span class="NLM_lpage">1715</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1693-1715&author=P.+Vianelloauthor=L.+Sartoriauthor=F.+Amigoniauthor=A.+Cappaauthor=G.+Fag%C3%A1author=R.+Fattoriauthor=E.+Legnaghiauthor=G.+Ciossaniauthor=A.+Matteviauthor=G.+Meroniauthor=L.+Morettiauthor=V.+Cecatielloauthor=S.+Pasqualatoauthor=A.+Romussiauthor=F.+Thalerauthor=P.+Trifir%C3%B3author=O.+A.+Botrugnoauthor=M.+Villaauthor=P.+Dessantiauthor=S.+Minucciauthor=S.+Vultaggioauthor=E.+Zagarr%C3%ADauthor=M.+Varasiauthor=C.+Mercurio&title=Thieno%5B3%2C2-b%5Dpyrrole-5-carboxamides+as+new+reversible+inhibitors+of+histone+lysine+demethylase+KDM1A%2FLSD1.+Part+2%3A+structure+based+drug+design+and+structure-activity+relationship&doi=10.1021%2Facs.jmedchem.6b01019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01019%26sid%3Dliteratum%253Aachs%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DSartori%26aufirst%3DL.%26aulast%3DAmigoni%26aufirst%3DF.%26aulast%3DCappa%26aufirst%3DA.%26aulast%3DFag%25C3%25A1%26aufirst%3DG.%26aulast%3DFattori%26aufirst%3DR.%26aulast%3DLegnaghi%26aufirst%3DE.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DMeroni%26aufirst%3DG.%26aulast%3DMoretti%26aufirst%3DL.%26aulast%3DCecatiello%26aufirst%3DV.%26aulast%3DPasqualato%26aufirst%3DS.%26aulast%3DRomussi%26aufirst%3DA.%26aulast%3DThaler%26aufirst%3DF.%26aulast%3DTrifir%25C3%25B3%26aufirst%3DP.%26aulast%3DBotrugno%26aufirst%3DO.%2BA.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DDessanti%26aufirst%3DP.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DVultaggio%26aufirst%3DS.%26aulast%3DZagarr%25C3%25AD%26aufirst%3DE.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DMercurio%26aufirst%3DC.%26atitle%3DThieno%255B3%252C2-b%255Dpyrrole-5-carboxamides%2520as%2520new%2520reversible%2520inhibitors%2520of%2520histone%2520lysine%2520demethylase%2520KDM1A%252FLSD1.%2520Part%25202%253A%2520structure%2520based%2520drug%2520design%2520and%2520structure-activity%2520relationship%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1693%26epage%3D1715%26doi%3D10.1021%2Facs.jmedchem.6b01019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Speranzini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotili, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilotto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrocco, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgione, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucidi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forneris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehdipour, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velankar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Polymyxins and quinazolines are LSD1/KDM1A inhibitors with unusual structural features</span> <span class="citation_source-journal">Sci. Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">e1601017</span><span class="refDoi"> DOI: 10.1126/sciadv.1601017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1126%2Fsciadv.1601017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=27626075" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=e1601017&issue=9&author=V.+Speranziniauthor=D.+Rotiliauthor=G.+Ciossaniauthor=S.+Pilottoauthor=B.+Marroccoauthor=M.+Forgioneauthor=A.+Lucidiauthor=F.+Fornerisauthor=P.+Mehdipourauthor=S.+Velankarauthor=A.+Maiauthor=A.+Mattevi&title=Polymyxins+and+quinazolines+are+LSD1%2FKDM1A+inhibitors+with+unusual+structural+features&doi=10.1126%2Fsciadv.1601017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.1601017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.1601017%26sid%3Dliteratum%253Aachs%26aulast%3DSperanzini%26aufirst%3DV.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DPilotto%26aufirst%3DS.%26aulast%3DMarrocco%26aufirst%3DB.%26aulast%3DForgione%26aufirst%3DM.%26aulast%3DLucidi%26aufirst%3DA.%26aulast%3DForneris%26aufirst%3DF.%26aulast%3DMehdipour%26aufirst%3DP.%26aulast%3DVelankar%26aufirst%3DS.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DPolymyxins%2520and%2520quinazolines%2520are%2520LSD1%252FKDM1A%2520inhibitors%2520with%2520unusual%2520structural%2520features%26jtitle%3DSci.%2520Adv.%26date%3D2016%26volume%3D2%26issue%3D9%26spage%3De1601017%26doi%3D10.1126%2Fsciadv.1601017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, C.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span> </span><span class="NLM_article-title">Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluation</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.03.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.ejmech.2016.03.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=27043267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVWkurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=13-26&author=Y.+Songauthor=X.+Xueauthor=X.+Wuauthor=R.+Wangauthor=Y.+Xingauthor=W.+Yanauthor=Y.+Zhouauthor=C.-N.+Qianauthor=Y.+Zhangauthor=Y.+Xu&title=Identification+of+N-phenyl-2-%28N-phenylphenylsulfonamido%29acetamides+as+new+ROR%CE%B3+inverse+agonists%3A+Virtual+screening%2C+structure-based+optimization%2C+and+biological+evaluation&doi=10.1016%2Fj.ejmech.2016.03.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluation</span></div><div class="casAuthors">Song, Yu; Xue, Xiaoqian; Wu, Xishan; Wang, Rui; Xing, Yanli; Yan, Weiqun; Zhou, Yulai; Qian, Chao-Nan; Zhang, Yan; Xu, Yong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-26</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Retinoic acid receptor-related orphan receptors (RORs) are ligand-dependent transcriptional factors and members of the nuclear receptor superfamily.  RORs regulate inflammation, metabolic disorders and circadian rhythm.  RORγ is a promising therapeutic drug target for treating Th17-mediated autoimmune diseases.  In the authors' study, the authors performed structure-based virtual screening and ligand-based virtual screening targeting the RORγ ligand-binding domain and successfully identified N-phenyl-2-(N-phenylphenylsulfonamido) acetamides as a type of RORγ inverse agonist.  Among the 28 purchased compds., C11 (I) was confirmed to be active with micromolar IC50 values in both an AlphaScreen assay (62.58 μM) and a cell-based reporter gene assay (4.54 μM).  Structure-guided optimization of the compd. C11 led to the identification of compd. N-(4-cyanophenyl)-2-(N-(3,4-dichlorophenyl)-4-methylphenylsulfonamido)acetamide (39), which significantly enhanced RORγ inhibition with an IC50 value of 630 nM.  The RORγ antagonism of (39) was 7-fold higher than that of hit compd. C11.  These results represent a promising starting point for developing potent small mol. RORγ inverse agonists for the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaA4dGfyShVLVg90H21EOLACvtfcHk0lh3PoAKgSfTjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVWkurY%253D&md5=609fd2e8fabad02c0a96262d6d829deb</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.052%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DXing%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DQian%26aufirst%3DC.-N.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DIdentification%2520of%2520N-phenyl-2-%2528N-phenylphenylsulfonamido%2529acetamides%2520as%2520new%2520ROR%25CE%25B3%2520inverse%2520agonists%253A%2520Virtual%2520screening%252C%2520structure-based%2520optimization%252C%2520and%2520biological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D116%26spage%3D13%26epage%3D26%26doi%3D10.1016%2Fj.ejmech.2016.03.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Lynch, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiseman, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somervaille, T. C. P.</span><span> </span><span class="NLM_article-title">CD86 expression as a surrogate cellular biomarker for pharmacological inhibition of the histone demethylase lysine-specific demethylase 1</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">442</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1016/j.ab.2013.07.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1016%2Fj.ab.2013.07.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=442&publication_year=2013&pages=104-106&author=J.+T.+Lynchauthor=M.+J.+Cockerillauthor=J.+R.+Hitchinauthor=D.+H.+Wisemanauthor=T.+C.+P.+Somervaille&title=CD86+expression+as+a+surrogate+cellular+biomarker+for+pharmacological+inhibition+of+the+histone+demethylase+lysine-specific+demethylase+1&doi=10.1016%2Fj.ab.2013.07.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2013.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2013.07.032%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DJ.%2BT.%26aulast%3DCockerill%26aufirst%3DM.%2BJ.%26aulast%3DHitchin%26aufirst%3DJ.%2BR.%26aulast%3DWiseman%26aufirst%3DD.%2BH.%26aulast%3DSomervaille%26aufirst%3DT.%2BC.%2BP.%26atitle%3DCD86%2520expression%2520as%2520a%2520surrogate%2520cellular%2520biomarker%2520for%2520pharmacological%2520inhibition%2520of%2520the%2520histone%2520demethylase%2520lysine-specific%2520demethylase%25201%26jtitle%3DAnal.%2520Biochem.%26date%3D2013%26volume%3D442%26spage%3D104%26epage%3D106%26doi%3D10.1016%2Fj.ab.2013.07.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Wu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">3-(Piperidin-4-ylmethoxy)pyridine containing compounds are potent inhibitors of lysine specific demethylase 1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01361</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01361" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFylu77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=253-263&author=F.+Wuauthor=C.+Zhouauthor=Y.+Yaoauthor=L.+Weiauthor=Z.+Fengauthor=L.+Dengauthor=Y.+Song&title=3-%28Piperidin-4-ylmethoxy%29pyridine+containing+compounds+are+potent+inhibitors+of+lysine+specific+demethylase+1&doi=10.1021%2Facs.jmedchem.5b01361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1</span></div><div class="casAuthors">Wu, Fangrui; Zhou, Chao; Yao, Yuan; Wei, Liping; Feng, Zizhen; Deng, Lisheng; Song, Yongcheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">253-263</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Methylation of histone lysine residues plays important roles in gene expression regulation as well as cancer initiation.  Lysine specific demethylase 1 (LSD1) is responsible for maintaining balanced methylation levels at histone H3 lysine 4 (H3K4).  LSD1 is a drug target for certain cancers, due to important functions of methylated H3K4 or LSD1 overexpression.  We report the design, synthesis, and structure-activity relationships of 3-(piperidin-4-ylmethoxy)pyridine contg. compds. as potent LSD1 inhibitors with Ki values as low as 29 nM.  These compds. exhibited high selectivity (>160×) against related monoamine oxidase A and B.  Enzyme kinetics and docking studies suggested they are competitive inhibitors against a dimethylated H3K4 substrate and provided a possible binding mode.  The potent LSD1 inhibitors can increase cellular H3K4 methylation and strongly inhibit proliferation of several leukemia and solid tumor cells with EC50 values as low as 280 nM, while they had negligible effects on normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKAqQdCeodaLVg90H21EOLACvtfcHk0lh3PoAKgSfTjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFylu77N&md5=2c74e06ed3c755826d25917d02cb845f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01361%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DC.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DY.%26atitle%3D3-%2528Piperidin-4-ylmethoxy%2529pyridine%2520containing%2520compounds%2520are%2520potent%2520inhibitors%2520of%2520lysine%2520specific%2520demethylase%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D253%26epage%3D263%26doi%3D10.1021%2Facs.jmedchem.5b01361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Cheeseright, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melville, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinter, J. G.</span><span> </span><span class="NLM_article-title">FieldScreen: virtual screening using molecular fields. Application to the DUD data set</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2108</span><span class="NLM_x">–</span> <span class="NLM_lpage">2117</span><span class="refDoi"> DOI: 10.1021/ci800110p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci800110p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlCrs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=2108-2117&author=T.+J.+Cheeserightauthor=M.+D.+Mackeyauthor=J.+L.+Melvilleauthor=J.+G.+Vinter&title=FieldScreen%3A+virtual+screening+using+molecular+fields.+Application+to+the+DUD+data+set&doi=10.1021%2Fci800110p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">FieldScreen: Virtual Screening Using Molecular Fields. Application to the DUD Data Set</span></div><div class="casAuthors">Cheeseright, Timothy J.; Mackey, Mark D.; Melville, James L.; Vinter, Jeremy G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2108-2117</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">FieldScreen, a ligand-based Virtual Screening (VS) method, is described.  Its use of 3D mol. fields makes it particularly suitable for scaffold hopping, and we have rigorously validated it for this purpose using a clustered version of the Directory of Useful Decoys (DUD).  Using thirteen pharmaceutically relevant targets, we demonstrate that FieldScreen produces superior early chemotype enrichments, compared to DOCK.  Addnl., hits retrieved by FieldScreen are consistently lower in mol. wt. than those retrieved by docking.  Where no X-ray protein structures are available, FieldScreen searches are more robust than docking into homol. models or apo structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql1Ac_qCT-T7Vg90H21EOLACvtfcHk0lh3PoAKgSfTjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlCrs7fK&md5=01485c82f1801e5df5ad1b142a7c80c8</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fci800110p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci800110p%26sid%3Dliteratum%253Aachs%26aulast%3DCheeseright%26aufirst%3DT.%2BJ.%26aulast%3DMackey%26aufirst%3DM.%2BD.%26aulast%3DMelville%26aufirst%3DJ.%2BL.%26aulast%3DVinter%26aufirst%3DJ.%2BG.%26atitle%3DFieldScreen%253A%2520virtual%2520screening%2520using%2520molecular%2520fields.%2520Application%2520to%2520the%2520DUD%2520data%2520set%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D2108%26epage%3D2117%26doi%3D10.1021%2Fci800110p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Park, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boobis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldring, C. E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenna, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laverty, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naisbitt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweedie, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeulen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Managing the challenge of chemically reactive metabolites in drug development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span><span class="refDoi"> DOI: 10.1038/nrd3408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1038%2Fnrd3408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=21455238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=292-306&author=B.+K.+Parkauthor=A.+Boobisauthor=S.+Clarkeauthor=C.+E.+P.+Goldringauthor=D.+Jonesauthor=J.+G.+Kennaauthor=C.+Lambertauthor=H.+G.+Lavertyauthor=D.+J.+Naisbittauthor=S.+Nelsonauthor=D.+A.+Nicoll-Griffithauthor=R.+S.+Obachauthor=P.+Routledgeauthor=D.+A.+Smithauthor=D.+J.+Tweedieauthor=N.+Vermeulenauthor=D.+P.+Williamsauthor=I.+D.+Wilsonauthor=T.+A.+Baillie&title=Managing+the+challenge+of+chemically+reactive+metabolites+in+drug+development&doi=10.1038%2Fnrd3408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Managing the challenge of chemically reactive metabolites in drug development</span></div><div class="casAuthors">Park, B. Kevin; Boobis, Alan; Clarke, Stephen; Goldring, Chris E. P.; Jones, David; Kenna, J. Gerry; Lambert, Craig; Laverty, Hugh G.; Naisbitt, Dean J.; Nelson, Sidney; Nicoll-Griffith, Deborah A.; Obach, R. Scott; Routledge, Philip; Smith, Dennis A.; Tweedie, Donald J.; Vermeulen, Nico; Williams, Dominic P.; Wilson, Ian D.; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">292-306</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The normal metab. of drugs can generate metabolites that have intrinsic chem. reactivity towards cellular mols., and therefore have the potential to alter biol. function and initiate serious adverse drug reactions.  Here, we present an assessment of the current approaches used for the evaluation of chem. reactive metabolites.  We also describe how these approaches are being used within the pharmaceutical industry to assess and minimize the potential of drug candidates to cause toxicity.  At early stages of drug discovery, iteration between medicinal chem. and drug metab. can eliminate perceived reactive metabolite-mediated chem. liabilities without compromising pharmacol. activity or the need for extensive safety evaluation beyond std. practices.  In the future, reactive metabolite evaluation may also be useful during clin. development for improving clin. risk assessment and risk management.  Currently, there remains a huge gap in our understanding of the basic mechanisms that underlie chem. stress-mediated adverse reactions in humans.  This Review summarizes our views on this complex topic, and includes insights into practices considered by the pharmaceutical industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBv41vr7ZlNLVg90H21EOLACvtfcHk0lhCCkyRfYjrgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGnu78%253D&md5=8f6865f17bbe50b51aa4282379e82a08</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnrd3408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3408%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DB.%2BK.%26aulast%3DBoobis%26aufirst%3DA.%26aulast%3DClarke%26aufirst%3DS.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%2BP.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26aulast%3DLambert%26aufirst%3DC.%26aulast%3DLaverty%26aufirst%3DH.%2BG.%26aulast%3DNaisbitt%26aufirst%3DD.%2BJ.%26aulast%3DNelson%26aufirst%3DS.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DRoutledge%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DTweedie%26aufirst%3DD.%2BJ.%26aulast%3DVermeulen%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26aulast%3DWilson%26aufirst%3DI.%2BD.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DManaging%2520the%2520challenge%2520of%2520chemically%2520reactive%2520metabolites%2520in%2520drug%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D292%26epage%3D306%26doi%3D10.1038%2Fnrd3408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Luka, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pakhomova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loukachevitch, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calcutt, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomer, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C.</span><span> </span><span class="NLM_article-title">Crystal structure of the histone lysine specific demethylase LSD1 complexed with tetrahydrofolate</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">998</span><span class="refDoi"> DOI: 10.1002/pro.2469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=10.1002%2Fpro.2469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=24715612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=993-998&author=Z.+Lukaauthor=S.+Pakhomovaauthor=L.+V.+Loukachevitchauthor=M.+W.+Calcuttauthor=M.+E.+Newcomerauthor=C.+Wagner&title=Crystal+structure+of+the+histone+lysine+specific+demethylase+LSD1+complexed+with+tetrahydrofolate&doi=10.1002%2Fpro.2469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the histone lysine specific demethylase LSD1 complexed with tetrahydrofolate</span></div><div class="casAuthors">Luka, Zigmund; Pakhomova, Svetlana; Loukachevitch, Lioudmila V.; Calcutt, M. Wade; Newcomer, Marcia E.; Wagner, Conrad</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">993-998</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">An important epigenetic modification is the methylation/demethylation of histone lysine residues.  The first histone demethylase to be discovered was a lysine-specific demethylase 1, LSD1, a flavin contg. enzyme which carries out the demethylation of di- and monomethyllysine 4 in histone H3.  The removed Me groups are oxidized to formaldehyde.  This reaction is similar to those performed by dimethylglycine dehydrogenase and sarcosine dehydrogenase, in which protein-bound tetrahydrofolate (THF) was proposed to serve as an acceptor of the generated formaldehyde.  The authors showed earlier that LSD1 binds THF with high affinity which suggests its possible participation in the histone demethylation reaction.  In the cell, LSD1 interacts with co-repressor for repressor element 1 silencing transcription factor (CoREST).  In order to elucidate the role of folate in the demethylating reaction the authors solved the crystal structure of the LSD1-CoREST-THF complex.  In the complex, the folate-binding site is located in the active center in close proximity to FAD.  This position of the folate suggests that the bound THF accepts the formaldehyde generated in the course of histone demethylation to form 5,10-methylene-THF.  The authors also show the formation of 5,10-methylene-THF during the course of the enzymic reaction in the presence of THF by mass spectrometry.  Prodn. of this form of folate could act to prevent accumulation of potentially toxic formaldehyde in the cell.  These studies suggest that folate may play a role in the epigenetic control of gene expression in addn. to its traditional role in the transfer of one-carbon units in metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_2NE_odCJR7Vg90H21EOLACvtfcHk0lgHXxKyA3t-cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL%252FE&md5=d4330f49c208bee3e42b426c9f39680f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fpro.2469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.2469%26sid%3Dliteratum%253Aachs%26aulast%3DLuka%26aufirst%3DZ.%26aulast%3DPakhomova%26aufirst%3DS.%26aulast%3DLoukachevitch%26aufirst%3DL.%2BV.%26aulast%3DCalcutt%26aufirst%3DM.%2BW.%26aulast%3DNewcomer%26aufirst%3DM.%2BE.%26aulast%3DWagner%26aufirst%3DC.%26atitle%3DCrystal%2520structure%2520of%2520the%2520histone%2520lysine%2520specific%2520demethylase%2520LSD1%2520complexed%2520with%2520tetrahydrofolate%26jtitle%3DProtein%2520Sci.%26date%3D2014%26volume%3D23%26spage%3D993%26epage%3D998%26doi%3D10.1002%2Fpro.2469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1749</span><span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lgHXxKyA3t-cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KUM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KUM','PDB','4KUM'); return false;">PDB: 4KUM</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i75"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00462">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_24328"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00462">10.1021/acs.jmedchem.7b00462</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">SPR sensorgrams for selected compounds; LC-MS methods and solvent gradients; preparative HPLC instrument and solvent gradients; summary of purity data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00462/suppl_file/jm7b00462_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00462/suppl_file/jm7b00462_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00462/suppl_file/jm7b00462_si_001.pdf">jm7b00462_si_001.pdf (360.62 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00462/suppl_file/jm7b00462_si_002.csv">jm7b00462_si_002.csv (2.46 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00462&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00462%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-19%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00462" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799945d1b981252","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
